[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

WO2022225340A1 - Compound for organic optoelectronic element, composition for organic optoelectronic element including same, organic optoelectronic element, and display device - Google Patents

Compound for organic optoelectronic element, composition for organic optoelectronic element including same, organic optoelectronic element, and display device Download PDF

Info

Publication number
WO2022225340A1
WO2022225340A1 PCT/KR2022/005689 KR2022005689W WO2022225340A1 WO 2022225340 A1 WO2022225340 A1 WO 2022225340A1 KR 2022005689 W KR2022005689 W KR 2022005689W WO 2022225340 A1 WO2022225340 A1 WO 2022225340A1
Authority
WO
WIPO (PCT)
Prior art keywords
formula
group
substituted
unsubstituted
compound
Prior art date
Application number
PCT/KR2022/005689
Other languages
French (fr)
Korean (ko)
Inventor
강동민
이남헌
장기포
정성현
서주희
최종우
박준모
정호국
권지윤
서한솔
Original Assignee
삼성에스디아이 주식회사
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from KR1020220048304A external-priority patent/KR20220146332A/en
Application filed by 삼성에스디아이 주식회사 filed Critical 삼성에스디아이 주식회사
Priority to CN202280030104.XA priority Critical patent/CN117203190A/en
Publication of WO2022225340A1 publication Critical patent/WO2022225340A1/en

Links

Images

Classifications

    • HELECTRICITY
    • H10SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
    • H10KORGANIC ELECTRIC SOLID-STATE DEVICES
    • H10K50/00Organic light-emitting devices
    • H10K50/10OLEDs or polymer light-emitting diodes [PLED]
    • H10K50/11OLEDs or polymer light-emitting diodes [PLED] characterised by the electroluminescent [EL] layers
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D251/00Heterocyclic compounds containing 1,3,5-triazine rings
    • C07D251/02Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings
    • C07D251/12Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D251/14Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hydrogen or carbon atoms directly attached to at least one ring carbon atom
    • C07D251/24Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hydrogen or carbon atoms directly attached to at least one ring carbon atom to three ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/04Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02EREDUCTION OF GREENHOUSE GAS [GHG] EMISSIONS, RELATED TO ENERGY GENERATION, TRANSMISSION OR DISTRIBUTION
    • Y02E10/00Energy generation through renewable energy sources
    • Y02E10/50Photovoltaic [PV] energy
    • Y02E10/549Organic PV cells

Definitions

  • It relates to a compound for an organic optoelectronic device, a composition for an organic optoelectronic device, an organic optoelectronic device, and a display device.
  • An organic optoelectronic diode is a device capable of converting electrical energy and optical energy.
  • Organic optoelectronic devices can be roughly divided into two types according to their operating principles.
  • One is a photoelectric device that generates electrical energy as excitons formed by light energy are separated into electrons and holes, and electrons and holes are transferred to different electrodes, and the other is electrical energy by supplying voltage or current to the electrode
  • It is a light emitting device that generates light energy from
  • Examples of the organic optoelectronic device include an organic optoelectronic device, an organic light emitting device, an organic solar cell, and an organic photo conductor drum.
  • organic light emitting diodes have recently attracted much attention due to an increase in demand for flat panel display devices.
  • An organic light emitting device is a device that converts electrical energy into light, and the performance of the organic light emitting device is greatly affected by an organic material positioned between electrodes.
  • One embodiment provides a compound for an organic optoelectronic device capable of realizing a high-efficiency and long-life organic optoelectronic device.
  • Another embodiment provides a composition for an organic optoelectronic device comprising the compound.
  • Another embodiment provides an organic optoelectronic device including the compound.
  • Another embodiment provides a display device including the organic optoelectronic device.
  • a compound for an organic optoelectronic device represented by the following formula (1).
  • Z 1 to Z 3 are each independently N or CR a ,
  • At least two of Z 1 to Z 3 are N,
  • L 1 to L 3 are each independently a single bond, or a substituted or unsubstituted C6 to C30 arylene group,
  • Ar 1 and Ar 2 are each independently a substituted or unsubstituted C6 to C30 aryl group or a substituted or unsubstituted C2 to C30 heterocyclic group,
  • R a and R 1 to R 4 are each independently hydrogen, deuterium, a substituted or unsubstituted C1 to C20 alkyl group, or a substituted or unsubstituted C6 to C20 aryl group,
  • n1 is one of integers from 1 to 3
  • n2 and n3 are each independently an integer of 1 or 2
  • n4 is one of integers from 1 to 4.
  • composition for an organic optoelectronic device comprising a first compound and a second compound.
  • the first compound may be the compound for an organic optoelectronic device described above, and the second compound may be represented by Formula 2 below.
  • X 1 is O, S, NR b , CR c R d or SiR e R f ,
  • R b , R c , R d , Re , R f , R 7 and R 8 are each independently hydrogen, deuterium, a substituted or unsubstituted amine group, a substituted or unsubstituted C1 to C30 alkyl group, a substituted or unsubstituted a C6 to C30 aryl group or a substituted or unsubstituted C2 to C30 heterocyclic group,
  • n5 is one of integers from 1 to 4,
  • Ring A is any one selected from the rings listed in Group II,
  • X 2 is O, S, NR g , CR h R i or SiR j R k ,
  • R g , R h , R i , R j , R k , and R 6 to R 10 are each independently hydrogen, deuterium, a substituted or unsubstituted amine group, a substituted or unsubstituted C1 to C30 alkyl group, a substituted or unsubstituted a cyclic C6 to C30 aryl group or a substituted or unsubstituted C2 to C30 heterocyclic group,
  • n6, n8 and n10 are each independently one of an integer of 1 to 4,
  • n7 and n9 are each independently an integer of 1 or 2
  • At least one of R 5 to R 10 is a group represented by the following formula (a),
  • L 4 To L 6 are each independently a single bond, or a substituted or unsubstituted C6 to C30 arylene group,
  • Ar 3 and Ar 4 are each independently a substituted or unsubstituted amine group, a substituted or unsubstituted C6 to C30 aryl group, or a substituted or unsubstituted C2 to C30 heterocyclic group,
  • it includes an anode and a cathode facing each other, and at least one organic layer positioned between the anode and the cathode, wherein the organic layer comprises the compound for an organic optoelectronic device or a composition for an organic optoelectronic device An organic optoelectronic device is provided.
  • a display device including the organic optoelectronic device is provided.
  • a high-efficiency, long-life organic optoelectronic device can be realized.
  • FIG. 1 is a cross-sectional view illustrating an organic light emitting diode according to an exemplary embodiment.
  • At least one hydrogen in a substituent or compound is deuterium, a halogen group, a hydroxyl group, an amino group, a substituted or unsubstituted C1 to C30 amine group, a nitro group, a substituted or Unsubstituted C1 to C40 silyl group, C1 to C30 alkyl group, C1 to C10 alkylsilyl group, C6 to C30 arylsilyl group, C3 to C30 cycloalkyl group, C3 to C30 heterocycloalkyl group, C6 to C30 aryl group, C2 to C30 It means substituted with a heteroaryl group, a C1 to C20 alkoxy group, a C1 to C10 trifluoroalkyl group, a cyano group, or a combination thereof.
  • substitution means that at least one hydrogen in a substituent or compound is deuterium, C1 to C30 alkyl group, C1 to C10 alkylsilyl group, C6 to C30 arylsilyl group, C3 to C30 cycloalkyl group, C3 to C30 It means substituted with a heterocycloalkyl group, a C6 to C30 aryl group, a C2 to C30 heteroaryl group, or a cyano group.
  • substitution means that at least one hydrogen in a substituent or compound is substituted with deuterium, a C1 to C20 alkyl group, a C6 to C30 aryl group, or a cyano group.
  • substitution means that at least one hydrogen in a substituent or compound is substituted with deuterium, a C1 to C5 alkyl group, a C6 to C18 aryl group, or a cyano group.
  • substitution means that at least one hydrogen in a substituent or compound is substituted with deuterium, a cyano group, a methyl group, an ethyl group, a propyl group, a butyl group, a phenyl group, a biphenyl group, a terphenyl group or a naphthyl group means it has been
  • hetero means that one functional group contains 1 to 3 heteroatoms selected from the group consisting of N, O, S, P and Si, and the remainder is carbon. .
  • aryl group is a concept that encompasses a group having one or more hydrocarbon aromatic moieties, and all elements of the hydrocarbon aromatic moiety have p-orbitals, and these p-orbitals are conjugated.
  • It contains a form that forms, for example, a phenyl group, a naphthyl group, etc., and includes a form in which two or more hydrocarbon aromatic moieties are connected through a sigma bond, such as a biphenyl group, a terphenyl group, a quaterphenyl group, etc., and two or more hydrocarbon aromatic moieties They may include a fused non-aromatic fused ring, such as a fluorenyl group, directly or indirectly.
  • Aryl groups include monocyclic, polycyclic or fused ring polycyclic (ie, rings that share adjacent pairs of carbon atoms) functional groups.
  • heterocyclic group is a higher concept including a heteroaryl group, and instead of carbon (C), N, O, It means containing at least one hetero atom selected from the group consisting of S, P and Si.
  • C carbon
  • N nitrogen
  • O oxygen
  • the heterocyclic group is a fused ring, the entire heterocyclic group or each ring may include one or more heteroatoms.
  • heteroaryl group means containing at least one hetero atom selected from the group consisting of N, O, S, P and Si in the aryl group.
  • Two or more heteroaryl groups may be directly connected through a sigma bond, or when the heteroaryl group includes two or more rings, the two or more rings may be fused to each other.
  • each ring may include 1 to 3 heteroatoms.
  • a substituted or unsubstituted C6 to C30 aryl group includes a substituted or unsubstituted phenyl group, a substituted or unsubstituted naphthyl group, a substituted or unsubstituted anthracenyl group, a substituted or unsubstituted phenanthrenyl group, a substituted or Unsubstituted naphthacenyl group, substituted or unsubstituted pyrenyl group, substituted or unsubstituted biphenyl group, substituted or unsubstituted p-terphenyl group, substituted or unsubstituted m-terphenyl group, substituted or unsubstituted o- Terphenyl group, substituted or unsubstituted chrysenyl group, substituted or unsubstituted triphenylene group, substituted or unsubstituted perylenyl group, substituted or un
  • a substituted or unsubstituted C2 to C30 heterocyclic group is a substituted or unsubstituted thiophenyl group, a substituted or unsubstituted pyrrolyl group, a substituted or unsubstituted pyrazolyl group, a substituted or unsubstituted imidazolyl group, A substituted or unsubstituted triazolyl group, a substituted or unsubstituted oxazolyl group, a substituted or unsubstituted thiazolyl group, a substituted or unsubstituted oxadiazolyl group, a substituted or unsubstituted thiadiazolyl group, a substituted or unsubstituted A substituted or unsubstituted pyrimidinyl group, a substituted or unsubstituted pyrazinyl group, a substituted or unsubstituted triazinyl group,
  • hydrofluorescence substitution may include “deuterium substitution (-D)” or “tritium substitution (-T)".
  • the hole property refers to a property capable of forming a hole by donating electrons when an electric field is applied. It refers to a property that facilitates the movement of holes formed in the anode and in the light emitting layer.
  • the electronic property refers to a property that can receive electrons when an electric field is applied. It has conduction properties along the LUMO level, so electrons formed in the cathode are injected into the light emitting layer, electrons formed in the light emitting layer are moved to the cathode, and in the light emitting layer. properties that facilitate movement.
  • the compound for an organic optoelectronic device according to an embodiment is represented by the following Chemical Formula 1.
  • Z 1 to Z 3 are each independently N or CR a ,
  • At least two of Z 1 to Z 3 are N,
  • L 1 to L 3 are each independently a single bond, or a substituted or unsubstituted C6 to C30 arylene group,
  • Ar 1 and Ar 2 are each independently a substituted or unsubstituted C6 to C30 aryl group or a substituted or unsubstituted C2 to C30 heterocyclic group,
  • R a and R 1 to R 4 are each independently hydrogen, deuterium, a substituted or unsubstituted C1 to C20 alkyl group, or a substituted or unsubstituted C6 to C20 aryl group,
  • n1 is one of integers from 1 to 3
  • n2 and n3 are each independently an integer of 1 or 2
  • n4 is one of integers from 1 to 4.
  • the compound represented by Formula 1 has a structure in which pyrimidine or triazine is substituted in the core to which phenyl is further fused at positions 1 and 2 of phenanthrene.
  • the length of the conjugation becomes longer compared to that linked to the center, and thus the molecule is stabilized, thereby having the effect of long life.
  • Formula 1 may be represented by any one of the following Formulas 1-1 to 1-4 according to a specific substitution point of the triazine.
  • Z 1 to Z 3 , L 1 to L 3 , Ar 1 , Ar 2 , R 1 to R 4 and n1 to n4 are the same as described above.
  • L 1 to L 3 may each independently be a single bond, a substituted or unsubstituted phenylene group, or a substituted or unsubstituted naphthylene group.
  • Ar 1 and Ar 2 are each independently a substituted or unsubstituted phenyl group, a substituted or unsubstituted biphenyl group, a substituted or unsubstituted naphthyl group, a substituted or unsubstituted phenanthrenyl group, a substituted or unsubstituted A substituted or unsubstituted carbazolyl group, a substituted or unsubstituted carbazolyl group, a substituted or unsubstituted dibenzofuranyl group, a substituted or unsubstituted dibenzothiophenyl group, a substituted or unsubstituted dibenzosilolyl group, or a substituted or unsubstituted It may be a benzonaphthofuranyl group.
  • Ar 1 and Ar 2 are each independently a substituted or unsubstituted phenyl group, a substituted or unsubstituted naphthyl group, a substituted or unsubstituted carbazolyl group, a substituted or unsubstituted dibenzofuranyl group, It may be a substituted or unsubstituted dibenzothiophenyl group or a substituted or unsubstituted benzonaphthofuranyl group.
  • *-L 2 -Ar 1 and *-L 3 -Ar 2 may each independently be selected from the substituents listed in Group I below.
  • n11 is one of integers from 1 to 5
  • n12 is one of integers from 1 to 4,
  • n13 is one of integers from 1 to 3
  • the compound for an organic optoelectronic device represented by Formula 1 may be one selected from the compounds listed in Group 1 below, but is not limited thereto.
  • composition for an organic optoelectronic device includes a first compound and a second compound, wherein the first compound is the above-described compound for an organic optoelectronic device, and the second compound may be represented by the following Chemical Formula 2 have.
  • X 1 is O, S, NR b , CR c R d or SiR e R f ,
  • R b , R c , R d , R e , R f and R 5 are each independently hydrogen, deuterium, a substituted or unsubstituted amine group, a substituted or unsubstituted C1 to C30 alkyl group, a substituted or unsubstituted C6 to a C30 aryl group or a substituted or unsubstituted C2 to C30 heterocyclic group,
  • n5 is one of integers from 1 to 4,
  • Ring A is any one selected from the rings listed in Group II,
  • X 2 is O, S, NR g , CR h R i or SiR j R k ,
  • R g , R h , R i , R j , R k , and R 6 to R 10 are each independently hydrogen, deuterium, a substituted or unsubstituted amine group, a substituted or unsubstituted C1 to C30 alkyl group, a substituted or unsubstituted a cyclic C6 to C30 aryl group or a substituted or unsubstituted C2 to C30 heterocyclic group,
  • n6, n8 and n10 are each independently one of an integer of 1 to 4,
  • n7 and n9 are each independently an integer of 1 or 2
  • At least one of R 5 to R 10 is a group represented by the following formula (a),
  • L 4 To L 6 are each independently a single bond, or a substituted or unsubstituted C6 to C30 arylene group,
  • Ar 3 and Ar 4 are each independently a substituted or unsubstituted amine group, a substituted or unsubstituted C6 to C30 aryl group, or a substituted or unsubstituted C2 to C30 heterocyclic group,
  • the second compound may have a structure in which an amine is substituted for carbazole / fused carbazole / fused dibenzofuran / fused dibenzothiophene / fused dibenzosilol, depending on the type and fusion position of the additional benzene ring, for example, the following formula It may be represented by any one of 2-I to Formula 2-X.
  • X 1 , X 2 , R 5 to R 10 and n5 to n10 are the same as described above.
  • the second compound may be represented by any one of the following Chemical Formulas 2-IA to 2-XA, Formula 2-IIB to Formula 2-IVB, and Formula 2-IIC to Formula 2-IXC have.
  • X 1 , X 2 , L 4 to L 6 , Ar 3 , Ar 4 , and n6 to n10 are the same as described above,
  • n5 is one of integers from 1 to 3.
  • n8 is one of integers from 1 to 3.
  • n7 is 1.
  • X 1 , X 2 , L 4 to L 6 , Ar 3 , Ar 4 , n5 and n10 are the same as described above,
  • n9 is 1.
  • R 5 to R 10 are each independently hydrogen, deuterium, a substituted or unsubstituted C1 to C30 alkyl group, or a substituted or unsubstituted C6 to C30 aryl group.
  • the second compound according to an embodiment may be represented by Formula 2-IVB or Formula 2-VIIIB.
  • X 1 in Formula 2-IVB may be NR b .
  • X 1 may be CR c R d or SiR e R f
  • X 2 may be O or S.
  • R b , R c , R d , R e and R f may each independently represent a substituted or unsubstituted C1 to C10 alkyl group, or a substituted or unsubstituted C6 to C20 aryl group.
  • the second compound according to a specific embodiment may be represented by the following Chemical Formula 2-IVB-2 or 2-VIIIB-2.
  • L 4 To L 6 are each independently a single bond or a substituted or unsubstituted phenylene group
  • Ar 3 and Ar 4 are each independently a substituted or unsubstituted phenyl group, a substituted or unsubstituted biphenyl group, or a substituted or unsubstituted naphthyl group,
  • R 5 , and R 7 to R 10 are each independently hydrogen, deuterium, a substituted or unsubstituted C1 to C30 alkyl group, or a substituted or unsubstituted C6 to C30 aryl group,
  • n7 and n9 are each independently an integer of 1 or 2
  • n8 and n10 are each independently one of an integer of 1 to 3,
  • X 1 is NR b , O or S
  • n5 of Formula 2-IVB-2 is one of integers from 1 to 4,
  • X 1 is CR c R d or SiR e R f ,
  • X 2 of Formula 2-VIIIA-2 is O or S
  • n5 in Formula 2-VIIIA-2 is one of integers from 1 to 3,
  • R b , R c , R d , R e and R f are each independently a substituted or unsubstituted C1 to C30 alkyl group, or a substituted or unsubstituted C6 to C30 aryl group.
  • L 5 and L 6 may each independently represent a single bond, a substituted or unsubstituted phenylene group, or a substituted or unsubstituted biphenylene group.
  • Ar 3 and Ar 4 are each independently a substituted or unsubstituted phenyl group, a substituted or unsubstituted biphenyl group, a substituted or unsubstituted terphenyl group, a substituted or unsubstituted naphthyl group, or a substituted or unsubstituted phenantre A nyl group, a substituted or unsubstituted triphenylene group, a substituted or unsubstituted fluorenyl group, a substituted or unsubstituted carbazolyl group, a substituted or unsubstituted dibenzofuranyl group, a substituted or unsubstituted dibenzothiophenyl group, It may be a substituted or unsubstituted benzofuranofluorenyl group, or a substituted or unsubstituted benzothiophenefluorenyl group.
  • the second compound may be one selected from the compounds listed in Group 2, but is not limited thereto.
  • the first compound and the second compound may be included, for example, in a weight ratio of 1:99 to 99:1.
  • a weight ratio of 1:99 to 99:1 By being included in the above range, it is possible to implement bipolar characteristics by matching an appropriate weight ratio using the electron transport ability of the first compound and the hole transport ability of the second compound to improve efficiency and lifespan.
  • it may be included in a weight ratio of about 10:90 to 90:10, about 20:80 to 80:20, such as about 20:80 to about 70:30, about 20:80 to about 60:40, And it may be included in a weight ratio of about 30:70 to about 60:40.
  • it may be included in a weight ratio of 40:60, 50:50, or 60:40.
  • the compound for an organic optoelectronic device or the composition for an organic optoelectronic device described above may be a composition further comprising a dopant.
  • the dopant may be for example a phosphorescent dopant, for example a red, green or blue phosphorescent dopant, for example a red or green phosphorescent dopant.
  • a dopant is a material that emits light by being mixed in a small amount in a compound or composition for an organic optoelectronic device.
  • a material such as a metal complex that emits light by multiple excitation excitation to a triplet state or more may be used.
  • the dopant may be, for example, an inorganic, organic, or organic-inorganic compound, and may include one or two or more kinds.
  • Examples of the dopant include a phosphorescent dopant, and examples of the phosphorescent dopant include Ir, Pt, Os, Ti, Zr, Hf, Eu, Tb, Tm, Fe, Co, Ni, Ru, Rh, Pd, or a combination thereof. and organometallic compounds containing them.
  • the phosphorescent dopant may be, for example, a compound represented by the following Chemical Formula Z, but is not limited thereto.
  • M is a metal
  • L 7 and X 3 are the same as or different from each other and are ligands forming a complex with M.
  • M may be, for example, Ir, Pt, Os, Ti, Zr, Hf, Eu, Tb, Tm, Fe, Co, Ni, Ru, Rh, Pd or a combination thereof, and L 7 and X 3 are, for example, bi It may be a dentate ligand.
  • Examples of the ligands represented by L 7 and X 3 may be selected from the formulas listed in Group A, but are not limited thereto.
  • R 300 to R 302 are each independently hydrogen, deuterium, a halogen substituted or unsubstituted C1 to C30 alkyl group, a C1 to C30 alkyl substituted or unsubstituted C6 to C30 aryl group or halogen,
  • R 303 to R 324 are each independently hydrogen, deuterium, halogen, a substituted or unsubstituted C1 to C30 alkyl group, a substituted or unsubstituted C1 to C30 alkoxy group, a substituted or unsubstituted C3 to C30 cycloalkyl group, substituted or an unsubstituted C2 to C30 alkenyl group, a substituted or unsubstituted C6 to C30 aryl group, a substituted or unsubstituted C1 to C30 heteroaryl group, a substituted or unsubstituted C1 to C30 amino group, a substituted or unsubstituted C6 to C30 arylamino group, SF 5 , a trialkylsilyl group having a substituted or unsubstituted C1 to C30 alkyl group, a dialkylarylsilyl group having a substituted or unsubstituted C1 to C30
  • it may include a dopant represented by the following Chemical Formula V.
  • R 101 to R 116 are each independently hydrogen, deuterium, a substituted or unsubstituted C1 to C10 alkyl group, a substituted or unsubstituted C6 to C20 aryl group, or —SiR 132 R 133 R 134 ;
  • R 132 to R 134 are each independently a C1 to C6 alkyl group
  • At least one of R 101 to R 116 is a functional group represented by the following formula IV-1,
  • L 100 is a bidentate ligand of a monovalent anion, and is a ligand that coordinates to iridium through a lone pair of electrons of carbon or heteroatom,
  • n1 and m2 are each independently any one of an integer of 0 to 3
  • m1 + m2 is any one of an integer of 1 to 3
  • R 135 to R 139 are each independently hydrogen, deuterium, a substituted or unsubstituted C1 to C10 alkyl group, a substituted or unsubstituted C6 to C20 aryl group, or —SiR 132 R 133 R 134 ;
  • a dopant represented by the following Chemical Formula Z-1 may be included.
  • rings A, B, C, and D each independently represent a 5- or 6-membered carbocyclic or heterocyclic ring;
  • R A , RB , R C , and R D each independently represent mono-, di-, tri-, or tetra-substituted, or unsubstituted;
  • R A , RB , R C , R D , R , and R' are each hydrogen, deuterium, halogen, an alkyl group, a cycloalkyl group, a heteroalkyl group, an arylalkyl group, an alkoxy group, an aryloxy group, an amino group, a silyl group, an alkenyl group , cycloalkenyl group, heteroalkenyl group, alkynyl group, aryl group, heteroaryl group, acyl group, carbonyl group, carboxylic acid group, ester group, nitrile group, isonitrile group, sulfanyl group, sulfinyl group, sulfonyl group, phosphino group independently selected from the group consisting of , and combinations thereof; any adjacent R A , R B , R C , R D , R , and R′ are optionally joined to form a ring; X B , X C
  • the dopant according to an embodiment may be a platinum complex, for example, it may be represented by the following Chemical Formula VI.
  • X 100 is selected from O, S and NR 131 ,
  • R 117 to R 131 are each independently hydrogen, deuterium, a substituted or unsubstituted C1 to C10 alkyl group, a substituted or unsubstituted C6 to C20 aryl group, or —SiR 132 R 133 R 134 ;
  • R 132 to R 134 are each independently a C1 to C6 alkyl group
  • At least one of R 117 to R 131 is -SiR 132 R 133 R 134 or a tert-butyl group.
  • the organic optoelectronic device is not particularly limited as long as it is a device capable of converting electrical energy and optical energy, and examples thereof include an organic photoelectric device, an organic light emitting device, an organic solar cell, and an organic photosensitive drum.
  • FIG. 1 is a cross-sectional view illustrating an organic light emitting diode according to an exemplary embodiment.
  • an organic light emitting device 100 includes an anode 120 and a cathode 110 facing each other, and an organic layer 105 positioned between the anode 120 and the cathode 110 .
  • the anode 120 may be made of, for example, a conductor having a high work function to facilitate hole injection, and may be made of, for example, a metal, a metal oxide, and/or a conductive polymer.
  • the anode 120 may include, for example, a metal such as nickel, platinum, vanadium, chromium, copper, zinc, gold, or an alloy thereof; metal oxides such as zinc oxide, indium oxide, indium tin oxide (ITO), and indium zinc oxide (IZO); combinations of metals and oxides such as ZnO and Al or SnO 2 and Sb; conductive polymers such as poly(3-methylthiophene), poly(3,4-(ethylene-1,2-dioxy)thiophene) (polyehtylenedioxythiophene: PEDOT), polypyrrole, and polyaniline, but the present invention is not limited thereto. it is not
  • the cathode 110 may be made of, for example, a conductor having a low work function to facilitate electron injection, and may be made of, for example, a metal, a metal oxide, and/or a conductive polymer.
  • the negative electrode 110 may include, for example, a metal such as magnesium, calcium, sodium, potassium, titanium, indium, yttrium, lithium, gadolinium, aluminum, silver, tin, lead, cesium, barium, or an alloy thereof; and a multilayer structure material such as LiF/Al, LiO 2 /Al, LiF/Ca, LiF/Al, and BaF 2 /Ca, but is not limited thereto.
  • the organic layer 105 may include the aforementioned compound for an organic optoelectronic device or a composition for an organic optoelectronic device.
  • the organic layer 105 may include the emission layer 130 , and the emission layer 130 may include the aforementioned compound for an organic optoelectronic device or a composition for an organic optoelectronic device.
  • composition for an organic optoelectronic device further comprising a dopant may be, for example, a red light-emitting composition.
  • the emission layer 130 may include, for example, the above-described first compound for an organic optoelectronic device and the second compound for an organic optoelectronic device, respectively, as a phosphorescent host.
  • the organic layer may further include a charge transport region in addition to the emission layer.
  • the charge transport region may be, for example, the hole transport region 140 .
  • the hole transport region 140 may further increase hole injection and/or hole mobility between the anode 120 and the emission layer 130 and block electrons.
  • the hole transport region 140 may include a hole transport layer between the anode 120 and the light emitting layer 130 and a hole transport auxiliary layer between the light emitting layer 130 and the hole transport layer. At least one of the listed compounds may be included in at least one of the hole transport layer and the hole transport auxiliary layer.
  • the charge transport region may be, for example, the electron transport region 150 .
  • the electron transport region 150 may further increase electron injection and/or electron mobility between the cathode 110 and the emission layer 130 and block holes.
  • the electron transport region 150 may include an electron transport layer between the cathode 110 and the light emitting layer 130, and an electron transport auxiliary layer between the light emitting layer 130 and the electron transport layer. At least one of the listed compounds may be included in at least one of the electron transport layer and the electron transport auxiliary layer.
  • One embodiment may be an organic light emitting device including a light emitting layer as an organic layer.
  • Another embodiment may be an organic light emitting device including a light emitting layer and a hole transport region as an organic layer.
  • Another embodiment may be an organic light emitting device including a light emitting layer and an electron transport region as an organic layer.
  • the organic light emitting device may include a hole transport region 140 and an electron transport region 150 in addition to the emission layer 130 as the organic layer 105 .
  • the organic light emitting device may further include an electron injection layer (not shown), a hole injection layer (not shown), etc. in addition to the light emitting layer as the above-described organic layer.
  • the organic light emitting device 100 After forming an anode or cathode on a substrate, the organic light emitting device 100 forms an organic layer by a dry film deposition method such as vacuum deposition, sputtering, plasma plating and ion plating, etc., and then a cathode or a It can be manufactured by forming an anode.
  • a dry film deposition method such as vacuum deposition, sputtering, plasma plating and ion plating, etc.
  • the above-described organic light emitting device may be applied to an organic light emitting display device.
  • a glass substrate coated with a thin film of ITO Indium tin oxide was washed with distilled water and ultrasonic waves. After washing with distilled water, ultrasonic cleaning was performed with a solvent such as isopropyl alcohol, acetone, methanol, etc., dried and transferred to a plasma cleaner. After cleaning the substrate using oxygen plasma for 10 minutes, the substrate was transferred to a vacuum evaporator.
  • compound A doped with 3% NDP-9 commercially available from Novaled was vacuum-deposited on the top of the ITO substrate to form a hole injection layer with a thickness of 100 ⁇ , and Compound A was deposited thereon to a thickness of 1300 ⁇ to form a hole transport layer.
  • Compound B was deposited on the hole transport layer to a thickness of 700 ⁇ to form a hole transport auxiliary layer.
  • Compound 32 obtained in Synthesis Example 3 was used as a host on the hole transport auxiliary layer, and [Ir(piq) 2 acac] was doped at 2 wt% as a dopant to form an emission layer with a thickness of 400 ⁇ by vacuum deposition.
  • compound C was deposited on the light emitting layer to a thickness of 50 ⁇ to form an electron transport auxiliary layer, and compound D and Liq were simultaneously vacuum deposited at a weight ratio of 1:1 to form an electron transport layer having a thickness of 300 ⁇ .
  • An organic light emitting diode was manufactured by sequentially vacuum-depositing 15 ⁇ of LiQ and 1,200 ⁇ of Al on the electron transport layer to form a cathode.
  • the organic light emitting device has a structure having a five-layer organic thin film layer, specifically as follows.
  • the host was changed as shown in Table 3 below, and the first host and the second host were mixed in a weight ratio of 5:5, and in Examples 9 to 20 and Comparative Examples 4 to 6 in the same manner as in Example 1 above.
  • the device was fabricated.
  • the current flowing through the unit device was measured using a current-voltmeter (Keithley 2400) while the voltage was increased from 0V to 10V, and the measured current value was divided by the area to obtain a result.
  • the luminance was measured at that time using a luminance meter (Minolta Cs-1000A) while increasing the voltage from 0V to 10V, and results were obtained.
  • the current efficiency (cd/A) of the same current density (10 mA/cm 2 ) was calculated using the luminance, current density, and voltage measured from (1) and (2) above.
  • the devices of Examples 1 to 20 and Comparative Examples 1 to 6 emit light at an initial luminance (cd/m 2 ) of 6,000 cd/m 2 using a polaronics lifetime measurement system, and time elapses The time when the luminance decreased to 95% compared to the initial luminance was measured as the T95 lifetime.

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Optics & Photonics (AREA)
  • Electroluminescent Light Sources (AREA)

Abstract

The present invention relates to: a compound for an organic optoelectronic element, wherein the compound is represented by chemical formula 1; a composition for an organic optoelectronic element, wherein the composition includes the compound; an organic optoelectronic element; and a display device. Chemical formula 1 is as defined in the specification.

Description

유기 광전자 소자용 화합물, 유기 광전자 소자용 조성물, 유기 광전자 소자 및 표시 장치Compound for organic optoelectronic device, composition for organic optoelectronic device, organic optoelectronic device and display device
유기 광전자 소자용 화합물, 유기 광전자 소자용 조성물, 유기 광전자 소자 및 표시 장치에 관한 것이다.It relates to a compound for an organic optoelectronic device, a composition for an organic optoelectronic device, an organic optoelectronic device, and a display device.
유기 광전자 소자(organic optoelectronic diode)는 전기 에너지와 광 에너지를 상호 전환할 수 있는 소자이다.An organic optoelectronic diode is a device capable of converting electrical energy and optical energy.
유기 광전자 소자는 동작 원리에 따라 크게 두 가지로 나눌 수 있다. 하나는 광 에너지에 의해 형성된 엑시톤(exciton)이 전자와 정공으로 분리되고 전자와 정공이 각각 다른 전극으로 전달되면서 전기 에너지를 발생하는 광전 소자이고, 다른 하나는 전극에 전압 또는 전류를 공급하여 전기 에너지로부터 광 에너지를 발생하는 발광 소자이다. Organic optoelectronic devices can be roughly divided into two types according to their operating principles. One is a photoelectric device that generates electrical energy as excitons formed by light energy are separated into electrons and holes, and electrons and holes are transferred to different electrodes, and the other is electrical energy by supplying voltage or current to the electrode It is a light emitting device that generates light energy from
유기 광전자 소자의 예로는 유기 광전 소자, 유기 발광 소자, 유기 태양 전지 및 유기 감광체 드럼(organic photo conductor drum) 등을 들 수 있다. Examples of the organic optoelectronic device include an organic optoelectronic device, an organic light emitting device, an organic solar cell, and an organic photo conductor drum.
이 중, 유기 발광 소자(organic light emitting diode, OLED)는 근래 평판 표시 장치(flat panel display device)의 수요 증가에 따라 크게 주목받고 있다. 유기 발광 소자는 전기 에너지를 빛으로 전환시키는 소자로서, 유기 발광 소자의 성능은 전극 사이에 위치하는 유기 재료에 의해 많은 영향을 받는다. Among them, organic light emitting diodes (OLEDs) have recently attracted much attention due to an increase in demand for flat panel display devices. An organic light emitting device is a device that converts electrical energy into light, and the performance of the organic light emitting device is greatly affected by an organic material positioned between electrodes.
일 구현예는 고효율 및 장수명 유기 광전자 소자를 구현할 수 있는 유기 광전자 소자용 화합물을 제공한다.One embodiment provides a compound for an organic optoelectronic device capable of realizing a high-efficiency and long-life organic optoelectronic device.
다른 구현예는 상기 화합물을 포함하는 유기 광전자 소자용 조성물을 제공한다.Another embodiment provides a composition for an organic optoelectronic device comprising the compound.
또 다른 구현예는 상기 화합물을 포함하는 유기 광전자 소자를 제공한다.Another embodiment provides an organic optoelectronic device including the compound.
또 다른 구현예는 상기 유기 광전자 소자를 포함하는 표시 장치를 제공한다.Another embodiment provides a display device including the organic optoelectronic device.
일 구현예에 따르면, 하기 화학식 1로 표현되는 유기 광전자 소자용 화합물을 제공한다.According to one embodiment, there is provided a compound for an organic optoelectronic device represented by the following formula (1).
[화학식 1][Formula 1]
Figure PCTKR2022005689-appb-img-000001
Figure PCTKR2022005689-appb-img-000001
상기 화학식 1에서,In Formula 1,
Z1 내지 Z3은 각각 독립적으로 N 또는 CRa이고,Z 1 to Z 3 are each independently N or CR a ,
Z1 내지 Z3 중 적어도 둘은 N이고,At least two of Z 1 to Z 3 are N,
L1 내지 L3은 각각 독립적으로 단일 결합, 또는 치환 또는 비치환된 C6 내지 C30 아릴렌기이고,L 1 to L 3 are each independently a single bond, or a substituted or unsubstituted C6 to C30 arylene group,
Ar1 및 Ar2는 각각 독립적으로 치환 또는 비치환된 C6 내지 C30 아릴기 또는 치환 또는 비치환된 C2 내지 C30 헤테로고리기이고,Ar 1 and Ar 2 are each independently a substituted or unsubstituted C6 to C30 aryl group or a substituted or unsubstituted C2 to C30 heterocyclic group,
Ra 및 R1 내지 R4는 각각 독립적으로 수소, 중수소, 치환 또는 비치환된 C1 내지 C20 알킬기, 또는 치환 또는 비치환된 C6 내지 C20 아릴기이고,R a and R 1 to R 4 are each independently hydrogen, deuterium, a substituted or unsubstituted C1 to C20 alkyl group, or a substituted or unsubstituted C6 to C20 aryl group,
n1은 1 내지 3의 정수 중 하나이고,n1 is one of integers from 1 to 3,
n2 및 n3은 각각 독립적으로 1 또는 2의 정수이며,n2 and n3 are each independently an integer of 1 or 2,
n4는 1 내지 4의 정수 중 하나이다.n4 is one of integers from 1 to 4.
다른 구현예에 따르면, 제1 화합물, 및 제2 화합물을 포함하는 유기 광전자 소자용 조성물을 제공한다. According to another embodiment, there is provided a composition for an organic optoelectronic device comprising a first compound and a second compound.
상기 제1 화합물은 전술한 유기 광전자 소자용 화합물이며, 상기 제2 화합물은 하기 화학식 2로 표현될 수 있다.The first compound may be the compound for an organic optoelectronic device described above, and the second compound may be represented by Formula 2 below.
[화학식 2][Formula 2]
Figure PCTKR2022005689-appb-img-000002
Figure PCTKR2022005689-appb-img-000002
상기 화학식 2에서,In Formula 2,
X1은 O, S, NRb, CRcRd 또는 SiReRf이고,X 1 is O, S, NR b , CR c R d or SiR e R f ,
Rb, Rc, Rd, Re, Rf, R7 및 R8은 각각 독립적으로 수소, 중수소, 치환 또는 비치환된 아민기, 치환 또는 비치환된 C1 내지 C30 알킬기, 치환 또는 비치환된 C6 내지 C30 아릴기 또는 치환 또는 비치환된 C2 내지 C30 헤테로고리기이고,R b , R c , R d , Re , R f , R 7 and R 8 are each independently hydrogen, deuterium, a substituted or unsubstituted amine group, a substituted or unsubstituted C1 to C30 alkyl group, a substituted or unsubstituted a C6 to C30 aryl group or a substituted or unsubstituted C2 to C30 heterocyclic group,
n5는 1 내지 4의 정수 중 하나이고,n5 is one of integers from 1 to 4,
환 A는 하기 그룹 Ⅱ에 나열된 고리 중에서 선택되는 어느 하나이고,Ring A is any one selected from the rings listed in Group II,
[그룹 Ⅱ][Group II]
Figure PCTKR2022005689-appb-img-000003
Figure PCTKR2022005689-appb-img-000003
상기 그룹 Ⅱ에서,In group II,
*은 연결 지점이고,* is the connection point,
X2는 O, S, NRg, CRhRi 또는 SiRjRk이고,X 2 is O, S, NR g , CR h R i or SiR j R k ,
Rg, Rh, Ri, Rj, Rk, 및 R6 내지 R10은 각각 독립적으로 수소, 중수소, 치환 또는 비치환된 아민기, 치환 또는 비치환된 C1 내지 C30 알킬기, 치환 또는 비치환된 C6 내지 C30 아릴기 또는 치환 또는 비치환된 C2 내지 C30 헤테로고리기이고,R g , R h , R i , R j , R k , and R 6 to R 10 are each independently hydrogen, deuterium, a substituted or unsubstituted amine group, a substituted or unsubstituted C1 to C30 alkyl group, a substituted or unsubstituted a cyclic C6 to C30 aryl group or a substituted or unsubstituted C2 to C30 heterocyclic group,
n6, n8 및 n10은 각각 독립적으로 1 내지 4의 정수 중 하나이고,n6, n8 and n10 are each independently one of an integer of 1 to 4,
n7 및 n9는 각각 독립적으로 1 또는 2의 정수이고,n7 and n9 are each independently an integer of 1 or 2,
R5 내지 R10 중 적어도 하나는 하기 화학식 a로 표현되는 기이고,At least one of R 5 to R 10 is a group represented by the following formula (a),
[화학식 a][Formula a]
Figure PCTKR2022005689-appb-img-000004
Figure PCTKR2022005689-appb-img-000004
상기 화학식 a에서,In the above formula (a),
L4 내지 L6은 각각 독립적으로 단일 결합, 또는 치환 또는 비치환된 C6 내지 C30 아릴렌기이고,L 4 To L 6 are each independently a single bond, or a substituted or unsubstituted C6 to C30 arylene group,
Ar3 및 Ar4는 각각 독립적으로 치환 또는 비치환된 아민기, 치환 또는 비치환된 C6 내지 C30 아릴기, 또는 치환 또는 비치환된 C2 내지 C30 헤테로고리기이고,Ar 3 and Ar 4 are each independently a substituted or unsubstituted amine group, a substituted or unsubstituted C6 to C30 aryl group, or a substituted or unsubstituted C2 to C30 heterocyclic group,
*는 연결 지점이다.* is the connection point.
또 다른 구현예에 따르면, 서로 마주하는 양극과 음극, 상기 양극과 상기 음극 사이에 위치하는 적어도 1층의 유기층을 포함하고, 상기 유기층은 상기 유기 광전자 소자용 화합물 또는 유기 광전자 소자용 조성물을 포함하는 유기 광전자 소자를 제공한다.According to another embodiment, it includes an anode and a cathode facing each other, and at least one organic layer positioned between the anode and the cathode, wherein the organic layer comprises the compound for an organic optoelectronic device or a composition for an organic optoelectronic device An organic optoelectronic device is provided.
또 다른 구현예에 따르면, 상기 유기 광전자 소자를 포함하는 표시 장치를 제공한다.According to another embodiment, a display device including the organic optoelectronic device is provided.
고효율 장수명 유기 광전자 소자를 구현할 수 있다.A high-efficiency, long-life organic optoelectronic device can be realized.
도 1은 일 구현예에 따른 유기 발광 소자를 도시한 단면도이다.1 is a cross-sectional view illustrating an organic light emitting diode according to an exemplary embodiment.
<부호의 설명><Explanation of code>
100: 유기 발광 소자100: organic light emitting device
105: 유기층105: organic layer
110: 음극110: cathode
120: 양극120: positive electrode
130: 발광층130: light emitting layer
140: 정공 수송 영역140: hole transport region
150: 전자 수송 영역150: electron transport region
이하, 본 발명의 구현예를 상세히 설명하기로 한다. 다만, 이는 예시로서 제시되는 것으로, 이에 의해 본 발명이 제한되지는 않으며 본 발명은 후술할 청구범위의 범주에 의해 정의될 뿐이다.Hereinafter, embodiments of the present invention will be described in detail. However, this is provided as an example, and the present invention is not limited thereto, and the present invention is only defined by the scope of the claims to be described later.
본 명세서에서 "치환"이란 별도의 정의가 없는 한, 치환기 또는 화합물 중의 적어도 하나의 수소가 중수소, 할로겐기, 히드록실기, 아미노기, 치환 또는 비치환된 C1 내지 C30 아민기, 니트로기, 치환 또는 비치환된 C1 내지 C40 실릴기, C1 내지 C30 알킬기, C1 내지 C10 알킬실릴기, C6 내지 C30 아릴실릴기, C3 내지 C30 시클로알킬기, C3 내지 C30 헤테로시클로알킬기, C6 내지 C30 아릴기, C2 내지 C30 헤테로아릴기, C1 내지 C20 알콕시기, C1 내지 C10 트리플루오로알킬기, 시아노기, 또는 이들의 조합으로 치환된 것을 의미한다. As used herein, unless otherwise defined, at least one hydrogen in a substituent or compound is deuterium, a halogen group, a hydroxyl group, an amino group, a substituted or unsubstituted C1 to C30 amine group, a nitro group, a substituted or Unsubstituted C1 to C40 silyl group, C1 to C30 alkyl group, C1 to C10 alkylsilyl group, C6 to C30 arylsilyl group, C3 to C30 cycloalkyl group, C3 to C30 heterocycloalkyl group, C6 to C30 aryl group, C2 to C30 It means substituted with a heteroaryl group, a C1 to C20 alkoxy group, a C1 to C10 trifluoroalkyl group, a cyano group, or a combination thereof.
본 발명의 일 예에서, "치환"은 치환기 또는 화합물 중의 적어도 하나의 수소가 중수소, C1 내지 C30 알킬기, C1 내지 C10 알킬실릴기, C6 내지 C30 아릴실릴기, C3 내지 C30 시클로알킬기, C3 내지 C30 헤테로시클로알킬기, C6 내지 C30 아릴기, C2 내지 C30 헤테로아릴기, 또는 시아노기로 치환된 것을 의미한다. 또한, 본 발명의 구체적인 일 예에서, "치환"은 치환기 또는 화합물 중의 적어도 하나의 수소가 중수소, C1 내지 C20 알킬기, C6 내지 C30 아릴기, 또는 시아노기로 치환된 것을 의미한다. 또한, 본 발명의 구체적인 일 예에서, "치환"은 치환기 또는 화합물 중의 적어도 하나의 수소가 중수소, C1 내지 C5 알킬기, C6 내지 C18 아릴기, 시아노기로 치환된 것을 의미한다. 또한, 본 발명의 구체적인 일 예에서, "치환"은 치환기 또는 화합물 중의 적어도 하나의 수소가 중수소, 시아노기, 메틸기, 에틸기, 프로필기, 부틸기, 페닐기, 바이페닐기, 터페닐기 또는 나프틸기로 치환된 것을 의미한다. In one embodiment of the present invention, "substitution" means that at least one hydrogen in a substituent or compound is deuterium, C1 to C30 alkyl group, C1 to C10 alkylsilyl group, C6 to C30 arylsilyl group, C3 to C30 cycloalkyl group, C3 to C30 It means substituted with a heterocycloalkyl group, a C6 to C30 aryl group, a C2 to C30 heteroaryl group, or a cyano group. In addition, in a specific embodiment of the present invention, "substitution" means that at least one hydrogen in a substituent or compound is substituted with deuterium, a C1 to C20 alkyl group, a C6 to C30 aryl group, or a cyano group. In addition, in a specific embodiment of the present invention, "substitution" means that at least one hydrogen in a substituent or compound is substituted with deuterium, a C1 to C5 alkyl group, a C6 to C18 aryl group, or a cyano group. In addition, in a specific example of the present invention, "substitution" means that at least one hydrogen in a substituent or compound is substituted with deuterium, a cyano group, a methyl group, an ethyl group, a propyl group, a butyl group, a phenyl group, a biphenyl group, a terphenyl group or a naphthyl group means it has been
본 명세서에서 "헤테로"란 별도의 정의가 없는 한, 하나의 작용기 내에 N, O, S, P 및 Si로 이루어진 군에서 선택되는 헤테로 원자를 1 내지 3개 함유하고, 나머지는 탄소인 것을 의미한다.As used herein, unless otherwise defined, "hetero" means that one functional group contains 1 to 3 heteroatoms selected from the group consisting of N, O, S, P and Si, and the remainder is carbon. .
본 명세서에서 "아릴(aryl)기"는 탄화수소 방향족 모이어티를 하나 이상 갖는 그룹을 총괄하는 개념으로서, 탄화수소 방향족 모이어티의 모든 원소가 p-오비탈을 가지면서, 이들 p-오비탈이 공액(conjugation)을 형성하고 있는 형태, 예컨대 페닐기, 나프틸기 등을 포함하고, 2 이상의 탄화수소 방향족 모이어티들이 시그마 결합을 통하여 연결된 형태, 예컨대 바이페닐기, 터페닐기, 쿼터페닐기 등을 포함하며, 2 이상의 탄화수소 방향족 모이어티들이 직접 또는 간접적으로 융합된 비방향족 융합 고리, 예컨대 플루오레닐기 등을 포함할 수 있다.As used herein, the term "aryl group" is a concept that encompasses a group having one or more hydrocarbon aromatic moieties, and all elements of the hydrocarbon aromatic moiety have p-orbitals, and these p-orbitals are conjugated. It contains a form that forms, for example, a phenyl group, a naphthyl group, etc., and includes a form in which two or more hydrocarbon aromatic moieties are connected through a sigma bond, such as a biphenyl group, a terphenyl group, a quaterphenyl group, etc., and two or more hydrocarbon aromatic moieties They may include a fused non-aromatic fused ring, such as a fluorenyl group, directly or indirectly.
아릴기는 모노시클릭, 폴리시클릭 또는 융합 고리 폴리시클릭(즉, 탄소원자들의 인접한 쌍들을 나눠 가지는 고리) 작용기를 포함한다.Aryl groups include monocyclic, polycyclic or fused ring polycyclic (ie, rings that share adjacent pairs of carbon atoms) functional groups.
본 명세서에서 "헤테로고리기(heterocyclic group)"는 헤테로아릴기를 포함하는 상위 개념으로서, 아릴기, 시클로알킬기, 이들의 융합고리 또는 이들의 조합과 같은 고리 화합물 내에 탄소 (C) 대신 N, O, S, P 및 Si로 이루어진 군에서 선택되는 헤테로 원자를 적어도 한 개를 함유하는 것을 의미한다. 상기 헤테로고리기가 융합고리인 경우, 상기 헤테로고리기 전체 또는 각각의 고리마다 헤테로 원자를 한 개 이상 포함할 수 있다.In the present specification, "heterocyclic group" is a higher concept including a heteroaryl group, and instead of carbon (C), N, O, It means containing at least one hetero atom selected from the group consisting of S, P and Si. When the heterocyclic group is a fused ring, the entire heterocyclic group or each ring may include one or more heteroatoms.
일 예로 "헤테로아릴(heteroaryl)기"는 아릴기 내에 N, O, S, P 및 Si로 이루어진 군에서 선택되는 헤테로 원자를 적어도 한 개를 함유하는 것을 의미한다. 2 이상의 헤테로아릴기는 시그마 결합을 통하여 직접 연결되거나, 상기 헤테로아릴기가 2 이상의 고리를 포함할 경우, 2 이상의 고리들은 서로 융합될 수 있다. 상기 헤테로아릴기가 융합고리인 경우, 각각의 고리마다 상기 헤테로 원자를 1 내지 3개 포함할 수 있다.For example, "heteroaryl group" means containing at least one hetero atom selected from the group consisting of N, O, S, P and Si in the aryl group. Two or more heteroaryl groups may be directly connected through a sigma bond, or when the heteroaryl group includes two or more rings, the two or more rings may be fused to each other. When the heteroaryl group is a fused ring, each ring may include 1 to 3 heteroatoms.
보다 구체적으로, 치환 또는 비치환된 C6 내지 C30 아릴기는, 치환 또는 비치환된 페닐기, 치환 또는 비치환된 나프틸기, 치환 또는 비치환된 안트라세닐기, 치환 또는 비치환된 페난트레닐기, 치환 또는 비치환된 나프타세닐기, 치환 또는 비치환된 피레닐기, 치환 또는 비치환된 바이페닐기, 치환 또는 비치환된 p-터페닐기, 치환 또는 비치환된 m-터페닐기, 치환 또는 비치환된 o-터페닐기, 치환 또는 비치환된 크리세닐기, 치환 또는 비치환된 트리페닐렌기, 치환 또는 비치환된 페릴레닐기, 치환 또는 비치환된 플루오레닐기, 치환 또는 비치환된 인데닐기, 치환 또는 비치환된 퓨라닐기, 또는 이들의 조합일 수 있으나, 이에 제한되지는 않는다.More specifically, a substituted or unsubstituted C6 to C30 aryl group includes a substituted or unsubstituted phenyl group, a substituted or unsubstituted naphthyl group, a substituted or unsubstituted anthracenyl group, a substituted or unsubstituted phenanthrenyl group, a substituted or Unsubstituted naphthacenyl group, substituted or unsubstituted pyrenyl group, substituted or unsubstituted biphenyl group, substituted or unsubstituted p-terphenyl group, substituted or unsubstituted m-terphenyl group, substituted or unsubstituted o- Terphenyl group, substituted or unsubstituted chrysenyl group, substituted or unsubstituted triphenylene group, substituted or unsubstituted perylenyl group, substituted or unsubstituted fluorenyl group, substituted or unsubstituted indenyl group, substituted or unsubstituted It may be a cyclic furanyl group, or a combination thereof, but is not limited thereto.
보다 구체적으로, 치환 또는 비치환된 C2 내지 C30 헤테로고리기는, 치환 또는 비치환된 티오페닐기, 치환 또는 비치환된 피롤릴기, 치환 또는 비치환된 피라졸릴기, 치환 또는 비치환된 이미다졸일기, 치환 또는 비치환된 트리아졸일기, 치환 또는 비치환된 옥사졸일기, 치환 또는 비치환된 티아졸일기, 치환 또는 비치환된 옥사디아졸일기, 치환 또는 비치환된 티아디아졸일기, 치환 또는 비치환된 피리딜기, 치환 또는 비치환된 피리미디닐기, 치환 또는 비치환된 피라지닐기, 치환 또는 비치환된 트리아지닐기, 치환 또는 비치환된 벤조퓨라닐기, 치환 또는 비치환된 벤조티오페닐기, 치환 또는 비치환된 벤즈이미다졸일기, 치환 또는 비치환된 인돌일기, 치환 또는 비치환된 퀴놀리닐기, 치환 또는 비치환된 이소퀴놀리닐기, 치환 또는 비치환된 퀴나졸리닐기, 치환 또는 비치환된 퀴녹살리닐기, 치환 또는 비치환된 나프티리디닐기, 치환 또는 비치환된 벤즈옥사진일기, 치환 또는 비치환된 벤즈티아진일기, 치환 또는 비치환된 아크리디닐기, 치환 또는 비치환된 페나진일기, 치환 또는 비치환된 페노티아진일기, 치환 또는 비치환된 페녹사진일기, 치환 또는 비치환된 카바졸일기, 치환 또는 비치환된 디벤조퓨란일기, 치환 또는 비치환된 디벤조티오펜일기, 치환 또는 비치환된 벤조나프토퓨란일기, 치환 또는 비치환된 벤조나프토티오펜일기 치환 또는 비치환된 디벤조실롤일기 또는 이들의 조합일 수 있으나, 이에 제한되지는 않는다.More specifically, a substituted or unsubstituted C2 to C30 heterocyclic group is a substituted or unsubstituted thiophenyl group, a substituted or unsubstituted pyrrolyl group, a substituted or unsubstituted pyrazolyl group, a substituted or unsubstituted imidazolyl group, A substituted or unsubstituted triazolyl group, a substituted or unsubstituted oxazolyl group, a substituted or unsubstituted thiazolyl group, a substituted or unsubstituted oxadiazolyl group, a substituted or unsubstituted thiadiazolyl group, a substituted or unsubstituted A substituted or unsubstituted pyrimidinyl group, a substituted or unsubstituted pyrazinyl group, a substituted or unsubstituted triazinyl group, a substituted or unsubstituted benzofuranyl group, a substituted or unsubstituted benzothiophenyl group, A substituted or unsubstituted benzimidazolyl group, a substituted or unsubstituted indolyl group, a substituted or unsubstituted quinolinyl group, a substituted or unsubstituted isoquinolinyl group, a substituted or unsubstituted quinazolinyl group, a substituted or unsubstituted quinoxalinyl group, substituted or unsubstituted naphthyridinyl group, substituted or unsubstituted benzoxazinyl group, substituted or unsubstituted benzthiazinyl group, substituted or unsubstituted acridinyl group, substituted or unsubstituted phenazine A diyl group, a substituted or unsubstituted phenothiazinyl group, a substituted or unsubstituted phenoxazinyl group, a substituted or unsubstituted carbazolyl group, a substituted or unsubstituted dibenzofuranyl group, a substituted or unsubstituted dibenzothiophenyl group , a substituted or unsubstituted benzonaphthofuranyl group, a substituted or unsubstituted benzonaphthothiophenyl group, a substituted or unsubstituted dibenzosilolyl group, or a combination thereof, but is not limited thereto.
본 명세서에서, "수소 치환 (-H)"은 "중수소 치환 (-D)" 또는 "삼중수소 치환 (-T)"을 포함할 수 있다.As used herein, "hydrogen substitution (-H)" may include "deuterium substitution (-D)" or "tritium substitution (-T)".
본 명세서에서, 정공 특성이란, 전기장(electric field)을 가했을 때 전자를 공여하여 정공을 형성할 수 있는 특성을 말하는 것으로, HOMO 준위를 따라 전도 특성을 가져 양극에서 형성된 정공의 발광층으로의 주입, 발광층에서 형성된 정공의 양극으로의 이동 및 발광층에서의 이동을 용이하게 하는 특성을 의미한다. As used herein, the hole property refers to a property capable of forming a hole by donating electrons when an electric field is applied. It refers to a property that facilitates the movement of holes formed in the anode and in the light emitting layer.
또한 전자 특성이란, 전기장을 가했을 때 전자를 받을 수 있는 특성을 말하는 것으로, LUMO 준위를 따라 전도 특성을 가져 음극에서 형성된 전자의 발광층으로의 주입, 발광층에서 형성된 전자의 음극으로의 이동 및 발광층에서의 이동을 용이하게 하는 특성을 의미한다. In addition, the electronic property refers to a property that can receive electrons when an electric field is applied. It has conduction properties along the LUMO level, so electrons formed in the cathode are injected into the light emitting layer, electrons formed in the light emitting layer are moved to the cathode, and in the light emitting layer. properties that facilitate movement.
이하 일 구현예에 따른 유기 광전자 소자용 화합물을 설명한다.Hereinafter, a compound for an organic optoelectronic device according to an embodiment will be described.
일 구현예에 따른 유기 광전자 소자용 화합물은 하기 화학식 1로 표현된다.The compound for an organic optoelectronic device according to an embodiment is represented by the following Chemical Formula 1.
[화학식 1][Formula 1]
Figure PCTKR2022005689-appb-img-000005
Figure PCTKR2022005689-appb-img-000005
상기 화학식 1에서,In Formula 1,
Z1 내지 Z3은 각각 독립적으로 N 또는 CRa이고,Z 1 to Z 3 are each independently N or CR a ,
Z1 내지 Z3 중 적어도 둘은 N이고,At least two of Z 1 to Z 3 are N,
L1 내지 L3은 각각 독립적으로 단일 결합, 또는 치환 또는 비치환된 C6 내지 C30 아릴렌기이고,L 1 to L 3 are each independently a single bond, or a substituted or unsubstituted C6 to C30 arylene group,
Ar1 및 Ar2는 각각 독립적으로 치환 또는 비치환된 C6 내지 C30 아릴기 또는 치환 또는 비치환된 C2 내지 C30 헤테로고리기이고,Ar 1 and Ar 2 are each independently a substituted or unsubstituted C6 to C30 aryl group or a substituted or unsubstituted C2 to C30 heterocyclic group,
Ra 및 R1 내지 R4는 각각 독립적으로 수소, 중수소, 치환 또는 비치환된 C1 내지 C20 알킬기, 또는 치환 또는 비치환된 C6 내지 C20 아릴기이고,R a and R 1 to R 4 are each independently hydrogen, deuterium, a substituted or unsubstituted C1 to C20 alkyl group, or a substituted or unsubstituted C6 to C20 aryl group,
n1은 1 내지 3의 정수 중 하나이고,n1 is one of integers from 1 to 3,
n2 및 n3은 각각 독립적으로 1 또는 2의 정수이며,n2 and n3 are each independently an integer of 1 or 2,
n4는 1 내지 4의 정수 중 하나이다.n4 is one of integers from 1 to 4.
화학식 1로 표현되는 화합물은 페난트렌의 1,2번 위치에서 페닐이 추가 융합된 코어에 피리미딘 또는 트리아진이 치환된 구조를 갖는다.The compound represented by Formula 1 has a structure in which pyrimidine or triazine is substituted in the core to which phenyl is further fused at positions 1 and 2 of phenanthrene.
페난트렌에 페닐이 추가 융합됨으로써 보다 안정적인 T1 에너지 레벨을 갖게 되어 장수명 특성을 구현할 수 있고, 방향족 고리의 융합에 의해 고리의 안정화를 강하게 하여 수명을 더욱 극대화시킬 수 있다.By further fusion of phenyl to phenanthrene, it has a more stable T1 energy level, so that long-life characteristics can be realized.
특히, 페난트렌의 1,2번 위치에서 융합됨으로써 안정적인 T1 에너지 레벨을 갖게 되며, 형성된 다융합고리가 완전 평면 상태가 아니라 약 17°정도 뒤틀려 있어 결정성이 감소하며, Tg가 개선되는 특성을 나타낸다. 또한 결정성이 감소함으로써 증착시 공정성이 향상된다.In particular, by fusion at positions 1 and 2 of phenanthrene, a stable T1 energy level is obtained, and the formed polyfused ring is not in a perfectly planar state but is twisted by about 17°, so crystallinity is reduced and Tg is improved. . In addition, the processability during deposition is improved by decreasing crystallinity.
또한 상기 융합페난트렌에 피리미딘 또는 트리아진이 치환됨에 따라, 높은 전자 이동도를 가지게 되어 구동 전압을 낮출 수 있다.In addition, as pyrimidine or triazine is substituted for the fused phenanthrene, it has high electron mobility and thus the driving voltage can be lowered.
더욱이 상기 융합페난트렌의 말단에 피리미딘 또는 트리아진이 치환됨에 따라, 중앙에 연결되는 것에 비해 컨쥬게이션 길이가 더 길어지고 이에 따라 분자가 안정하게 되어 장수명의 효과를 가질 수 있다. Moreover, as pyrimidine or triazine is substituted at the end of the fused phenanthrene, the length of the conjugation becomes longer compared to that linked to the center, and thus the molecule is stabilized, thereby having the effect of long life.
상기 화학식 1은 트리아진의 구체적인 치환 지점에 따라 하기 화학식 1-1 내지 화학식 1-4 중 어느 하나로 표현될 수 있다.Formula 1 may be represented by any one of the following Formulas 1-1 to 1-4 according to a specific substitution point of the triazine.
[화학식 1-1][Formula 1-1]
Figure PCTKR2022005689-appb-img-000006
Figure PCTKR2022005689-appb-img-000006
[화학식 1-2][Formula 1-2]
Figure PCTKR2022005689-appb-img-000007
Figure PCTKR2022005689-appb-img-000007
[화학식 1-3][Formula 1-3]
Figure PCTKR2022005689-appb-img-000008
Figure PCTKR2022005689-appb-img-000008
[화학식 1-4][Formula 1-4]
Figure PCTKR2022005689-appb-img-000009
Figure PCTKR2022005689-appb-img-000009
상기 화학식 1-1 내지 화학식 1-4에서,In Formulas 1-1 to 1-4,
Z1 내지 Z3, L1 내지 L3, Ar1, Ar2, R1 내지 R4 및 n1 내지 n4는 전술한 바와 같다.Z 1 to Z 3 , L 1 to L 3 , Ar 1 , Ar 2 , R 1 to R 4 and n1 to n4 are the same as described above.
일 실시예에서, 상기 L1 내지 L3은 각각 독립적으로 단일 결합, 치환 또는 비치환된 페닐렌기 또는 치환 또는 비치환된 나프틸렌기일 수 있다.In an embodiment, L 1 to L 3 may each independently be a single bond, a substituted or unsubstituted phenylene group, or a substituted or unsubstituted naphthylene group.
일 실시예에서, 상기 Ar1 및 Ar2는 각각 독립적으로 치환 또는 비치환된 페닐기, 치환 또는 비치환된 바이페닐기, 치환 또는 비치환된 나프틸기, 치환 또는 비치환된 페난트레닐기, 치환 또는 비치환된 플루오레닐기, 치환 또는 비치환된 카바졸일기, 치환 또는 비치환된 디벤조퓨란일기, 치환 또는 비치환된 디벤조티오펜일기, 치환 또는 비치환된 디벤조실롤일기 또는 치환 또는 비치환된 벤조나프토퓨란일기일 수 있다. In one embodiment, Ar 1 and Ar 2 are each independently a substituted or unsubstituted phenyl group, a substituted or unsubstituted biphenyl group, a substituted or unsubstituted naphthyl group, a substituted or unsubstituted phenanthrenyl group, a substituted or unsubstituted A substituted or unsubstituted carbazolyl group, a substituted or unsubstituted carbazolyl group, a substituted or unsubstituted dibenzofuranyl group, a substituted or unsubstituted dibenzothiophenyl group, a substituted or unsubstituted dibenzosilolyl group, or a substituted or unsubstituted It may be a benzonaphthofuranyl group.
구체적인 일 실시예에서, 상기 Ar1 및 Ar2는 각각 독립적으로 치환 또는 비치환된 페닐기, 치환 또는 비치환된 나프틸기, 치환 또는 비치환된 카바졸일기, 치환 또는 비치환된 디벤조퓨란일기, 치환 또는 비치환된 디벤조티오펜일기 또는 치환 또는 비치환된 벤조나프토퓨란일기일 수 있다.In a specific embodiment, Ar 1 and Ar 2 are each independently a substituted or unsubstituted phenyl group, a substituted or unsubstituted naphthyl group, a substituted or unsubstituted carbazolyl group, a substituted or unsubstituted dibenzofuranyl group, It may be a substituted or unsubstituted dibenzothiophenyl group or a substituted or unsubstituted benzonaphthofuranyl group.
더욱 구체적인 일 예로 상기 *-L2-Ar1 및 *-L3-Ar2는 각각 독립적으로 하기 그룹 Ⅰ에 나열된 치환기 중에서 선택될 수 있다.In a more specific example, *-L 2 -Ar 1 and *-L 3 -Ar 2 may each independently be selected from the substituents listed in Group I below.
[그룹 Ⅰ][Group I]
Figure PCTKR2022005689-appb-img-000010
Figure PCTKR2022005689-appb-img-000010
상기 그룹 Ⅰ에서, In group I,
D는 중수소를 의미하고,D means deuterium,
n11은 1 내지 5의 정수 중 하나이고,n11 is one of integers from 1 to 5,
n12는 1 내지 4의 정수 중 하나이고,n12 is one of integers from 1 to 4,
n13은 1 내지 3의 정수 중 하나이며,n13 is one of integers from 1 to 3,
*은 연결 지점이다.* is the connection point.
예컨대 화학식 1로 표현되는 유기 광전자 소자용 화합물은 하기 그룹 1에 나열된 화합물에서 선택된 하나일 수 있으나, 이에 한정되는 것은 아니다.For example, the compound for an organic optoelectronic device represented by Formula 1 may be one selected from the compounds listed in Group 1 below, but is not limited thereto.
[그룹 1][Group 1]
[1] [2] [3] [4][1] [2] [3] [4]
Figure PCTKR2022005689-appb-img-000011
Figure PCTKR2022005689-appb-img-000011
[5] [6] [7] [8][5] [6] [7] [8]
Figure PCTKR2022005689-appb-img-000012
Figure PCTKR2022005689-appb-img-000012
[9] [10] [11] [12][9] [10] [11] [12]
Figure PCTKR2022005689-appb-img-000013
Figure PCTKR2022005689-appb-img-000013
[13] [14] [15] [16][13] [14] [15] [16]
Figure PCTKR2022005689-appb-img-000014
Figure PCTKR2022005689-appb-img-000014
[17] [18] [19] [20][17] [18] [19] [20]
Figure PCTKR2022005689-appb-img-000015
Figure PCTKR2022005689-appb-img-000015
[21] [22] [23] [24][21] [22] [23] [24]
Figure PCTKR2022005689-appb-img-000016
Figure PCTKR2022005689-appb-img-000016
[25] [26] [27] [28][25] [26] [27] [28]
Figure PCTKR2022005689-appb-img-000017
Figure PCTKR2022005689-appb-img-000017
[29] [30] [31] [32][29] [30] [31] [32]
Figure PCTKR2022005689-appb-img-000018
Figure PCTKR2022005689-appb-img-000018
[33] [34] [35] [36][33] [34] [35] [36]
Figure PCTKR2022005689-appb-img-000019
Figure PCTKR2022005689-appb-img-000019
[37] [38] [39] [40][37] [38] [39] [40]
Figure PCTKR2022005689-appb-img-000020
Figure PCTKR2022005689-appb-img-000020
[41] [42] [43] [44][41] [42] [43] [44]
Figure PCTKR2022005689-appb-img-000021
Figure PCTKR2022005689-appb-img-000021
[45] [46] [47] [48][45] [46] [47] [48]
Figure PCTKR2022005689-appb-img-000022
Figure PCTKR2022005689-appb-img-000022
[49] [50] [51] [52][49] [50] [51] [52]
Figure PCTKR2022005689-appb-img-000023
Figure PCTKR2022005689-appb-img-000023
[52] [54] [55] [56][52] [54] [55] [56]
Figure PCTKR2022005689-appb-img-000024
Figure PCTKR2022005689-appb-img-000024
[57] [58] [59] [60][57] [58] [59] [60]
Figure PCTKR2022005689-appb-img-000025
Figure PCTKR2022005689-appb-img-000025
[61] [62] [63] [64][61] [62] [63] [64]
Figure PCTKR2022005689-appb-img-000026
Figure PCTKR2022005689-appb-img-000026
[65] [66] [67] [68][65] [66] [67] [68]
Figure PCTKR2022005689-appb-img-000027
Figure PCTKR2022005689-appb-img-000027
[69] [70] [71] [72][69] [70] [71] [72]
Figure PCTKR2022005689-appb-img-000028
Figure PCTKR2022005689-appb-img-000028
[73] [74] [75] [76][73] [74] [75] [76]
Figure PCTKR2022005689-appb-img-000029
Figure PCTKR2022005689-appb-img-000029
[77] [78] [79] [80][77] [78] [79] [80]
Figure PCTKR2022005689-appb-img-000030
Figure PCTKR2022005689-appb-img-000030
[81] [82] [83] [84][81] [82] [83] [84]
Figure PCTKR2022005689-appb-img-000031
Figure PCTKR2022005689-appb-img-000031
[85] [86] [87] [88][85] [86] [87] [88]
Figure PCTKR2022005689-appb-img-000032
Figure PCTKR2022005689-appb-img-000032
[89] [90] [91] [92][89] [90] [91] [92]
Figure PCTKR2022005689-appb-img-000033
Figure PCTKR2022005689-appb-img-000033
[93] [94] [95] [96][93] [94] [95] [96]
Figure PCTKR2022005689-appb-img-000034
Figure PCTKR2022005689-appb-img-000034
[97] [98] [99] [100][97] [98] [99] [100]
Figure PCTKR2022005689-appb-img-000035
Figure PCTKR2022005689-appb-img-000035
[101] [102] [103] [104][101] [102] [103] [104]
Figure PCTKR2022005689-appb-img-000036
Figure PCTKR2022005689-appb-img-000036
[105] [106] [107] [108][105] [106] [107] [108]
Figure PCTKR2022005689-appb-img-000037
Figure PCTKR2022005689-appb-img-000037
[109] [110] [111] [112][109] [110] [111] [112]
Figure PCTKR2022005689-appb-img-000038
Figure PCTKR2022005689-appb-img-000038
[113] [114] [115] [116][113] [114] [115] [116]
Figure PCTKR2022005689-appb-img-000039
Figure PCTKR2022005689-appb-img-000039
[117] [118] [119] [120][117] [118] [119] [120]
Figure PCTKR2022005689-appb-img-000040
Figure PCTKR2022005689-appb-img-000040
[121] [122] [123] [124][121] [122] [123] [124]
Figure PCTKR2022005689-appb-img-000041
Figure PCTKR2022005689-appb-img-000041
[125] [126] [127] [128][125] [126] [127] [128]
Figure PCTKR2022005689-appb-img-000042
Figure PCTKR2022005689-appb-img-000042
다른 일 구현예에 따른 유기 광전자 소자용 조성물은 제1 화합물, 및 제2 화합물을 포함하고, 상기 제1 화합물은 전술한 유기 광전자 소자용 화합물이며, 상기 제2 화합물은 하기 화학식 2로 표현될 수 있다.The composition for an organic optoelectronic device according to another embodiment includes a first compound and a second compound, wherein the first compound is the above-described compound for an organic optoelectronic device, and the second compound may be represented by the following Chemical Formula 2 have.
[화학식 2][Formula 2]
Figure PCTKR2022005689-appb-img-000043
Figure PCTKR2022005689-appb-img-000043
상기 화학식 2에서,In Formula 2,
X1은 O, S, NRb, CRcRd 또는 SiReRf이고,X 1 is O, S, NR b , CR c R d or SiR e R f ,
Rb, Rc, Rd, Re, Rf 및 R5는 각각 독립적으로 수소, 중수소, 치환 또는 비치환된 아민기, 치환 또는 비치환된 C1 내지 C30 알킬기, 치환 또는 비치환된 C6 내지 C30 아릴기 또는 치환 또는 비치환된 C2 내지 C30 헤테로고리기이고,R b , R c , R d , R e , R f and R 5 are each independently hydrogen, deuterium, a substituted or unsubstituted amine group, a substituted or unsubstituted C1 to C30 alkyl group, a substituted or unsubstituted C6 to a C30 aryl group or a substituted or unsubstituted C2 to C30 heterocyclic group,
n5는 1 내지 4의 정수 중 하나이고,n5 is one of integers from 1 to 4,
환 A는 하기 그룹 Ⅱ에 나열된 고리 중에서 선택되는 어느 하나이고,Ring A is any one selected from the rings listed in Group II,
[그룹 Ⅱ][Group II]
Figure PCTKR2022005689-appb-img-000044
Figure PCTKR2022005689-appb-img-000044
상기 그룹 Ⅱ에서,In group II,
*은 연결 지점이고,* is the connection point,
X2는 O, S, NRg, CRhRi 또는 SiRjRk이고,X 2 is O, S, NR g , CR h R i or SiR j R k ,
Rg, Rh, Ri, Rj, Rk, 및 R6 내지 R10은 각각 독립적으로 수소, 중수소, 치환 또는 비치환된 아민기, 치환 또는 비치환된 C1 내지 C30 알킬기, 치환 또는 비치환된 C6 내지 C30 아릴기 또는 치환 또는 비치환된 C2 내지 C30 헤테로고리기이고,R g , R h , R i , R j , R k , and R 6 to R 10 are each independently hydrogen, deuterium, a substituted or unsubstituted amine group, a substituted or unsubstituted C1 to C30 alkyl group, a substituted or unsubstituted a cyclic C6 to C30 aryl group or a substituted or unsubstituted C2 to C30 heterocyclic group,
n6, n8 및 n10은 각각 독립적으로 1 내지 4의 정수 중 하나이고,n6, n8 and n10 are each independently one of an integer of 1 to 4,
n7 및 n9는 각각 독립적으로 1 또는 2의 정수이고,n7 and n9 are each independently an integer of 1 or 2,
R5 내지 R10 중 적어도 하나는 하기 화학식 a로 표현되는 기이고,At least one of R 5 to R 10 is a group represented by the following formula (a),
[화학식 a][Formula a]
Figure PCTKR2022005689-appb-img-000045
Figure PCTKR2022005689-appb-img-000045
상기 화학식 a에서,In the above formula (a),
L4 내지 L6은 각각 독립적으로 단일 결합, 또는 치환 또는 비치환된 C6 내지 C30 아릴렌기이고,L 4 To L 6 are each independently a single bond, or a substituted or unsubstituted C6 to C30 arylene group,
Ar3 및 Ar4는 각각 독립적으로 치환 또는 비치환된 아민기, 치환 또는 비치환된 C6 내지 C30 아릴기, 또는 치환 또는 비치환된 C2 내지 C30 헤테로고리기이고,Ar 3 and Ar 4 are each independently a substituted or unsubstituted amine group, a substituted or unsubstituted C6 to C30 aryl group, or a substituted or unsubstituted C2 to C30 heterocyclic group,
*는 연결 지점이다.* is the connection point.
상기 제2 화합물은 카바졸/융합카바졸/융합디벤조퓨란/융합디벤조티오펜/융합디벤조실롤에 아민이 치환된 구조일 수 있고, 추가 벤젠 고리의 종류 및 융합 위치에 따라 예컨대 하기 화학식 2-Ⅰ 내지 화학식 2-Ⅹ 중 어느 하나로 표현될 수 있다.The second compound may have a structure in which an amine is substituted for carbazole / fused carbazole / fused dibenzofuran / fused dibenzothiophene / fused dibenzosilol, depending on the type and fusion position of the additional benzene ring, for example, the following formula It may be represented by any one of 2-I to Formula 2-X.
[화학식 2-Ⅰ] [화학식 2-Ⅱ][Formula 2-Ⅰ] [Formula 2-Ⅱ]
Figure PCTKR2022005689-appb-img-000046
Figure PCTKR2022005689-appb-img-000046
[화학식 2-Ⅲ] [화학식 2-Ⅳ][Formula 2-Ⅲ] [Formula 2-IV]
Figure PCTKR2022005689-appb-img-000047
Figure PCTKR2022005689-appb-img-000047
[화학식 2-Ⅴ] [화학식 2-Ⅵ][Formula 2-V] [Formula 2-VI]
Figure PCTKR2022005689-appb-img-000048
Figure PCTKR2022005689-appb-img-000048
[화학식 2-Ⅶ] [화학식 2-ⅤⅢ][Formula 2-VII] [Formula 2-VIII]
Figure PCTKR2022005689-appb-img-000049
Figure PCTKR2022005689-appb-img-000049
[화학식 2-Ⅸ] [화학식 2-Ⅹ][Formula 2-IX] [Formula 2-X]
Figure PCTKR2022005689-appb-img-000050
Figure PCTKR2022005689-appb-img-000050
상기 화학식 2-Ⅰ 내지 화학식 2-Ⅹ에서, In Formula 2-I to Formula 2-X,
X1, X2, R5 내지 R10 및 n5 내지 n10은 전술한 바와 같다.X 1 , X 2 , R 5 to R 10 and n5 to n10 are the same as described above.
또한, 아민기의 치환 방향에 따라 상기 제2 화합물은 하기 화학식 2-ⅠA 내지 화학식 2-ⅩA, 화학식 2-ⅡB 내지 화학식 2-ⅣB 및 화학식 2-ⅡC 내지 화학식 2-ⅨC 중 어느 하나로 표현될 수 있다.In addition, depending on the substitution direction of the amine group, the second compound may be represented by any one of the following Chemical Formulas 2-IA to 2-XA, Formula 2-IIB to Formula 2-IVB, and Formula 2-IIC to Formula 2-IXC have.
[화학식 2-ⅠA] [화학식 2-ⅡA][Formula 2-IA] [Formula 2-IIA]
Figure PCTKR2022005689-appb-img-000051
Figure PCTKR2022005689-appb-img-000051
[화학식 2-ⅢA] [화학식 2-ⅣA][Formula 2-ⅢA] [Formula 2-IVA]
Figure PCTKR2022005689-appb-img-000052
Figure PCTKR2022005689-appb-img-000052
[화학식 2-ⅤA] [화학식 2-ⅥA][Formula 2-VIA] [Formula 2-VIA]
Figure PCTKR2022005689-appb-img-000053
Figure PCTKR2022005689-appb-img-000053
[화학식 2-ⅦA] [화학식 2-ⅤⅢA][Formula 2-VIIA] [Formula 2-VIIIA]
Figure PCTKR2022005689-appb-img-000054
Figure PCTKR2022005689-appb-img-000054
[화학식 2-ⅨA] [화학식 2-ⅩA][Formula 2-XA] [Formula 2-XA]
Figure PCTKR2022005689-appb-img-000055
Figure PCTKR2022005689-appb-img-000055
상기 화학식 2-ⅠA 내지 화학식 2-ⅩA에서, In Formula 2-IA to Formula 2-XA,
X1, X2, L4 내지 L6, Ar3, Ar4, 및 n6 내지 n10은 전술한 바와 같고,X 1 , X 2 , L 4 to L 6 , Ar 3 , Ar 4 , and n6 to n10 are the same as described above,
n5는 1 내지 3의 정수 중 하나이다.n5 is one of integers from 1 to 3.
[화학식 2-ⅡB][Formula 2-IIB]
Figure PCTKR2022005689-appb-img-000056
Figure PCTKR2022005689-appb-img-000056
[화학식 2-ⅢB] [화학식 2-ⅣB][Formula 2-ⅢB] [Formula 2-IVB]
Figure PCTKR2022005689-appb-img-000057
Figure PCTKR2022005689-appb-img-000057
상기 화학식 2-ⅡB 내지 화학식 2-ⅣB에서, In Formulas 2-IIB to Formula 2-IVB,
X1, L4 내지 L6, Ar3, Ar4, n5 및 n7은 전술한 바와 같고,X 1 , L 4 to L 6 , Ar 3 , Ar 4 , n5 and n7 are the same as described above,
n8은 1 내지 3의 정수 중 하나이다.n8 is one of integers from 1 to 3.
[화학식 2-ⅡC] [화학식 2-ⅢC][Formula 2-IIC] [Formula 2-IIIC]
Figure PCTKR2022005689-appb-img-000058
Figure PCTKR2022005689-appb-img-000058
[화학식 2-ⅣC][Formula 2-IVC]
Figure PCTKR2022005689-appb-img-000059
Figure PCTKR2022005689-appb-img-000059
상기 화학식 2-ⅡC 내지 화학식 2-ⅣC 에서, In the formula 2-IIC to formula 2-IVC,
X1, L4 내지 L6, Ar3, Ar4, n5 및 n8은 전술한 바와 같고,X 1 , L 4 To L 6 , Ar 3 , Ar 4 , n5 and n8 are the same as described above,
n7은 1이다.n7 is 1.
[화학식 2-ⅤC] [화학식 2-ⅥC] [Formula 2-VC] [Formula 2-VIC]
Figure PCTKR2022005689-appb-img-000060
Figure PCTKR2022005689-appb-img-000060
[화학식 2-ⅦC] [화학식 2-ⅤⅢC][Formula 2-VIIC] [Formula 2-VIIIC]
Figure PCTKR2022005689-appb-img-000061
Figure PCTKR2022005689-appb-img-000061
[화학식 2-ⅨC][Formula 2-ⅨC]
Figure PCTKR2022005689-appb-img-000062
Figure PCTKR2022005689-appb-img-000062
상기 화학식 2-ⅤC 내지 화학식 2-ⅨC에서,In Formula 2-VC to Formula 2-IXC,
X1, X2, L4 내지 L6, Ar3, Ar4, n5 및 n10은 전술한 바와 같고,X 1 , X 2 , L 4 to L 6 , Ar 3 , Ar 4 , n5 and n10 are the same as described above,
n9는 1이다.n9 is 1.
일 예로 R5 내지 R10은 각각 독립적으로 수소, 중수소, 치환 또는 비치환된 C1 내지 C30 알킬기, 또는 치환 또는 비치환된 C6 내지 C30 아릴기이다.For example, R 5 to R 10 are each independently hydrogen, deuterium, a substituted or unsubstituted C1 to C30 alkyl group, or a substituted or unsubstituted C6 to C30 aryl group.
일 실시예에 따른 제2 화합물은 상기 화학식 2-ⅣB 또는 화학식 2-ⅤⅢB로 표현될 수 있다.The second compound according to an embodiment may be represented by Formula 2-IVB or Formula 2-VIIIB.
일 예로 상기 화학식 2-ⅣB의 X1은 NRb일 수 있다.For example, X 1 in Formula 2-IVB may be NR b .
일 예로 상기 화학식 2-ⅩA의 X1은 CRcRd 또는 SiReRf이고, X2는 O 또는 S일 수 있다.For example, in Formula 2-XA, X 1 may be CR c R d or SiR e R f , and X 2 may be O or S.
여기서 Rb, Rc, Rd, Re 및 Rf는 각각 독립적으로 치환 또는 비치환된 C1 내지 C10 알킬기, 또는 치환 또는 비치환된 C6 내지 C20 아릴기일 수 있다.Here, R b , R c , R d , R e and R f may each independently represent a substituted or unsubstituted C1 to C10 alkyl group, or a substituted or unsubstituted C6 to C20 aryl group.
구체적인 일 실시예에 따른 제2 화합물은 하기 화학식 2-ⅣB-2 또는 화학식 2-ⅤⅢB-2로 표현될 수 있다. The second compound according to a specific embodiment may be represented by the following Chemical Formula 2-IVB-2 or 2-VIIIB-2.
[화학식 2-ⅣB-2] [화학식 2-ⅤⅢA-2][Formula 2-IVB-2] [Formula 2-VIIIA-2]
Figure PCTKR2022005689-appb-img-000063
Figure PCTKR2022005689-appb-img-000063
상기 화학식 2-ⅣB-2 및 화학식 2-ⅤⅢA-2에서,In Formula 2-IVB-2 and Formula 2-VIIIA-2,
L4 내지 L6은 각각 독립적으로 단일 결합 또는 치환 또는 비치환된 페닐렌기이고,L 4 To L 6 are each independently a single bond or a substituted or unsubstituted phenylene group,
상기 Ar3 및 Ar4는 각각 독립적으로 치환 또는 비치환된 페닐기, 치환 또는 비치환된 바이페닐기, 또는 치환 또는 비치환된 나프틸기이고,wherein Ar 3 and Ar 4 are each independently a substituted or unsubstituted phenyl group, a substituted or unsubstituted biphenyl group, or a substituted or unsubstituted naphthyl group,
R5, 및 R7 내지 R10은 각각 독립적으로 수소, 중수소, 치환 또는 비치환된 C1 내지 C30 알킬기 또는 치환 또는 비치환된 C6 내지 C30 아릴기이고,R 5 , and R 7 to R 10 are each independently hydrogen, deuterium, a substituted or unsubstituted C1 to C30 alkyl group, or a substituted or unsubstituted C6 to C30 aryl group,
n7 및 n9는 각각 독립적으로 1 또는 2의 정수이고,n7 and n9 are each independently an integer of 1 or 2,
n8 및 n10은 각각 독립적으로 1 내지 3의 정수 중 하나이고,n8 and n10 are each independently one of an integer of 1 to 3,
화학식 2-ⅣB-2의 X1은 NRb, O 또는 S이고,In Formula 2-IVB-2, X 1 is NR b , O or S,
화학식 2-ⅣB-2의 n5는 1 내지 4의 정수 중 하나이고,n5 of Formula 2-IVB-2 is one of integers from 1 to 4,
화학식 2-ⅤⅢA-2의 X1은 CRcRd 또는 SiReRf이고,In Formula 2-VIIIA-2, X 1 is CR c R d or SiR e R f ,
화학식 2-ⅤⅢA-2의 X2는 O 또는 S이고,X 2 of Formula 2-VIIIA-2 is O or S,
화학식 2-ⅤⅢA-2의 n5는 1 내지 3의 정수 중 하나이고,n5 in Formula 2-VIIIA-2 is one of integers from 1 to 3,
Rb, Rc, Rd, Re 및 Rf는 각각 독립적으로 치환 또는 비치환된 C1 내지 C30 알킬기, 또는 치환 또는 비치환된 C6 내지 C30 아릴기이다.R b , R c , R d , R e and R f are each independently a substituted or unsubstituted C1 to C30 alkyl group, or a substituted or unsubstituted C6 to C30 aryl group.
일 예로 상기 L5 및 L6은 각각 독립적으로 단일 결합, 치환 또는 비치환된 페닐렌기, 또는 치환 또는 비치환된 바이페닐렌기일 수 있다.For example, L 5 and L 6 may each independently represent a single bond, a substituted or unsubstituted phenylene group, or a substituted or unsubstituted biphenylene group.
일 예로 상기 Ar3 및 Ar4는 각각 독립적으로 치환 또는 비치환된 페닐기, 치환 또는 비치환된 바이페닐기, 치환 또는 비치환된 터페닐기, 치환 또는 비치환된 나프틸기, 치환 또는 비치환된 페난트레닐기, 치환 또는 비치환된 트리페닐렌기, 치환 또는 비치환된 플루오레닐기, 치환 또는 비치환된 카바졸일기, 치환 또는 비치환된 디벤조퓨란일기, 치환 또는 비치환된 디벤조티오펜일기, 치환 또는 비치환된 벤조퓨라노플루오레닐기, 또는 치환 또는 비치환된 벤조티오펜플루오레닐기일 수 있다.For example, Ar 3 and Ar 4 are each independently a substituted or unsubstituted phenyl group, a substituted or unsubstituted biphenyl group, a substituted or unsubstituted terphenyl group, a substituted or unsubstituted naphthyl group, or a substituted or unsubstituted phenantre A nyl group, a substituted or unsubstituted triphenylene group, a substituted or unsubstituted fluorenyl group, a substituted or unsubstituted carbazolyl group, a substituted or unsubstituted dibenzofuranyl group, a substituted or unsubstituted dibenzothiophenyl group, It may be a substituted or unsubstituted benzofuranofluorenyl group, or a substituted or unsubstituted benzothiophenefluorenyl group.
예컨대 상기 제2 화합물은 하기 그룹 2에 나열된 화합물에서 선택된 하나일 수 있으나, 이에 한정되는 것은 아니다.For example, the second compound may be one selected from the compounds listed in Group 2, but is not limited thereto.
[그룹 2][Group 2]
Figure PCTKR2022005689-appb-img-000064
Figure PCTKR2022005689-appb-img-000064
Figure PCTKR2022005689-appb-img-000065
Figure PCTKR2022005689-appb-img-000065
Figure PCTKR2022005689-appb-img-000066
Figure PCTKR2022005689-appb-img-000066
Figure PCTKR2022005689-appb-img-000067
Figure PCTKR2022005689-appb-img-000067
Figure PCTKR2022005689-appb-img-000068
Figure PCTKR2022005689-appb-img-000068
Figure PCTKR2022005689-appb-img-000069
Figure PCTKR2022005689-appb-img-000069
Figure PCTKR2022005689-appb-img-000070
Figure PCTKR2022005689-appb-img-000070
Figure PCTKR2022005689-appb-img-000071
Figure PCTKR2022005689-appb-img-000071
Figure PCTKR2022005689-appb-img-000072
Figure PCTKR2022005689-appb-img-000072
Figure PCTKR2022005689-appb-img-000073
Figure PCTKR2022005689-appb-img-000073
Figure PCTKR2022005689-appb-img-000074
Figure PCTKR2022005689-appb-img-000074
Figure PCTKR2022005689-appb-img-000075
Figure PCTKR2022005689-appb-img-000075
Figure PCTKR2022005689-appb-img-000076
Figure PCTKR2022005689-appb-img-000076
Figure PCTKR2022005689-appb-img-000077
Figure PCTKR2022005689-appb-img-000077
Figure PCTKR2022005689-appb-img-000078
Figure PCTKR2022005689-appb-img-000078
Figure PCTKR2022005689-appb-img-000079
Figure PCTKR2022005689-appb-img-000079
Figure PCTKR2022005689-appb-img-000080
Figure PCTKR2022005689-appb-img-000080
Figure PCTKR2022005689-appb-img-000081
Figure PCTKR2022005689-appb-img-000081
Figure PCTKR2022005689-appb-img-000082
Figure PCTKR2022005689-appb-img-000082
[2-1] [2-2] [2-3] [2-4][2-1] [2-2] [2-3] [2-4]
Figure PCTKR2022005689-appb-img-000083
Figure PCTKR2022005689-appb-img-000083
[2-5] [2-6] [2-7][2-5] [2-6] [2-7]
Figure PCTKR2022005689-appb-img-000084
Figure PCTKR2022005689-appb-img-000085
Figure PCTKR2022005689-appb-img-000084
Figure PCTKR2022005689-appb-img-000085
[2-8] [2-9][2-8] [2-9]
Figure PCTKR2022005689-appb-img-000086
Figure PCTKR2022005689-appb-img-000086
[2-10] [2-11] [2-12] [2-10] [2-11] [2-12]
Figure PCTKR2022005689-appb-img-000087
Figure PCTKR2022005689-appb-img-000087
[2-13] [2-14] [2-15][2-13] [2-14] [2-15]
Figure PCTKR2022005689-appb-img-000088
Figure PCTKR2022005689-appb-img-000089
Figure PCTKR2022005689-appb-img-000088
Figure PCTKR2022005689-appb-img-000089
[2-16] [2-17] [2-16] [2-17]
Figure PCTKR2022005689-appb-img-000090
Figure PCTKR2022005689-appb-img-000090
[2-18] [2-19] [2-20][2-18] [2-19] [2-20]
Figure PCTKR2022005689-appb-img-000091
Figure PCTKR2022005689-appb-img-000091
[2-21] [2-22] [2-21] [2-22]
Figure PCTKR2022005689-appb-img-000092
Figure PCTKR2022005689-appb-img-000093
Figure PCTKR2022005689-appb-img-000092
Figure PCTKR2022005689-appb-img-000093
[2-23] [2-24] [2-25] [2-26][2-23] [2-24] [2-25] [2-26]
Figure PCTKR2022005689-appb-img-000094
Figure PCTKR2022005689-appb-img-000094
[2-27] [2-28] [2-29] [2-30][2-27] [2-28] [2-29] [2-30]
Figure PCTKR2022005689-appb-img-000095
Figure PCTKR2022005689-appb-img-000096
Figure PCTKR2022005689-appb-img-000095
Figure PCTKR2022005689-appb-img-000096
[2-31] [2-32] [2-33] [2-34] [2-31] [2-32] [2-33] [2-34]
Figure PCTKR2022005689-appb-img-000097
Figure PCTKR2022005689-appb-img-000098
Figure PCTKR2022005689-appb-img-000097
Figure PCTKR2022005689-appb-img-000098
[2-35] [2-36] [2-37] [2-38][2-35] [2-36] [2-37] [2-38]
Figure PCTKR2022005689-appb-img-000099
Figure PCTKR2022005689-appb-img-000099
[2-39] [2-40] [2-39] [2-40]
Figure PCTKR2022005689-appb-img-000100
Figure PCTKR2022005689-appb-img-000100
[2-41] [2-42] [2-43] [2-44][2-41] [2-42] [2-43] [2-44]
Figure PCTKR2022005689-appb-img-000101
Figure PCTKR2022005689-appb-img-000102
Figure PCTKR2022005689-appb-img-000101
Figure PCTKR2022005689-appb-img-000102
[2-45] [2-46] [2-47] [2-48][2-45] [2-46] [2-47] [2-48]
Figure PCTKR2022005689-appb-img-000103
Figure PCTKR2022005689-appb-img-000103
[2-49] [2-50][2-49] [2-50]
Figure PCTKR2022005689-appb-img-000104
Figure PCTKR2022005689-appb-img-000104
[2-51] [2-52] [2-51] [2-52]
Figure PCTKR2022005689-appb-img-000105
Figure PCTKR2022005689-appb-img-000105
[2-53] [2-54] [2-55] [2-56] [2-57] [2-53] [2-54] [2-55] [2-56] [2-57]
Figure PCTKR2022005689-appb-img-000106
Figure PCTKR2022005689-appb-img-000106
[2-58] [2-59] [2-60] [2-58] [2-59] [2-60]
Figure PCTKR2022005689-appb-img-000107
Figure PCTKR2022005689-appb-img-000107
[2-61] [2-62] [2-63] [2-64] [2-61] [2-62] [2-63] [2-64]
Figure PCTKR2022005689-appb-img-000108
Figure PCTKR2022005689-appb-img-000108
[2-65] [2-66] [2-67] [2-68] [2-65] [2-66] [2-67] [2-68]
Figure PCTKR2022005689-appb-img-000109
Figure PCTKR2022005689-appb-img-000110
Figure PCTKR2022005689-appb-img-000109
Figure PCTKR2022005689-appb-img-000110
[2-69] [2-70] [2-71] [2-72] [2-69] [2-70] [2-71] [2-72]
Figure PCTKR2022005689-appb-img-000111
Figure PCTKR2022005689-appb-img-000111
[2-73] [2-74] [2-75] [2-76] [2-73] [2-74] [2-75] [2-76]
Figure PCTKR2022005689-appb-img-000112
Figure PCTKR2022005689-appb-img-000112
[2-77] [2-78] [2-79] [2-80] [2-77] [2-78] [2-79] [2-80]
Figure PCTKR2022005689-appb-img-000113
Figure PCTKR2022005689-appb-img-000114
Figure PCTKR2022005689-appb-img-000115
Figure PCTKR2022005689-appb-img-000113
Figure PCTKR2022005689-appb-img-000114
Figure PCTKR2022005689-appb-img-000115
[2-81] [2-82] [2-83] [2-81] [2-82] [2-83]
Figure PCTKR2022005689-appb-img-000116
Figure PCTKR2022005689-appb-img-000117
Figure PCTKR2022005689-appb-img-000118
Figure PCTKR2022005689-appb-img-000116
Figure PCTKR2022005689-appb-img-000117
Figure PCTKR2022005689-appb-img-000118
[2-84] [2-85] [2-86] [2-84] [2-85] [2-86]
Figure PCTKR2022005689-appb-img-000119
Figure PCTKR2022005689-appb-img-000120
Figure PCTKR2022005689-appb-img-000121
Figure PCTKR2022005689-appb-img-000119
Figure PCTKR2022005689-appb-img-000120
Figure PCTKR2022005689-appb-img-000121
[2-87] [2-88] [2-89] [2-87] [2-88] [2-89]
Figure PCTKR2022005689-appb-img-000122
Figure PCTKR2022005689-appb-img-000123
Figure PCTKR2022005689-appb-img-000122
Figure PCTKR2022005689-appb-img-000123
[2-90] [2-91][2-90] [2-91]
Figure PCTKR2022005689-appb-img-000124
Figure PCTKR2022005689-appb-img-000124
[2-92] [2-93][2-92] [2-93]
Figure PCTKR2022005689-appb-img-000125
Figure PCTKR2022005689-appb-img-000125
[2-94] [2-95] [2-96] [2-97] [2-94] [2-95] [2-96] [2-97]
Figure PCTKR2022005689-appb-img-000126
Figure PCTKR2022005689-appb-img-000126
[2-98] [2-99] [2-100] [2-101] [2-98] [2-99] [2-100] [2-101]
Figure PCTKR2022005689-appb-img-000127
Figure PCTKR2022005689-appb-img-000127
[2-102] [2-103] [2-104] [2-105] [2-102] [2-103] [2-104] [2-105]
Figure PCTKR2022005689-appb-img-000128
Figure PCTKR2022005689-appb-img-000128
[2-106] [2-107] [2-108] [2-109][2-106] [2-107] [2-108] [2-109]
Figure PCTKR2022005689-appb-img-000129
Figure PCTKR2022005689-appb-img-000129
[2-110] [2-111] [2-112] [2-113] [2-110] [2-111] [2-112] [2-113]
Figure PCTKR2022005689-appb-img-000130
Figure PCTKR2022005689-appb-img-000130
[2-114] [2-115] [2-116] [2-117] [2-114] [2-115] [2-116] [2-117]
Figure PCTKR2022005689-appb-img-000131
Figure PCTKR2022005689-appb-img-000131
[2-118] [2-119] [2-120] [2-121] [2-118] [2-119] [2-120] [2-121]
Figure PCTKR2022005689-appb-img-000132
Figure PCTKR2022005689-appb-img-000132
[2-122] [2-123] [2-124] [2-125] [2-122] [2-123] [2-124] [2-125]
Figure PCTKR2022005689-appb-img-000133
Figure PCTKR2022005689-appb-img-000133
[2-126] [2-127] [2-128] [2-129] [2-126] [2-127] [2-128] [2-129]
Figure PCTKR2022005689-appb-img-000134
Figure PCTKR2022005689-appb-img-000134
[2-130] [2-131] [2-132] [2-133][2-130] [2-131] [2-132] [2-133]
Figure PCTKR2022005689-appb-img-000135
Figure PCTKR2022005689-appb-img-000135
[2-134] [2-135] [2-136] [2-137][2-134] [2-135] [2-136] [2-137]
Figure PCTKR2022005689-appb-img-000136
Figure PCTKR2022005689-appb-img-000136
[2-138] [2-139] [2-140] [2-141] [2-138] [2-139] [2-140] [2-141]
Figure PCTKR2022005689-appb-img-000137
Figure PCTKR2022005689-appb-img-000137
[2-142] [2-143] [2-144] [2-145][2-142] [2-143] [2-144] [2-145]
Figure PCTKR2022005689-appb-img-000138
Figure PCTKR2022005689-appb-img-000138
[2-146] [2-147] [2-148] [2-149][2-146] [2-147] [2-148] [2-149]
Figure PCTKR2022005689-appb-img-000139
Figure PCTKR2022005689-appb-img-000139
[2-150] [2-151] [2-152] [2-153] [2-150] [2-151] [2-152] [2-153]
Figure PCTKR2022005689-appb-img-000140
Figure PCTKR2022005689-appb-img-000140
[2-154] [2-155] [2-156] [2-157][2-154] [2-155] [2-156] [2-157]
Figure PCTKR2022005689-appb-img-000141
Figure PCTKR2022005689-appb-img-000141
[2-158] [2-159] [2-160] [2-161][2-158] [2-159] [2-160] [2-161]
Figure PCTKR2022005689-appb-img-000142
Figure PCTKR2022005689-appb-img-000142
[2-162] [2-163] [2-164] [2-165] [2-162] [2-163] [2-164] [2-165]
Figure PCTKR2022005689-appb-img-000143
Figure PCTKR2022005689-appb-img-000143
[2-166] [2-167] [2-168] [2-169][2-166] [2-167] [2-168] [2-169]
Figure PCTKR2022005689-appb-img-000144
Figure PCTKR2022005689-appb-img-000144
[2-170] [2-171] [2-172] [2-173][2-170] [2-171] [2-172] [2-173]
Figure PCTKR2022005689-appb-img-000145
Figure PCTKR2022005689-appb-img-000145
[2-174] [2-175] [2-176] [2-177][2-174] [2-175] [2-176] [2-177]
Figure PCTKR2022005689-appb-img-000146
Figure PCTKR2022005689-appb-img-000146
[2-178] [2-179] [2-180] [2-181][2-178] [2-179] [2-180] [2-181]
Figure PCTKR2022005689-appb-img-000147
Figure PCTKR2022005689-appb-img-000147
[2-182] [2-183] [2-184] [2-185][2-182] [2-183] [2-184] [2-185]
Figure PCTKR2022005689-appb-img-000148
Figure PCTKR2022005689-appb-img-000148
[2-186] [2-187] [2-188] [2-189][2-186] [2-187] [2-188] [2-189]
Figure PCTKR2022005689-appb-img-000149
Figure PCTKR2022005689-appb-img-000149
[2-190] [2-191] [2-192] [2-193][2-190] [2-191] [2-192] [2-193]
Figure PCTKR2022005689-appb-img-000150
Figure PCTKR2022005689-appb-img-000150
[2-194] [2-195] [2-196] [2-197][2-194] [2-195] [2-196] [2-197]
Figure PCTKR2022005689-appb-img-000151
Figure PCTKR2022005689-appb-img-000151
[2-198] [2-199] [2-200] [2-201][2-198] [2-199] [2-200] [2-201]
Figure PCTKR2022005689-appb-img-000152
Figure PCTKR2022005689-appb-img-000152
[2-202] [2-203] [2-204] [2-205][2-202] [2-203] [2-204] [2-205]
Figure PCTKR2022005689-appb-img-000153
Figure PCTKR2022005689-appb-img-000153
[2-206] [2-207] [2-208] [2-209][2-206] [2-207] [2-208] [2-209]
Figure PCTKR2022005689-appb-img-000154
Figure PCTKR2022005689-appb-img-000154
[2-210] [2-211] [2-212] [2-213][2-210] [2-211] [2-212] [2-213]
Figure PCTKR2022005689-appb-img-000155
Figure PCTKR2022005689-appb-img-000155
[2-214] [2-215] [2-216] [2-217][2-214] [2-215] [2-216] [2-217]
Figure PCTKR2022005689-appb-img-000156
Figure PCTKR2022005689-appb-img-000156
[2-218] [2-219] [2-220] [2-221][2-218] [2-219] [2-220] [2-221]
Figure PCTKR2022005689-appb-img-000157
Figure PCTKR2022005689-appb-img-000157
[2-222] [2-223][2-222] [2-223]
제1 화합물과 제2 화합물은 예컨대 1:99 내지 99:1의 중량비로 포함될 수 있다. 상기 범위로 포함됨으로써 제1 화합물의 전자 수송 능력과 제2 화합물의 정공 수송 능력을 이용해 적절한 중량비를 맞추어 바이폴라 특성을 구현하여 효율과 수명을 개선할 수 있다. 상기 범위 내에서 예컨대 약 10:90 내지 90:10, 약 20:80 내지 80:20의 중량비로 포함될 수 있고, 예컨대 약 20:80 내지 약 70: 30, 약 20:80 내지 약 60:40, 그리고 약 30:70 내지 약 60:40의 중량비로 포함될 수 있다. 구체적인 일 예로, 40:60, 50:50, 또는 60:40의 중량비로 포함될 수 있다.The first compound and the second compound may be included, for example, in a weight ratio of 1:99 to 99:1. By being included in the above range, it is possible to implement bipolar characteristics by matching an appropriate weight ratio using the electron transport ability of the first compound and the hole transport ability of the second compound to improve efficiency and lifespan. Within the above range, for example, it may be included in a weight ratio of about 10:90 to 90:10, about 20:80 to 80:20, such as about 20:80 to about 70:30, about 20:80 to about 60:40, And it may be included in a weight ratio of about 30:70 to about 60:40. As a specific example, it may be included in a weight ratio of 40:60, 50:50, or 60:40.
전술한 제1 화합물 및 제2 화합물 외에 1종 이상의 화합물을 더 포함할 수 있다. It may further include one or more compounds in addition to the first compound and the second compound described above.
전술한 유기 광전자 소자용 화합물 또는 유기 광전자 소자용 조성물은 도펀트를 더 포함하는 조성물일 수 있다. The compound for an organic optoelectronic device or the composition for an organic optoelectronic device described above may be a composition further comprising a dopant.
도펀트는 예컨대 인광 도펀트일 수 있고, 예컨대 적색, 녹색 또는 청색의 인광 도펀트일 수 있고, 예컨대 적색 또는 녹색 인광 도펀트일 수 있다.The dopant may be for example a phosphorescent dopant, for example a red, green or blue phosphorescent dopant, for example a red or green phosphorescent dopant.
도펀트는 유기 광전자 소자용 화합물 또는 조성물에 미량 혼합되어 발광을 일으키는 물질로, 일반적으로 삼중항 상태 이상으로 여기시키는 다중항 여기(multiple excitation)에 의해 발광하는 금속 착체(metal complex)와 같은 물질이 사용될 수 있다. 도펀트는 예컨대 무기, 유기, 유무기 화합물일 수 있으며, 1종 또는 2종 이상 포함될 수 있다.A dopant is a material that emits light by being mixed in a small amount in a compound or composition for an organic optoelectronic device. In general, a material such as a metal complex that emits light by multiple excitation excitation to a triplet state or more may be used. can The dopant may be, for example, an inorganic, organic, or organic-inorganic compound, and may include one or two or more kinds.
도펀트의 일 예로 인광 도펀트를 들 수 있으며, 인광 도펀트의 예로는 Ir, Pt, Os, Ti, Zr, Hf, Eu, Tb, Tm, Fe, Co, Ni, Ru, Rh, Pd 또는 이들의 조합을 포함하는 유기 금속화합물을 들 수 있다. 인광 도펀트는 예컨대 하기 화학식 Z로 표현되는 화합물을 사용할 수 있으나, 이에 한정되는 것은 아니다.Examples of the dopant include a phosphorescent dopant, and examples of the phosphorescent dopant include Ir, Pt, Os, Ti, Zr, Hf, Eu, Tb, Tm, Fe, Co, Ni, Ru, Rh, Pd, or a combination thereof. and organometallic compounds containing them. The phosphorescent dopant may be, for example, a compound represented by the following Chemical Formula Z, but is not limited thereto.
[화학식 Z][Formula Z]
L7MX3 L 7 MX 3
상기 화학식 Z에서, M은 금속이고, L7 및 X3은 서로 같거나 다르며 M과 착화합물을 형성하는 리간드이다. In Formula Z, M is a metal, and L 7 and X 3 are the same as or different from each other and are ligands forming a complex with M.
상기 M은 예컨대 Ir, Pt, Os, Ti, Zr, Hf, Eu, Tb, Tm, Fe, Co, Ni, Ru, Rh, Pd 또는 이들의 조합일 수 있고, 상기 L7 및 X3은 예컨대 바이덴테이트 리간드일 수 있다.M may be, for example, Ir, Pt, Os, Ti, Zr, Hf, Eu, Tb, Tm, Fe, Co, Ni, Ru, Rh, Pd or a combination thereof, and L 7 and X 3 are, for example, bi It may be a dentate ligand.
L7 및 X3 로 표시되는 리간드의 예로는 하기 그룹 A에 나열된 화학식에서 선택될 수 있으나 이에 한정되는 것은 아니다.Examples of the ligands represented by L 7 and X 3 may be selected from the formulas listed in Group A, but are not limited thereto.
[그룹 A][Group A]
Figure PCTKR2022005689-appb-img-000158
Figure PCTKR2022005689-appb-img-000158
상기 그룹 A에서,In group A,
R300 내지 R302는 각각 독립적으로, 수소, 중수소, 할로겐이 치환되거나 치환되지 않은 C1 내지 C30의 알킬기, C1 내지 C30의 알킬이 치환되거나 치환되지 않은 C6 내지 C30 아릴기 또는 할로겐이고,R 300 to R 302 are each independently hydrogen, deuterium, a halogen substituted or unsubstituted C1 to C30 alkyl group, a C1 to C30 alkyl substituted or unsubstituted C6 to C30 aryl group or halogen,
R303 내지 R324는 각각 독립적으로, 수소, 중수소, 할로겐, 치환 또는 비치환된 C1 내지 C30의 알킬기, 치환 또는 비치환된 C1 내지 C30 알콕시기, 치환 또는 비치환된 C3 내지 C30 시클로알킬기, 치환 또는 비치환된 C2 내지 C30의 알케닐기, 치환 또는 비치환된 C6 내지 C30 아릴기, 치환 또는 비치환된 C1 내지 C30 헤테로아릴기, 치환 또는 비치환된 C1 내지 C30 아미노기, 치환 또는 비치환된 C6 내지 C30 아릴아미노기, SF5, 치환 또는 비치환된 C1 내지 C30의 알킬기를 가지는 트리알킬실릴기, 치환 또는 비치환된 C1 내지 C30의 알킬기와 C6 내지 C30의 아릴기를 가지는 디알킬아릴실릴기, 또는 치환 또는 비치환된 C6 내지 C30의 아릴기를 가지는 트리아릴실릴기이다.R 303 to R 324 are each independently hydrogen, deuterium, halogen, a substituted or unsubstituted C1 to C30 alkyl group, a substituted or unsubstituted C1 to C30 alkoxy group, a substituted or unsubstituted C3 to C30 cycloalkyl group, substituted or an unsubstituted C2 to C30 alkenyl group, a substituted or unsubstituted C6 to C30 aryl group, a substituted or unsubstituted C1 to C30 heteroaryl group, a substituted or unsubstituted C1 to C30 amino group, a substituted or unsubstituted C6 to C30 arylamino group, SF 5 , a trialkylsilyl group having a substituted or unsubstituted C1 to C30 alkyl group, a dialkylarylsilyl group having a substituted or unsubstituted C1 to C30 alkyl group and a C6 to C30 aryl group, or It is a triarylsilyl group having a substituted or unsubstituted C6 to C30 aryl group.
일 예로 하기 화학식 Ⅴ로 표시되는 도펀트를 포함할 수 있다.For example, it may include a dopant represented by the following Chemical Formula V.
[화학식 Ⅴ] [Formula V]
Figure PCTKR2022005689-appb-img-000159
Figure PCTKR2022005689-appb-img-000159
상기 화학식 Ⅴ에서,In the above formula (V),
R101 내지 R116은 각각 독립적으로 수소, 중수소, 치환 또는 비치환된 C1 내지 C10 알킬기, 치환 또는 비치환된 C6 내지 C20 아릴기, 또는 -SiR132R133R134이고,R 101 to R 116 are each independently hydrogen, deuterium, a substituted or unsubstituted C1 to C10 alkyl group, a substituted or unsubstituted C6 to C20 aryl group, or —SiR 132 R 133 R 134 ;
상기 R132 내지 R134은 각각 독립적으로 C1 내지 C6 알킬기이고,wherein R 132 to R 134 are each independently a C1 to C6 alkyl group,
R101 내지 R116 중 적어도 하나는 하기 화학식 Ⅳ-1로 표시되는 작용기이고,At least one of R 101 to R 116 is a functional group represented by the following formula IV-1,
L100은 1가 음이온의 두자리(bidentate) 리간드로, 탄소 또는 헤테로원자의 비공유 전자쌍을 통하여 이리듐에 배위결합하는 리간드이고,L 100 is a bidentate ligand of a monovalent anion, and is a ligand that coordinates to iridium through a lone pair of electrons of carbon or heteroatom,
m1 및 m2은 서로 독립적으로 0 내지 3의 정수 중 어느 하나이고, m1 + m2는 1 내지 3의 정수 중 어느 하나이고,m1 and m2 are each independently any one of an integer of 0 to 3, m1 + m2 is any one of an integer of 1 to 3,
[화학식 Ⅴ-1][Formula V-1]
Figure PCTKR2022005689-appb-img-000160
Figure PCTKR2022005689-appb-img-000160
상기 화학식 Ⅴ-1에서,In Formula V-1,
R135 내지 R139은 각각 독립적으로 수소, 중수소, 치환 또는 비치환된 C1 내지 C10 알킬기, 치환 또는 비치환된 C6 내지 C20 아릴기, 또는 -SiR132R133R134이고,R 135 to R 139 are each independently hydrogen, deuterium, a substituted or unsubstituted C1 to C10 alkyl group, a substituted or unsubstituted C6 to C20 aryl group, or —SiR 132 R 133 R 134 ;
*는 탄소 원자와 연결되는 부분을 의미한다.* means a part connected to a carbon atom.
일 예로 하기 화학식 Z-1로 표시되는 도펀트를 포함할 수도 있다.For example, a dopant represented by the following Chemical Formula Z-1 may be included.
[화학식 Z-1][Formula Z-1]
Figure PCTKR2022005689-appb-img-000161
Figure PCTKR2022005689-appb-img-000161
상기 화학식 Z-1에서, 고리 A, B, C, 및 D는 각각 독립적으로 5원 또는 6원 카르보시클릭 또는 헤테로시클릭 고리를 나타내고;In the above formula (Z-1), rings A, B, C, and D each independently represent a 5- or 6-membered carbocyclic or heterocyclic ring;
RA, RB, RC, 및 RD는 각각 독립적으로 일치환, 이치환, 삼치환, 또는 사치환, 또는 비치환을 나타내고;R A , RB , R C , and R D each independently represent mono-, di-, tri-, or tetra-substituted, or unsubstituted;
LB, LC, 및 LD은 각각 직접 결합, BR, NR, PR, O, S, Se, C=O, S=O, SO2, CRR', SiRR', GeRR', 및 이의 조합으로 이루어진 군에서 독립적으로 선택되고;L B , L C , and L D are each a direct bond, BR, NR, PR, O, S, Se, C=O, S=O, SO 2 , CRR′, SiRR′, GeRR′, and combinations thereof independently selected from the group consisting of;
nA이 1인 경우, LE는 직접 결합, BR, NR, PR, O, S, Se, C=O, S=O, SO2, CRR', SiRR', GeRR', 및 이의 조합으로 이루어진 군에서 선택되고; nA이 0인 경우, LE는 존재하지 않고;When nA is 1, L E is a direct bond, BR, NR, PR, O, S, Se, C=O, S=O, SO 2 , CRR', SiRR', GeRR', and combinations thereof. is selected from; when nA is 0, L E is absent;
RA, RB, RC, RD, R, 및 R'은 각각 수소, 중수소, 할로겐, 알킬기, 시클로알킬기, 헤테로알킬기, 아릴알킬기, 알콕시기, 아릴옥시기, 아미노기, 실릴기, 알케닐기, 시클로알케닐기, 헤테로알케닐기, 알키닐기, 아릴기, 헤테로아릴기, 아실기, 카르보닐기, 카르복실산기, 에스테르기, 니트릴기, 이소니트릴기, 설파닐기, 설피닐기, 설포닐기, 포스피노기, 및 이의 조합으로 이루어진 군에서 독립적으로 선택되고; 임의의 인접 RA, RB, RC, RD, R, 및 R'은 임의 연결되어 고리를 형성하고; XB, XC, XD, 및 XE는 각각 탄소 및 질소로 이루어진 군에서 독립적으로 선택되고; Q1, Q2, Q3, 및 Q4는 각각 산소 또는 직접 결합을 나타낸다.R A , RB , R C , R D , R , and R' are each hydrogen, deuterium, halogen, an alkyl group, a cycloalkyl group, a heteroalkyl group, an arylalkyl group, an alkoxy group, an aryloxy group, an amino group, a silyl group, an alkenyl group , cycloalkenyl group, heteroalkenyl group, alkynyl group, aryl group, heteroaryl group, acyl group, carbonyl group, carboxylic acid group, ester group, nitrile group, isonitrile group, sulfanyl group, sulfinyl group, sulfonyl group, phosphino group independently selected from the group consisting of , and combinations thereof; any adjacent R A , R B , R C , R D , R , and R′ are optionally joined to form a ring; X B , X C , X D , and X E are each independently selected from the group consisting of carbon and nitrogen; Q 1 , Q 2 , Q 3 , and Q 4 each represent oxygen or a direct bond.
일 실시예에 따른 도펀트는 백금 착물일 수 있으며, 예컨대 하기 화학식 Ⅵ로 표현될 수 있다.The dopant according to an embodiment may be a platinum complex, for example, it may be represented by the following Chemical Formula VI.
[화학식 Ⅵ][Formula Ⅵ]
Figure PCTKR2022005689-appb-img-000162
Figure PCTKR2022005689-appb-img-000162
상기 화학식 Ⅵ에서,In the above formula (VI),
X100은 O, S 및 NR131 중에서 선택되고,X 100 is selected from O, S and NR 131 ,
R117 내지 R131은 각각 독립적으로 수소, 중수소, 치환 또는 비치환된 C1 내지 C10 알킬기, 치환 또는 비치환된 C6 내지 C20 아릴기, 또는 - SiR132R133R134이고,R 117 to R 131 are each independently hydrogen, deuterium, a substituted or unsubstituted C1 to C10 alkyl group, a substituted or unsubstituted C6 to C20 aryl group, or —SiR 132 R 133 R 134 ;
상기 R132 내지 R134은 각각 독립적으로 C1 내지 C6 알킬기이고,wherein R 132 to R 134 are each independently a C1 to C6 alkyl group,
R117 내지 R131중 적어도 하나는 -SiR132R133R134 또는 tert-부틸기이다.At least one of R 117 to R 131 is -SiR 132 R 133 R 134 or a tert-butyl group.
이하 상술한 유기 광전자 소자용 화합물 또는 유기 광전자 소자용 조성물을 적용한 유기 광전자 소자를 설명한다.Hereinafter, an organic optoelectronic device to which the above-described compound for an organic optoelectronic device or a composition for an organic optoelectronic device is applied will be described.
유기 광전자 소자는 전기 에너지와 광 에너지를 상호 전환할 수 있는 소자이면 특별히 한정되지 않으며, 예컨대 유기 광전 소자, 유기 발광 소자, 유기 태양 전지 및 유기 감광체 드럼 등을 들 수 있다.The organic optoelectronic device is not particularly limited as long as it is a device capable of converting electrical energy and optical energy, and examples thereof include an organic photoelectric device, an organic light emitting device, an organic solar cell, and an organic photosensitive drum.
여기서는 유기 광전자 소자의 일 예인 유기 발광 소자를 도면을 참고하여 설명한다.Herein, an organic light emitting device, which is an example of an organic optoelectronic device, will be described with reference to the drawings.
도 1은 일 구현예에 따른 유기 발광 소자를 보여주는 단면도이다.1 is a cross-sectional view illustrating an organic light emitting diode according to an exemplary embodiment.
도 1을 참고하면, 일 구현예에 따른 유기 발광 소자 (100)는 서로 마주하는 양극(120)과 음극(110), 그리고 양극(120)과 음극(110) 사이에 위치하는 유기층(105)을 포함한다.Referring to FIG. 1 , an organic light emitting device 100 according to an embodiment includes an anode 120 and a cathode 110 facing each other, and an organic layer 105 positioned between the anode 120 and the cathode 110 . include
양극(120)은 예컨대 정공 주입이 원활하도록 일 함수가 높은 도전체로 만들어질 수 있으며, 예컨대 금속, 금속 산화물 및/또는 도전성 고분자로 만들어질 수 있다. 양극(120)은 예컨대 니켈, 백금, 바나듐, 크롬, 구리, 아연, 금과 같은 금속 또는 이들의 합금; 아연산화물, 인듐산화물, 인듐주석산화물(ITO), 인듐아연산화물(IZO)과 같은 금속 산화물; ZnO와 Al 또는 SnO2와 Sb와 같은 금속과 산화물의 조합; 폴리(3-메틸티오펜), 폴리(3,4-(에틸렌-1,2-디옥시)티오펜)(polyehtylenedioxythiophene: PEDOT), 폴리피롤 및 폴리아닐린과 같은 도전성 고분자 등을 들 수 있으나, 이에 한정되는 것은 아니다. The anode 120 may be made of, for example, a conductor having a high work function to facilitate hole injection, and may be made of, for example, a metal, a metal oxide, and/or a conductive polymer. The anode 120 may include, for example, a metal such as nickel, platinum, vanadium, chromium, copper, zinc, gold, or an alloy thereof; metal oxides such as zinc oxide, indium oxide, indium tin oxide (ITO), and indium zinc oxide (IZO); combinations of metals and oxides such as ZnO and Al or SnO 2 and Sb; conductive polymers such as poly(3-methylthiophene), poly(3,4-(ethylene-1,2-dioxy)thiophene) (polyehtylenedioxythiophene: PEDOT), polypyrrole, and polyaniline, but the present invention is not limited thereto. it is not
음극(110)은 예컨대 전자 주입이 원활하도록 일 함수가 낮은 도전체로 만들어질 수 있으며, 예컨대 금속, 금속 산화물 및/또는 도전성 고분자로 만들어질 수 있다. 음극(110)은 예컨대 마그네슘, 칼슘, 나트륨, 칼륨, 타이타늄, 인듐, 이트륨, 리튬, 가돌리늄, 알루미늄, 은, 주석, 납, 세슘, 바륨 등과 같은 금속 또는 이들의 합금; LiF/Al, LiO2/Al, LiF/Ca, LiF/Al 및 BaF2/Ca과 같은 다층 구조 물질을 들 수 있으나, 이에 한정되는 것은 아니다. The cathode 110 may be made of, for example, a conductor having a low work function to facilitate electron injection, and may be made of, for example, a metal, a metal oxide, and/or a conductive polymer. The negative electrode 110 may include, for example, a metal such as magnesium, calcium, sodium, potassium, titanium, indium, yttrium, lithium, gadolinium, aluminum, silver, tin, lead, cesium, barium, or an alloy thereof; and a multilayer structure material such as LiF/Al, LiO 2 /Al, LiF/Ca, LiF/Al, and BaF 2 /Ca, but is not limited thereto.
유기층(105)은 전술한 유기 광전자 소자용 화합물 또는 유기 광전자 소자용 조성물을 포함할 수 있다. The organic layer 105 may include the aforementioned compound for an organic optoelectronic device or a composition for an organic optoelectronic device.
상기 유기층(105)는 발광층(130)을 포함하고, 발광층(130)은 전술한 유기 광전자 소자용 화합물 또는 유기 광전자 소자용 조성물을 포함할 수 있다. The organic layer 105 may include the emission layer 130 , and the emission layer 130 may include the aforementioned compound for an organic optoelectronic device or a composition for an organic optoelectronic device.
도펀트를 더욱 포함하는 상기 유기 광전자 소자용 조성물은 예컨대 적색 발광 조성물일 수 있다.The composition for an organic optoelectronic device further comprising a dopant may be, for example, a red light-emitting composition.
발광층(130)은 예컨대 전술한 제1 유기 광전자 소자용 화합물과 제2 유기 광전자 소자용 화합물을 각각 인광 호스트로서 포함할 수 있다.The emission layer 130 may include, for example, the above-described first compound for an organic optoelectronic device and the second compound for an organic optoelectronic device, respectively, as a phosphorescent host.
유기층은 발광층 외에 전하 수송 영역을 더 포함할 수 있다.The organic layer may further include a charge transport region in addition to the emission layer.
상기 전하 수송 영역은 예컨대 정공 수송 영역(140)일 수 있다.The charge transport region may be, for example, the hole transport region 140 .
상기 정공 수송 영역(140)은 양극(120)과 발광층(130) 사이의 정공 주입 및/또는 정공 이동성을 더욱 높이고 전자를 차단할 수 있다. 구체적으로 상기 정공 수송 영역(140)은 양극(120)과 발광층(130) 사이의 정공 수송층, 및 상기 발광층(130)과 상기 정공 수송층 사이의 정공 수송 보조층을 포함할 수 있고, 하기 그룹 E에 나열된 화합물 중 적어도 하나는 상기 정공 수송층, 및 정공 수송 보조층 중 적어도 하나의 층에 포함될 수 있다.The hole transport region 140 may further increase hole injection and/or hole mobility between the anode 120 and the emission layer 130 and block electrons. Specifically, the hole transport region 140 may include a hole transport layer between the anode 120 and the light emitting layer 130 and a hole transport auxiliary layer between the light emitting layer 130 and the hole transport layer. At least one of the listed compounds may be included in at least one of the hole transport layer and the hole transport auxiliary layer.
[그룹 E][Group E]
Figure PCTKR2022005689-appb-img-000163
Figure PCTKR2022005689-appb-img-000163
Figure PCTKR2022005689-appb-img-000164
Figure PCTKR2022005689-appb-img-000164
Figure PCTKR2022005689-appb-img-000165
Figure PCTKR2022005689-appb-img-000165
Figure PCTKR2022005689-appb-img-000166
Figure PCTKR2022005689-appb-img-000166
Figure PCTKR2022005689-appb-img-000167
Figure PCTKR2022005689-appb-img-000167
Figure PCTKR2022005689-appb-img-000168
Figure PCTKR2022005689-appb-img-000168
Figure PCTKR2022005689-appb-img-000169
Figure PCTKR2022005689-appb-img-000169
Figure PCTKR2022005689-appb-img-000170
Figure PCTKR2022005689-appb-img-000170
Figure PCTKR2022005689-appb-img-000171
Figure PCTKR2022005689-appb-img-000171
Figure PCTKR2022005689-appb-img-000172
Figure PCTKR2022005689-appb-img-000172
Figure PCTKR2022005689-appb-img-000173
Figure PCTKR2022005689-appb-img-000173
Figure PCTKR2022005689-appb-img-000174
Figure PCTKR2022005689-appb-img-000174
Figure PCTKR2022005689-appb-img-000175
Figure PCTKR2022005689-appb-img-000175
Figure PCTKR2022005689-appb-img-000176
Figure PCTKR2022005689-appb-img-000176
Figure PCTKR2022005689-appb-img-000177
Figure PCTKR2022005689-appb-img-000177
Figure PCTKR2022005689-appb-img-000178
Figure PCTKR2022005689-appb-img-000178
Figure PCTKR2022005689-appb-img-000179
Figure PCTKR2022005689-appb-img-000179
Figure PCTKR2022005689-appb-img-000180
Figure PCTKR2022005689-appb-img-000180
Figure PCTKR2022005689-appb-img-000181
Figure PCTKR2022005689-appb-img-000181
Figure PCTKR2022005689-appb-img-000182
Figure PCTKR2022005689-appb-img-000182
Figure PCTKR2022005689-appb-img-000183
Figure PCTKR2022005689-appb-img-000183
Figure PCTKR2022005689-appb-img-000184
Figure PCTKR2022005689-appb-img-000184
Figure PCTKR2022005689-appb-img-000185
Figure PCTKR2022005689-appb-img-000185
상기 정공 수송 영역(140)에는 전술한 화합물 외에도 US5061569A, JP1993-009471A, WO1995-009147A1, JP1995-126615A, JP1998-095973A 등에 기재된 공지의 화합물 및 이와 유사한 구조의 화합물도 사용될 수 있다.In the hole transport region 140, in addition to the compounds described above, known compounds described in US5061569A, JP1993-009471A, WO1995-009147A1, JP1995-126615A, JP1998-095973A, and the like, and compounds having a similar structure may also be used.
또한, 상기 전하 수송 영역은 예컨대 전자 수송 영역(150)일 수 있다.Also, the charge transport region may be, for example, the electron transport region 150 .
상기 전자 수송 영역(150)은 음극(110)과 발광층(130) 사이의 전자 주입 및/또는 전자 이동성을 더욱 높이고 정공을 차단할 수 있다.The electron transport region 150 may further increase electron injection and/or electron mobility between the cathode 110 and the emission layer 130 and block holes.
구체적으로 상기 전자 수송 영역(150)은 음극(110)과 발광층(130) 사이의 전자 수송층, 및 상기 발광층(130)과 상기 전자 수송층 사이의 전자 수송 보조층을 포함할 수 있고, 하기 그룹 F에 나열된 화합물 중 적어도 하나는 상기 전자 수송층, 및 전자 수송 보조층 중 적어도 하나의 층에 포함될 수 있다.Specifically, the electron transport region 150 may include an electron transport layer between the cathode 110 and the light emitting layer 130, and an electron transport auxiliary layer between the light emitting layer 130 and the electron transport layer. At least one of the listed compounds may be included in at least one of the electron transport layer and the electron transport auxiliary layer.
[그룹 F] [Group F]
Figure PCTKR2022005689-appb-img-000186
Figure PCTKR2022005689-appb-img-000186
Figure PCTKR2022005689-appb-img-000187
Figure PCTKR2022005689-appb-img-000187
Figure PCTKR2022005689-appb-img-000188
Figure PCTKR2022005689-appb-img-000188
Figure PCTKR2022005689-appb-img-000189
Figure PCTKR2022005689-appb-img-000189
Figure PCTKR2022005689-appb-img-000190
Figure PCTKR2022005689-appb-img-000190
Figure PCTKR2022005689-appb-img-000191
Figure PCTKR2022005689-appb-img-000191
Figure PCTKR2022005689-appb-img-000192
Figure PCTKR2022005689-appb-img-000192
Figure PCTKR2022005689-appb-img-000193
Figure PCTKR2022005689-appb-img-000193
Figure PCTKR2022005689-appb-img-000194
Figure PCTKR2022005689-appb-img-000194
Figure PCTKR2022005689-appb-img-000195
Figure PCTKR2022005689-appb-img-000195
Figure PCTKR2022005689-appb-img-000196
Figure PCTKR2022005689-appb-img-000196
Figure PCTKR2022005689-appb-img-000197
Figure PCTKR2022005689-appb-img-000197
Figure PCTKR2022005689-appb-img-000198
Figure PCTKR2022005689-appb-img-000198
Figure PCTKR2022005689-appb-img-000199
Figure PCTKR2022005689-appb-img-000199
Figure PCTKR2022005689-appb-img-000200
Figure PCTKR2022005689-appb-img-000200
Figure PCTKR2022005689-appb-img-000201
Figure PCTKR2022005689-appb-img-000201
Figure PCTKR2022005689-appb-img-000202
Figure PCTKR2022005689-appb-img-000202
일 구현예는 유기층으로서 발광층을 포함한 유기 발광 소자일 수 있다.One embodiment may be an organic light emitting device including a light emitting layer as an organic layer.
다른 일 구현예는 유기층으로서 발광층 및 정공 수송 영역을 포함한 유기 발광 소자일 수 있다.Another embodiment may be an organic light emitting device including a light emitting layer and a hole transport region as an organic layer.
또 다른 일 구현예는 유기층으로서 발광층 및 전자 수송 영역을 포함한 유기 발광 소자일 수 있다.Another embodiment may be an organic light emitting device including a light emitting layer and an electron transport region as an organic layer.
본 발명의 일 구현예에 따른 유기 발광 소자는 도 1에서와 같이 유기층(105)으로서 발광층(130) 외에 정공 수송 영역(140) 및 전자 수송 영역(150)을 포함할 수 있다.As shown in FIG. 1 , the organic light emitting device according to an embodiment of the present invention may include a hole transport region 140 and an electron transport region 150 in addition to the emission layer 130 as the organic layer 105 .
한편, 유기 발광 소자는 전술한 유기층으로서 발광층 외에 추가로 전자주입층(미도시), 정공주입층(미도시) 등을 더 포함할 수도 있다. On the other hand, the organic light emitting device may further include an electron injection layer (not shown), a hole injection layer (not shown), etc. in addition to the light emitting layer as the above-described organic layer.
유기 발광 소자(100)는 기판 위에 양극 또는 음극을 형성한 후, 진공증착법(evaporation), 스퍼터링(sputtering), 플라즈마 도금 및 이온도금과 같은 건식성막법 등으로 유기층을 형성한 후, 그 위에 음극 또는 양극을 형성하여 제조할 수 있다.After forming an anode or cathode on a substrate, the organic light emitting device 100 forms an organic layer by a dry film deposition method such as vacuum deposition, sputtering, plasma plating and ion plating, etc., and then a cathode or a It can be manufactured by forming an anode.
상술한 유기 발광 소자는 유기 발광 표시 장치에 적용될 수 있다.The above-described organic light emitting device may be applied to an organic light emitting display device.
이하 실시예를 통하여 상술한 구현예를 보다 상세하게 설명한다.  다만 하기의 실시예는 단지 설명의 목적을 위한 것이며 권리범위를 제한하는 것은 아니다.The above-described embodiment will be described in more detail through the following examples. However, the following examples are for illustrative purposes only and do not limit the scope of rights.
이하, 실시예 및 합성예에서 사용된 출발물질 및 반응물질은 특별한 언급이 없는 한, Sigma-Aldrich 社, TCI 社, tokyo chemical industry 또는 P&H tech에서 구입하였거나, 공지된 방법을 통해 합성하였다.Hereinafter, unless otherwise specified, starting materials and reactants used in Examples and Synthesis Examples were purchased from Sigma-Aldrich, TCI, Tokyo chemical industry, or P&H tech, or synthesized through a known method.
(유기 광전자 소자용 화합물의 제조)(Production of compounds for organic optoelectronic devices)
본 발명의 화합물의 보다 구체적인 예로서 제시된 화합물을 하기 단계를 통해 합성하였다.The compound presented as a more specific example of the compound of the present invention was synthesized through the following steps.
합성예 1: 중간체 A의 합성Synthesis Example 1: Synthesis of Intermediate A
[반응식 1][Scheme 1]
Figure PCTKR2022005689-appb-img-000203
Figure PCTKR2022005689-appb-img-000203
1단계: 중간체 A-1의 합성Step 1: Synthesis of Intermediate A-1
둥근바닥플라스크에 2-bromo-3-chlorobenzaldehyde 40.0 g (182.27 mmol), naphthalen-1-ylboronic acid 34.48 g (200.49 mmol), Pd(dppf)Cl2 8.93 g (10.94 mmol), K2CO3 75.57 g (546.80 mmol)을 Dioxane 400 m/ 증류수 200 ml에 현탁시킨 후 12 시간 동안 상온에서 교반 한다. 반응 종료 후 농축하고 Methylene Chloride로 추출하여 유기층을 Silicagel columm 하여 중간체 A-1 41.41 g (Yield 85%)을 획득하였다.In a round bottom flask, 40.0 g (182.27 mmol) of 2-bromo-3-chlorobenzaldehyde, 34.48 g (200.49 mmol) of naphthalen-1-ylboronic acid, 8.93 g (10.94 mmol) of Pd(dppf)Cl 2 , 75.57 g of K 2 CO 3 (546.80 mmol) was suspended in 400 m of Dioxane/200 ml of distilled water and stirred at room temperature for 12 hours. After completion of the reaction, the reaction was concentrated, extracted with methylene chloride, and the organic layer was subjected to silicagel column to obtain 41.41 g (yield 85%) of intermediate A-1.
2단계: 중간체 A-2의 합성Step 2: Synthesis of Intermediate A-2
중간체 A-1 41.4 g (155.29 mmol) 과 (methoxymethyl)triphenylphosphonium chloride 58.55 g (170.82 mmol)을 THF 400 ml에 현탁 시킨 후 Potassium tert-Butoxide 20.91 g (186.34 mmol)을 가한 후 12 시간 동안 상온에서 교반 하였다. 반응 종료 후 증류수 500 ml를 첨가한 후 추출하고, 유기층을 농축한 후 Methylene Chloride로 재추출하고 유기층을 Magnesium Sulfate를 첨가한 후 30분 교반한 후 Filter 하고 여액을 농축하였다. 농축한 여액에 다시 Methylene Chloride 100 ml 를 가한 후 Methanesulfonic acid 20 ml를 첨가한 후 1시간 교반하였다. 반응 종료 후 생성된 고체를 filter 하고 증류수 및 Methyl Alcohol로 씻어준 후 건조하여 중간체 A-2 20.5 g (50% Yield)를 획득하였다.Intermediate A-1 41.4 g (155.29 mmol) and (methoxymethyl)triphenylphosphonium chloride 58.55 g (170.82 mmol) were suspended in 400 ml of THF, and 20.91 g (186.34 mmol) of Potassium tert-Butoxide was added thereto, followed by stirring at room temperature for 12 hours. . After completion of the reaction, 500 ml of distilled water was added, followed by extraction, and the organic layer was concentrated and re-extracted with Methylene Chloride. Magnesium Sulfate was added to the organic layer, stirred for 30 minutes, filtered, and the filtrate was concentrated. After adding 100 ml of Methylene Chloride to the concentrated filtrate, 20 ml of Methanesulfonic acid was added, followed by stirring for 1 hour. After completion of the reaction, the resulting solid was filtered, washed with distilled water and methyl alcohol, and dried to obtain 20.5 g (50% yield) of Intermediate A-2.
3단계: 중간체 A의 합성Step 3: Synthesis of Intermediate A
중간체 A-2 10.0 g (38.06 mmol), Bis(pinacolato)diboron 12.56 g(49.48 mmol), Pd2(dba)3 2.09 g (2.28 mmol), P(Cy)3 2.56 g (9.13 mmol), 및 KOAc 11.21 g (114.18 mmol)을 Xylene 100 ml에 현탁시킨 후 12 시간 동안 환류 교반한다. 반응 종료 후 반응 용매를 회전식 증발기로 제거한 후 Methylene Chloride로 추출하여 유기층을 Hexane : EA = 4 : 1(v/v) 로 컬럼하여 중간체 A 13 g (96% Yield)을 획득하였다.Intermediate A-2 10.0 g (38.06 mmol), Bis(pinacolato)diboron 12.56 g (49.48 mmol), Pd 2 (dba) 3 2.09 g (2.28 mmol), P(Cy) 3 2.56 g (9.13 mmol), and KOAc 11.21 g (114.18 mmol) was suspended in 100 ml of Xylene and stirred under reflux for 12 hours. After completion of the reaction, the reaction solvent was removed with a rotary evaporator, extracted with methylene chloride, and the organic layer was columned with Hexane: EA = 4 : 1 (v/v) to obtain 13 g (96% Yield) of Intermediate A.
중간체 B, 중간체 C, 중간체 D는 상기 합성예 1의 1단계에서 2-bromo-3-chlorobenzaldehyde 대신 2-bromo-4-chlorobenzaldehyde, 2-bromo-5-chlorobenzaldehyde, 및 2-bromo-6-chlorobenzaldehyde를 각각 사용하여 반응을 진행시킨 것을 제외하고는 합성예 1과 동일한 방법으로 합성하였다.Intermediate B, Intermediate C, and Intermediate D were prepared by using 2-bromo-4-chlorobenzaldehyde, 2-bromo-5-chlorobenzaldehyde, and 2-bromo-6-chlorobenzaldehyde instead of 2-bromo-3-chlorobenzaldehyde in step 1 of Synthesis Example 1. It was synthesized in the same manner as in Synthesis Example 1, except that the reaction was carried out using each.
Figure PCTKR2022005689-appb-img-000204
Figure PCTKR2022005689-appb-img-000204
합성예 2: 화합물 12의 합성Synthesis Example 2: Synthesis of compound 12
[반응식 2][Scheme 2]
Figure PCTKR2022005689-appb-img-000205
Figure PCTKR2022005689-appb-img-000205
둥근 바닥 플라스크에 중간체 A 10.42 g (26.48 mmol), int-1 9.00 g (22.07 mmol), Pd(PPh3)4 0.76 g (0.66 mmol), 및 K2CO3 9.15 g (66.20 mmol)을 넣고 THF 150 mL, 및 증류수 75 mL에 녹인 후 질소 대기하에서 가열 환류한다. 12 시간 후 반응액을 냉각시키고, 물층을 제거한 후, 유기층을 감압하에서 건조시킨다. 얻어진 고체를 물과 Methanol로 씻어준 후, 고체를 Toluene 200 mL로 재결정하여 화합물 12를 10.0 g(76% 수율) 얻었다.Intermediate A 10.42 g (26.48 mmol), int-1 9.00 g (22.07 mmol), Pd(PPh 3 ) 4 0.76 g (0.66 mmol), and K 2 CO 3 9.15 g (66.20 mmol) were placed in a round bottom flask and THF After dissolving in 150 mL and 75 mL of distilled water, it is heated to reflux under nitrogen atmosphere. After 12 hours, the reaction solution is cooled, the water layer is removed, and the organic layer is dried under reduced pressure. After washing the obtained solid with water and methanol, the solid was recrystallized with 200 mL of Toluene to obtain 10.0 g (76% yield) of Compound 12.
LC/MS calculated for: C43H25N3O Exact Mass: 599.20 found for 599.84 [M+H]LC/MS calculated for: C43H25N3O Exact Mass: 599.20 found for 599.84 [M+H]
합성예 3 내지 15Synthesis Examples 3 to 15
합성예 2에서 중간체 A 및/또는 int-1 대신 Int A 및/또는 Int B를 각각 사용하여 합성예 2와 동일한 방법으로 반응시켜 하기 표 1에 따른 화합물을 각각 합성하였다.In Synthesis Example 2, each compound according to Table 1 was synthesized by reacting in the same manner as in Synthesis Example 2 using Int A and/or Int B instead of Intermediate A and/or int-1, respectively.
합성예Synthesis example Int AInt A Int BInt B 최종
생성물
final
product
수득량
(수율)
yield
(transference number)
최종생성물의
물성 데이터
of the final product
physical data
합성예 3Synthesis Example 3 중간체 BIntermediate B int-2int-2 화합물 32compound 32 7.94g, (75%)7.94 g, (75%) LC/MS calculated for: C43H27N3 Exact Mass: 585.22 found for 585.86 [M+H]LC/MS calculated for: C43H27N3 Exact Mass: 585.22 found for 585.86 [M+H]
합성예 4Synthesis Example 4 중간체 BIntermediate B int-3int-3 화합물 33compound 33 8.38g, (69%)8.38 g, (69%) LC/MS calculated for: C39H23N3O Exact Mass: 549.18 found for 549.85 [M+H]LC/MS calculated for: C39H23N3O Exact Mass: 549.18 found for 549.85 [M+H]
합성예 5Synthesis Example 5 중간체 BIntermediate B int-4int-4 화합물 36compound 36 8.69g, (71%)8.69 g, (71%) LC/MS calculated for: C39H24N4 Exact Mass: 548.20 found for 548.75 [M+H]LC/MS calculated for: C39H24N4 Exact Mass: 548.20 found for 548.75 [M+H]
합성예 6Synthesis Example 6 중간체 BIntermediate B int-1int-1 화합물 40compound 40 7.64g, (76%)7.64 g, (76%) LC/MS calculated for: C43H25N3O Exact Mass: 599.20 found for 599.68 [M+H]LC/MS calculated for: C43H25N3O Exact Mass: 599.20 found for 599.68 [M+H]
합성예 7Synthesis Example 7 중간체 BIntermediate B int-5int-5 화합물 43compound 43 5.41g, (70%)5.41 g, (70%) LC/MS calculated for: C43H27N3 Exact Mass: 585.22 found for 585.73 [M+H]LC/MS calculated for: C43H27N3 Exact Mass: 585.22 found for 585.73 [M+H]
합성예 8Synthesis Example 8 중간체 CIntermediate C int-2int-2 화합물 60compound 60 6.81g, (75%)6.81 g, (75%) LC/MS calculated for: C43H27N3 Exact Mass: 585.22 found for 585.87 [M+H]LC/MS calculated for: C43H27N3 Exact Mass: 585.22 found for 585.87 [M+H]
합성예 9Synthesis Example 9 중간체 CIntermediate C int-3int-3 화합물 61compound 61 7.51g, (65%)7.51 g, (65%) LC/MS calculated for: C39H23N3O Exact Mass: 549.18 found for 549.65 [M+H]LC/MS calculated for: C39H23N3O Exact Mass: 549.18 found for 549.65 [M+H]
합성예 10Synthesis Example 10 중간체 DIntermediate D int-2int-2 화합물 88compound 88 6.43g, (75%)6.43 g, (75%) LC/MS calculated for: C43H27N3 Exact Mass: 585.22 found for 585.89 [M+H]LC/MS calculated for: C43H27N3 Exact Mass: 585.22 found for 585.89 [M+H]
합성예 11Synthesis Example 11 중간체 DIntermediate D int-3int-3 화합물 89compound 89 6.09g, (68%)6.09 g, (68%) LC/MS calculated for: C39H23N3O Exact Mass: 549.18 found for 549.76 [M+H]LC/MS calculated for: C39H23N3O Exact Mass: 549.18 found for 549.76 [M+H]
합성예 12Synthesis Example 12 중간체 DIntermediate D int-4int-4 화합물 92compound 92 7.47g, (79%)7.47 g, (79%) LC/MS calculated for: C39H24N4 Exact Mass: 548.20 found for 549.24 [M+H]LC/MS calculated for: C39H24N4 Exact Mass: 548.20 found for 549.24 [M+H]
합성예 13Synthesis Example 13 중간체 DIntermediate D int-6int-6 화합물 97compound 97 5.74g, (77%)5.74 g, (77%) LC/MS calculated for: C43H27N3 Exact Mass: 585.22 found for 586.13 [M+H]LC/MS calculated for: C43H27N3 Exact Mass: 585.22 found for 586.13 [M+H]
합성예 14Synthesis Example 14 중간체 DIntermediate D int-5int-5 화합물 99compound 99 7.42g, (77%)7.42 g, (77%) LC/MS calculated for: C43H27N3 Exact Mass: 585.22 found for 586.15 [M+H]LC/MS calculated for: C43H27N3 Exact Mass: 585.22 found for 586.15 [M+H]
합성예 15Synthesis Example 15 중간체 DIntermediate D int-7int-7 화합물 103compound 103 8.55g, (77%)8.55 g, (77%) LC/MS calculated for: C49H29N3O Exact Mass: 675.23 found for 676.11 [M+H]LC/MS calculated for: C49H29N3O Exact Mass: 675.23 found for 676.11 [M+H]
<Int A><Int A>
Figure PCTKR2022005689-appb-img-000206
Figure PCTKR2022005689-appb-img-000206
<Int B><Int B>
Figure PCTKR2022005689-appb-img-000207
Figure PCTKR2022005689-appb-img-000207
비교합성예 1: 화합물 V1의 합성Comparative Synthesis Example 1: Synthesis of Compound V1
[반응식 3][Scheme 3]
Figure PCTKR2022005689-appb-img-000208
Figure PCTKR2022005689-appb-img-000208
1단계: 중간체 V1-1의 합성Step 1: Synthesis of Intermediate V1-1
둥근바닥플라스크에 2-bromobenzaldehyde 40.0 g (216.19 mmol), naphthalen-1-ylboronic acid 40.90 g (237.81 mmol), Pd(dppf)Cl2 10.59 g (12.97 mmol), 및 K2CO3 89.64 g (648.58 mmol)을 Dioxane 500 m/ 증류수 250 ml에 현탁시킨 후 12 시간 동안 상온에서 교반 한다. 반응 종료 후 농축하고 Methylene Chloride로 추출하여 유기층을 Silicagel columm 하여 중간체 V1-1 41.01 g (Yield 82%)을 획득하였다.In a round-bottom flask, 40.0 g (216.19 mmol) of 2-bromobenzaldehyde, 40.90 g (237.81 mmol) of naphthalen-1-ylboronic acid, 10.59 g (12.97 mmol) of Pd(dppf)Cl 2 , and 89.64 g (648.58 mmol) of K 2 CO 3 . ) was suspended in 500 m of Dioxane/250 ml of distilled water and stirred at room temperature for 12 hours. After completion of the reaction, the reaction was concentrated, extracted with methylene chloride, and the organic layer was subjected to silicagel column to obtain 41.01 g (yield 82%) of intermediate V1-1.
2단계: 중간체 V1-2의 합성Step 2: Synthesis of Intermediate V1-2
중간체 V1-1 40.70 g (175.22mmol) 과 (methoxymethyl)triphenylphosphonium chloride 66.07 g (192.74 mmol)을 THF 600 ml에 현탁 시킨 후 Potassium tert-Butoxide 23.59 g (210.26 mmol)을 가한 후 12 시간 동안 상온에서 교반 하였다. 반응 종료 후 증류수 500 ml를 첨가한 후 추출하고, 유기층을 농축한 후 Methylene Chloride로 재추출하고 유기층을 Magnesium Sulfate를 첨가한 후 30분 교반한 후 Filter 하고 여액을 농축하였다. 농축한 여액에 다시 Methylene Chloride 350 ml 를 가한 후 Methanesulfonic acid 23 ml를 첨가한 후 1시간 교반하였다. 반응 종료 후 생성된 고체를 filter 하고 증류수 및 Methyl Alcohol로 씻어준 후 건조하여 중간체 V1-2 20.0 g (50% Yield)를 획득하였다.Intermediate V1-1 40.70 g (175.22mmol) and (methoxymethyl)triphenylphosphonium chloride 66.07 g (192.74 mmol) were suspended in 600 ml of THF, 23.59 g (210.26 mmol) of Potassium tert-Butoxide was added thereto, followed by stirring at room temperature for 12 hours. . After completion of the reaction, 500 ml of distilled water was added, followed by extraction, and the organic layer was concentrated and re-extracted with Methylene Chloride, and the organic layer was stirred for 30 minutes after addition of Magnesium Sulfate, filtered and the filtrate was concentrated. To the concentrated filtrate, 350 ml of methylene chloride was added, 23 ml of methanesulfonic acid was added, and the mixture was stirred for 1 hour. After completion of the reaction, the resulting solid was filtered, washed with distilled water and methyl alcohol, and dried to obtain 20.0 g (50% yield) of intermediate V1-2.
3단계: 중간체 V1-3의 합성Step 3: Synthesis of intermediate V1-3
중간체 V1-2 9.0 g (39.42 mmol)을 클로로폼 용매(300mL)에 녹인다. Br2 4.45 mL (86.72 mmol)을 천천히 적가한다. 5시간 후에 물을 넣어 반응을 종결시킨 후 디클로로메탄으로 추출하여 얻어진 유기층에 무수황산마그네슘을 넣어 물을 제거한 후, 실리카여과를 하여준다. 얻어진 유기용매를 감압 증류를 통하여 제거한 후, 디클로로메탄(100mL)와 메탄올(300mL)로 재결정하여 중간체 V1-3 12.94 g (85 % Yield)를 얻었다.9.0 g (39.42 mmol) of intermediate V1-2 is dissolved in chloroform solvent (300 mL). 4.45 mL (86.72 mmol) of Br 2 is slowly added dropwise. After 5 hours, water was added to terminate the reaction, and anhydrous magnesium sulfate was added to the organic layer obtained by extraction with dichloromethane to remove water, followed by silica filtration. After removing the obtained organic solvent through distillation under reduced pressure, it was recrystallized from dichloromethane (100 mL) and methanol (300 mL) to obtain 12.94 g (85 % Yield) of Intermediate V1-3.
4단계: 중간체 V1-4의 합성Step 4: Synthesis of Intermediate V1-4
중간체 V1-3 15.2 g (39.37 mmol), Bis(pinacolato)diboron 23.99 g(94.49 mmol), Pd2(dba)3 2.16 g (2.36 mmol), P(Cy)3 2.65 g (9.45 mmol), 및 KOAc 11.59 g (118.11 mmol)을 Xylene 100 ml에 현탁시킨 후 12 시간 동안 환류 교반한다. 반응 종료 후 반응 용매를 회전식 증발기로 제거한 후 Methylene Chloride로 추출하여 유기층을 Hexane : EA = 4 : 1(v/v) 로 컬럼하여 중간체 V1-4 16.0 g (85% Yield)을 획득하였다.Intermediate V1-3 15.2 g (39.37 mmol), Bis(pinacolato)diboron 23.99 g (94.49 mmol), Pd 2 (dba) 3 2.16 g (2.36 mmol), P(Cy) 3 2.65 g (9.45 mmol), and KOAc 11.59 g (118.11 mmol) was suspended in 100 ml of Xylene and stirred under reflux for 12 hours. After completion of the reaction, the reaction solvent was removed with a rotary evaporator, extracted with methylene chloride, and the organic layer was columned with Hexane: EA = 4 : 1 (v/v) to obtain 16.0 g (85% Yield) of intermediate V1-4.
5단계: 화합물 V1의 합성Step 5: Synthesis of compound V1
둥근 바닥 플라스크에 중간체 V1-4 16.00 g (33.32 mmol), 2-chloro-1,3,5-triazine 9.41 g (73.30 mmol), Pd(PPh3)4 1.16 g (1.00 mmol), 및 K2CO3 13.81 g (99.95 mmol)을 넣고 THF 150 mL, 증류수 75 mL에 녹인 후 질소 대기하에서 가열 환류한다. 12 시간 후 반응액을 냉각시키고, 물층을 제거한 후, 유기층을 감압하에서 건조시킨다. 얻어진 고체를 물과 Methanol로 씻어준 후, 고체를 Toluene 100 mL로 재결정하여 화합물 V1을 9.0 g(70% Yield) 얻었다.In a round bottom flask, 16.00 g (33.32 mmol) of intermediate V1-4, 9.41 g (73.30 mmol) of 2-chloro-1,3,5-triazine, 1.16 g (1.00 mmol) of Pd(PPh 3 ) 4 , and K 2 CO 3 Add 13.81 g (99.95 mmol), dissolve in 150 mL of THF and 75 mL of distilled water, and heat to reflux under nitrogen atmosphere. After 12 hours, the reaction solution is cooled, the water layer is removed, and the organic layer is dried under reduced pressure. After washing the obtained solid with water and methanol, the solid was recrystallized with 100 mL of Toluene to obtain 9.0 g (70% Yield) of Compound V1.
LC/MS calculated for: C24H14N6 Exact Mass: 386.13 found for 386.89 [M+H]LC/MS calculated for: C24H14N6 Exact Mass: 386.13 found for 386.89 [M+H]
비교합성예 2: 화합물 V2의 합성Comparative Synthesis Example 2: Synthesis of Compound V2
[반응식 4][Scheme 4]
Figure PCTKR2022005689-appb-img-000209
Figure PCTKR2022005689-appb-img-000209
둥근 바닥 플라스크에 중간체 V1-4 10.00 g (20.82 mmol), 4-bromo-2,6-diphenylpyridine 15.79 g (45.81 mmol), Pd(PPh3)4 0.72 g (0.62 mmol), 및 K2CO3 8.63 g (62.47 mmol)을 넣고 THF 100 mL, 증류수 50 mL에 녹인 후 질소 대기하에서 가열 환류한다. 12 시간 후 반응액을 냉각시키고, 물층을 제거한 후, 유기층을 감압하에서 건조시킨다. 얻어진 고체를 물과 Methanol로 씻어준 후, 고체를 Toluene 100 mL로 재결정하여 화합물 V2을 10.0 g(70% Yield) 얻었다.In a round bottom flask, 10.00 g (20.82 mmol) of intermediate V1-4, 15.79 g (45.81 mmol) of 4-bromo-2,6-diphenylpyridine, 0.72 g (0.62 mmol) of Pd(PPh 3 ) 4 , and 8.63 of K 2 CO 3 g (62.47 mmol) is added, dissolved in 100 mL of THF and 50 mL of distilled water, and then heated to reflux under nitrogen atmosphere. After 12 hours, the reaction solution is cooled, the water layer is removed, and the organic layer is dried under reduced pressure. After washing the obtained solid with water and methanol, the solid was recrystallized with 100 mL of Toluene to obtain 10.0 g (70% Yield) of Compound V2.
LC/MS calculated for: C52H34N2 Exact Mass: 686.27 found for 686.84 [M+H]LC/MS calculated for: C52H34N2 Exact Mass: 686.27 found for 686.84 [M+H]
비교합성예 3: 화합물 V3의 합성Comparative Synthesis Example 3: Synthesis of Compound V3
[반응식 5][Scheme 5]
Figure PCTKR2022005689-appb-img-000210
Figure PCTKR2022005689-appb-img-000210
1단계: 중간체 V3-1의 합성Step 1: Synthesis of intermediate V3-1
둥근 바닥 플라스크에 중간체 V1-4 9.50 g (19.78 mmol), bromobenzene 3.32 g (19.78 mmol), Pd(PPh3)4 0.69 g (0.59 mmol), 및 K2CO3 8.20 g (59.35 mmol)을 넣고 THF 100 mL, 증류수 50 mL에 녹인 후 질소 대기하에서 가열 환류한다. 반응 종료 후 반응 용매를 회전식 증발기로 제거한 후 Methylene Chloride로 추출하여 유기층을 Hexane : EA = 4 : 1(v/v) 로 컬럼하여 중간체 V3-1 6.5 g (76% Yield)을 획득하였다.In a round-bottom flask, 9.50 g (19.78 mmol) of intermediate V1-4, 3.32 g (19.78 mmol) of bromobenzene, 0.69 g (0.59 mmol) of Pd(PPh 3 ) 4 , and 8.20 g (59.35 mmol) of K 2 CO 3 were placed in THF After dissolving in 100 mL of distilled water and 50 mL of distilled water, heat to reflux under nitrogen atmosphere. After completion of the reaction, the reaction solvent was removed with a rotary evaporator, extracted with methylene chloride, and the organic layer was columned with Hexane: EA = 4 : 1 (v/v) to obtain 6.5 g (76% Yield) of intermediate V3-1.
2단계: 화합물 V3의 합성Step 2: Synthesis of compound V3
둥근 바닥 플라스크에 중간체 V3-1 6.5 g (15.10 mmol), 2-bromopyridine 2.68 g (15.86 mmol), Pd(PPh3)4 0.52 g (0.45 mmol), 및 K2CO3 6.26 g (45.31 mmol)을 넣고 THF 100 mL, 증류수 50 mL에 녹인 후 질소 대기하에서 가열 환류한다. 12 시간 후 반응액을 냉각시키고, 물층을 제거한 후, 유기층을 감압하에서 건조시킨다. 얻어진 고체를 물과 Methanol로 씻어준 후, 고체를 Toluene 100 mL로 재결정하여 화합물 V3을 4.5 g(78% Yield) 얻었다.In a round bottom flask, 6.5 g (15.10 mmol) of intermediate V3-1, 2.68 g (15.86 mmol) of 2-bromopyridine, 0.52 g (0.45 mmol) of Pd(PPh 3 ) 4 , and 6.26 g (45.31 mmol) of K 2 CO 3 were added to a round bottom flask. After dissolving in 100 mL of THF and 50 mL of distilled water, heat to reflux under nitrogen atmosphere. After 12 hours, the reaction solution is cooled, the water layer is removed, and the organic layer is dried under reduced pressure. After washing the obtained solid with water and methanol, the solid was recrystallized with 100 mL of toluene to obtain 4.5 g (78% yield) of compound V3.
LC/MS calculated for: C29H19N Exact Mass: 381.15 found for 381.95 [M+H]LC/MS calculated for: C29H19N Exact Mass: 381.15 found for 381.95 [M+H]
합성예 16: 화합물 A-84의 합성Synthesis Example 16: Synthesis of compound A-84
[반응식 7][Scheme 7]
Figure PCTKR2022005689-appb-img-000211
Figure PCTKR2022005689-appb-img-000211
a) 중간체 2-1a의 합성 a) Synthesis of intermediate 2-1a
phenylhydrazinehydrochloride (70.0g, 484.1 mmol), 및 7-bromo-3,4-dihydro-2H-naphthalen-1-one (108.9g, 484.1 mmol)을 환저플라스크에 넣고 에탄올(1200ml)에 녹인다. 상온에서 염산 60 mL를 천천히 적가한 후 90℃에서 12시간 동안 교반한다. 반응이 종료되면 용매를 감압 하에서 제거한 후 과량의 EA로 추출한다. 유기용매를 감압하에 제거하고 소량의 메탄올 속에서 교반시킨 후 필터하여 중간체 2-1a을 95.2g(66%) 수득하였다.Put phenylhydrazinehydrochloride (70.0 g, 484.1 mmol) and 7-bromo-3,4-dihydro-2H-naphthalen-1-one (108.9 g, 484.1 mmol) in a round-bottom flask and dissolve in ethanol (1200 ml). After slowly adding 60 mL of hydrochloric acid dropwise at room temperature, the mixture was stirred at 90° C. for 12 hours. When the reaction is complete, the solvent is removed under reduced pressure, followed by extraction with an excess of EA. The organic solvent was removed under reduced pressure, stirred in a small amount of methanol, and filtered to obtain 95.2 g (66%) of Intermediate 2-1a.
b) 중간체 2-1b의 합성 b) synthesis of intermediate 2-1b
중간체 2-1a (95.2g, 319.3 mmol), 및 2,3-dichloro-5,6-dicyano-1,4-benzoquinone (108.7g, 478.9 mmol)을 둥근바닥 플라스크에 넣고 톨루엔(600ml)에 녹인다. 80℃에서 12시간 동안 교반한다. 반응이 종료되면 반응용매를 제거한 후 컬럼크로마토그래피를 이용하여 중간체 2-1b를 41.3g(44%) 수득하였다.Intermediate 2-1a (95.2 g, 319.3 mmol), and 2,3-dichloro-5,6-dicyano-1,4-benzoquinone (108.7 g, 478.9 mmol) were placed in a round-bottom flask and dissolved in toluene (600 ml). Stir at 80° C. for 12 hours. When the reaction was completed, 41.3 g (44%) of Intermediate 2-1b was obtained by using column chromatography after removing the reaction solvent.
c) 중간체 2-1c의 합성 c) synthesis of intermediate 2-1c
중간체 2-1b (41.3g, 139.0 mmol), iodobenzene (199.2g, 976.0 mmol), CuI (5.31g, 28.0 mmol), K2CO3 (28.9g, 209.0 mmol), 및 1,10-phenanthroline (5.03g, 28.0 mmol)을 환저플라스크에 넣고 DMF(500ml)에 녹인다. 180℃에서 12 시간 동안 교반한다. 반응이 종료되면 반응용매를 감압 하에서 제거한 후 디클로로메탄에 용해 후 실리카겔 여과한다. 디클로로메탄 농축 후 헥산으로 재결정하여 중간체 2-1c를 39.0g(75%) 수득하였다.Intermediate 2-1b (41.3 g, 139.0 mmol), iodobenzene (199.2 g, 976.0 mmol), CuI (5.31 g, 28.0 mmol), K 2 CO 3 (28.9 g, 209.0 mmol), and 1,10-phenanthroline (5.03) g, 28.0 mmol) in a round bottom flask and dissolved in DMF (500 ml). Stir at 180° C. for 12 hours. When the reaction is completed, the reaction solvent is removed under reduced pressure, dissolved in dichloromethane, and filtered through silica gel. After concentration in dichloromethane and recrystallization from hexane, 39.0 g (75%) of Intermediate 2-1c was obtained.
d) 화합물 A-84의 합성 d) Synthesis of compound A-84
중간체 2-1c 5.0 g (13.46 mmol)과 아민 중간체 2-1d 4.41 g (13.46 mmol), 소디움 t-부톡사이드(sodium t-butoxide) 1.94 g (20.19 mmol), 및 Tri-tert-부틸포스핀(butylphosphine) 0.54g (1.35 mmol)을 톨루엔 100 ml에 용해 시키고, Pd(dba)2 0.37g (0.4 mmol)을 넣은 후 질소 분위기 하에서 12시간 동안 환류 교반 시킨다. 반응 종료 후 톨루엔과 증류수로 추출 후 유기층을 무수황산마그네슘 으로 건조, 여과하고 여과액을 감압 농축하였다. 생성물을 노말헥산 / 디클로로 메탄 (2 : 1 부피비)으로 실리카겔 컬럼 크로마토 그래피로 정제하여 화합물 A-84를 6.4g (수율 82.0%) 을 수득 하였다.5.0 g (13.46 mmol) of intermediate 2-1c and 4.41 g (13.46 mmol) of amine intermediate 2-1d, 1.94 g (20.19 mmol) of sodium t-butoxide, and Tri-tert-butylphosphine ( butylphosphine) 0.54 g (1.35 mmol) was dissolved in 100 ml of toluene, 0.37 g (0.4 mmol) of Pd(dba) 2 was added, and the mixture was stirred under reflux for 12 hours under a nitrogen atmosphere. After completion of the reaction, extraction was performed with toluene and distilled water, the organic layer was dried over anhydrous magnesium sulfate, filtered, and the filtrate was concentrated under reduced pressure. The product was purified by silica gel column chromatography with n-hexane / dichloromethane (2: 1 volume ratio) to obtain 6.4 g (yield 82.0%) of Compound A-84.
합성예 17: 화합물 2-92의 합성Synthesis Example 17: Synthesis of compound 2-92
[반응식 8][Scheme 8]
Figure PCTKR2022005689-appb-img-000212
Figure PCTKR2022005689-appb-img-000212
a) 중간체 2-92a의 합성 a) Synthesis of intermediate 2-92a
KR10-1423173 B1 특허를 참고하여 합성하였다.It was synthesized with reference to the KR10-1423173 B1 patent.
b) 화합물 2-92의 합성 b) synthesis of compound 2-92
중간체 2-92a 5.0 g (16.93 mmol)과 아민 중간체 2-92b 5.4 g (16.93 mmol), 소디움 t-부톡사이드(sodium t-butoxide) 2.44 g (25.39 mmol), 및 Tri-tert-부틸포스핀(butylphosphine) 0.68g (1.69 mmol)을 톨루엔 100 ml에 용해 시키고, Pd(dba)2 0.47g (0.51 mmol)을 넣은 후 질소 분위기 하에서 12시간 동안 환류 교반 시킨다. 반응 종료 후 톨루엔과 증류수로 추출 후 유기층을 무수황산마그네슘 으로 건조, 여과하고 여과액을 감압 농축하였다. 생성물을 노말헥산/디클로로메탄(2 : 1 부피비)으로 실리카겔 컬럼 크로마토 그래피로 정제하여 목적 화합물인 2-92 를 8.2g (수율 84.0%) 을 수득 하였다.5.0 g (16.93 mmol) of intermediate 2-92a and 5.4 g (16.93 mmol) of amine intermediate 2-92b, 2.44 g (25.39 mmol) of sodium t-butoxide, and Tri-tert-butylphosphine ( butylphosphine) 0.68 g (1.69 mmol) was dissolved in 100 ml of toluene, 0.47 g (0.51 mmol) of Pd(dba) 2 was added, and the mixture was stirred under reflux for 12 hours under a nitrogen atmosphere. After completion of the reaction, extraction was performed with toluene and distilled water, the organic layer was dried over anhydrous magnesium sulfate, filtered, and the filtrate was concentrated under reduced pressure. The product was purified by silica gel column chromatography with normal hexane/dichloromethane (2:1 volume ratio) to obtain 8.2 g (yield 84.0%) of the target compound 2-92.
(유기 발광 소자의 제작)(Production of organic light emitting device)
실시예 1Example 1
ITO (Indium tin oxide)로 박막 코팅된 유리 기판을 증류수 초음파로 세척하였다. 증류수 세척이 끝나면 이소프로필 알코올, 아세톤, 메탄올 등의 용제로 초음파 세척을 하고 건조시킨 후 플라즈마 세정기로 이송시킨 다음 산소 플라즈마를 이용하여 상기 기판을 10분간 세정 한 후 진공 증착기로 기판을 이송하였다. 이렇게 준비된 ITO 투명 전극을 양극으로 사용하여 ITO 기판 상부에 3 % NDP-9 (Novaled社로부터 시판됨)으로 도핑된 화합물 A를 진공 증착하여 100Å 두께의 정공주입층을 형성하고, 상기 정공주입층의 상부에 화합물 A를 1300Å 두께로 증착하여 정공수송층을 형성하였다. 상기 정공수송층 상부에 화합물 B를 700Å의 두께로 증착하여 정공수송보조층을 형성하였다. 정공수송보조층 상부에 합성예 3에서 얻어진 화합물 32를 호스트로 사용하고 도판트로 [Ir(piq)2acac]를 2wt%로 도핑하여 진공 증착으로 400Å 두께의 발광층을 형성하였다. 이어서 상기 발광층 상부에 화합물 C를 50 Å의 두께로 증착하여 전자수송보조층을 형성하고, 화합물 D와 Liq를 동시에 1:1의 중량비로 진공 증착하여 300Å 두께의 전자수송층을 형성하였다. 상기 전자수송층 상부에 LiQ 15Å과 Al 1,200Å을 순차적으로 진공 증착하여 음극을 형성함으로써 유기발광소자를 제작하였다.A glass substrate coated with a thin film of ITO (Indium tin oxide) was washed with distilled water and ultrasonic waves. After washing with distilled water, ultrasonic cleaning was performed with a solvent such as isopropyl alcohol, acetone, methanol, etc., dried and transferred to a plasma cleaner. After cleaning the substrate using oxygen plasma for 10 minutes, the substrate was transferred to a vacuum evaporator. Using the prepared ITO transparent electrode as an anode, compound A doped with 3% NDP-9 (commercially available from Novaled) was vacuum-deposited on the top of the ITO substrate to form a hole injection layer with a thickness of 100 Å, and Compound A was deposited thereon to a thickness of 1300 Å to form a hole transport layer. Compound B was deposited on the hole transport layer to a thickness of 700 Å to form a hole transport auxiliary layer. Compound 32 obtained in Synthesis Example 3 was used as a host on the hole transport auxiliary layer, and [Ir(piq) 2 acac] was doped at 2 wt% as a dopant to form an emission layer with a thickness of 400 Å by vacuum deposition. Then, compound C was deposited on the light emitting layer to a thickness of 50 Å to form an electron transport auxiliary layer, and compound D and Liq were simultaneously vacuum deposited at a weight ratio of 1:1 to form an electron transport layer having a thickness of 300 Å. An organic light emitting diode was manufactured by sequentially vacuum-depositing 15 Å of LiQ and 1,200 Å of Al on the electron transport layer to form a cathode.
상기 유기발광소자는 5층의 유기 박막층을 가지는 구조로 되어 있으며, 구체적으로 다음과 같다.The organic light emitting device has a structure having a five-layer organic thin film layer, specifically as follows.
ITO / 화합물A (3 % NDP-9 doping, 100Å) / 화합물A (1300Å) / 화합물B (700Å) / EML [화합물 32 : [Ir(piq)2acac] = 98 : 2 (w/w]] (400Å) / 화합물C (50Å) / 화합물D : Liq(300Å) / LiQ (15Å) / Al (1200Å)의 구조로 제작하였다.ITO / Compound A (3% NDP-9 doping, 100 Å) / Compound A (1300 Å) / Compound B (700 Å) / EML [Compound 32: [Ir(piq) 2 acac] = 98: 2 (w/w]] (400 Å) / Compound C (50 Å) / Compound D: Liq (300 Å) / LiQ (15 Å) / Al (1200 Å) was prepared.
화합물 A: N-(biphenyl-4-yl)-9,9-dimethyl-N-(4-(9-phenyl-9H-carbazol-3-yl)phenyl)-9H-fluoren-2-amineCompound A: N-(biphenyl-4-yl)-9,9-dimethyl-N-(4-(9-phenyl-9H-carbazol-3-yl)phenyl)-9H-fluoren-2-amine
화합물 B: N,N-di([1,1'-biphenyl]-4-yl)-7,7-dimethyl-7H-fluoreno[4,3-b]benzofuran-10-amineCompound B: N,N-di([1,1'-biphenyl]-4-yl)-7,7-dimethyl-7H-fluoreno[4,3-b]benzofuran-10-amine
화합물 C: 2-(3-(3-(9,9-dimethyl-9H-fluoren-2-yl)phenyl)phenyl)-4,6-diphenyl-1,3,5-triazineCompound C: 2-(3-(3-(9,9-dimethyl-9H-fluoren-2-yl)phenyl)phenyl)-4,6-diphenyl-1,3,5-triazine
화합물 D: 8-(4-(4,6-di(naphthalen-2-yl)-1,3,5-triazin-2-yl)phenyl)quinolineCompound D: 8-(4-(4,6-di(naphthalen-2-yl)-1,3,5-triazin-2-yl)phenyl)quinoline
실시예 2 내지 8 및 비교예 1 내지 3Examples 2 to 8 and Comparative Examples 1 to 3
하기 표 2에 기재한 바와 같이 호스트를 변경한 것을 제외하고는, 상기 실시예 1과 동일한 방법으로 실시예 2 내지 8, 및 비교예 1 내지 3의 소자를 제작하였다.Devices of Examples 2 to 8 and Comparative Examples 1 to 3 were manufactured in the same manner as in Example 1, except that the host was changed as shown in Table 2 below.
실시예 9 내지 20 및 비교예 4 내지 6Examples 9 to 20 and Comparative Examples 4 to 6
하기 표 3에 기재한 바와 같이 호스트를 변경하고, 제1 호스트 및 제2 호스트를 5:5의 중량비로 혼합하여 상기 실시예 1과 동일한 방법으로 실시예 9 내지 20, 및 비교예 4 내지 6의 소자를 제작하였다.The host was changed as shown in Table 3 below, and the first host and the second host were mixed in a weight ratio of 5:5, and in Examples 9 to 20 and Comparative Examples 4 to 6 in the same manner as in Example 1 above. The device was fabricated.
평가evaluation
상기 실시예 1 내지 실시예 20, 비교예 1 내지 비교예 6에 따른 유기발광소자의 발광효율 및 수명 특성을 평가하였다. 구체적인 측정방법은 하기와 같고, 그 결과는 표 2 및 3와 같다.The luminous efficiency and lifespan characteristics of the organic light emitting diodes according to Examples 1 to 20 and Comparative Examples 1 to 6 were evaluated. Specific measurement methods are as follows, and the results are shown in Tables 2 and 3.
(1) 전압변화에 따른 전류밀도의 변화 측정(1) Measurement of change in current density according to voltage change
제조된 유기발광소자에 대해, 전압을 0V부터 10V까지 상승시키면서 전류-전압계(Keithley 2400)를 이용하여 단위소자에 흐르는 전류값을 측정하고, 측정된 전류값을 면적으로 나누어 결과를 얻었다.For the manufactured organic light emitting device, the current flowing through the unit device was measured using a current-voltmeter (Keithley 2400) while the voltage was increased from 0V to 10V, and the measured current value was divided by the area to obtain a result.
(2) 전압변화에 따른 휘도변화 측정(2) Measurement of luminance change according to voltage change
제조된 유기발광소자에 대해, 전압을 0V부터 10V까지 상승시키면서 휘도계(Minolta Cs-1000A)를 이용하여 그때의 휘도를 측정하여 결과를 얻었다.For the manufactured organic light emitting device, the luminance was measured at that time using a luminance meter (Minolta Cs-1000A) while increasing the voltage from 0V to 10V, and results were obtained.
(3) 발광효율 측정(3) Measurement of luminous efficiency
상기(1) 및 (2)로부터 측정된 휘도와 전류밀도 및 전압을 이용하여 동일 전류밀도(10mA/cm2)의 전류 효율(cd/A)을 계산하였다.The current efficiency (cd/A) of the same current density (10 mA/cm 2 ) was calculated using the luminance, current density, and voltage measured from (1) and (2) above.
비교예 1 및 비교예 4의 발광효율을 기준으로 한 상대 값을 계산하여 하기 표 2 및 표 3에 나타내었다.Relative values based on the luminous efficiency of Comparative Examples 1 and 4 were calculated and shown in Tables 2 and 3 below.
(4) 수명 측정(4) Lifetime measurement
제조된 유기발광소자에 대해 폴라로닉스 수명측정 시스템을 사용하여 실시예 1 내지 20, 비교예 1 내지 비교예 6의 소자를 초기휘도(cd/m2)를 6,000cd/m2로 발광시키고 시간경과에 따른 휘도의 감소를 측정하여 초기 휘도 대비 95%로 휘도가 감소된 시점을 T95 수명으로 측정하였다.For the manufactured organic light emitting device, the devices of Examples 1 to 20 and Comparative Examples 1 to 6 emit light at an initial luminance (cd/m 2 ) of 6,000 cd/m 2 using a polaronics lifetime measurement system, and time elapses The time when the luminance decreased to 95% compared to the initial luminance was measured as the T95 lifetime.
비교예 1 및 비교예 4의 T95 수명을 기준으로 한 상대 값을 계산하여 하기 표 2 및 표 3에 나타내었다.The relative values based on the T95 lifetime of Comparative Examples 1 and 4 were calculated and shown in Tables 2 and 3 below.
구분division 단독 호스트sole host T95 수명 (%)T95 Lifetime (%) 효율 (%)efficiency (%)
실시예 1Example 1 3232 195195 118118
실시예 2Example 2 3333 220220 120120
실시예 3Example 3 3636 198198 118118
실시예 4Example 4 4343 180180 120120
실시예 5Example 5 6161 160160 116116
실시예 6Example 6 8989 185185 122122
실시예 7Example 7 9292 180180 118118
실시예 8Example 8 9999 154154 123123
비교예 1Comparative Example 1 103103 152152 121121
비교예 2Comparative Example 2 V1 V1 100100 100100
비교예 3Comparative Example 3 V2 V2 105105 107107
비교예 4Comparative Example 4 V3 V3 100100 7575
구분division 호스트host T95 수명(%)T95 Life (%) 효율(%)efficiency(%)
제1
호스트
first
host
제2
호스트
second
host
실시예 9Example 9 3333 A-84A-84 250250 118118
실시예 10Example 10 3636 A-84A-84 235235 115115
실시예 11Example 11 4343 A-84A-84 196196 117117
실시예 12Example 12 6161 A-84A-84 187187 115115
실시예 13Example 13 8989 A-84A-84 192192 120120
실시예 14Example 14 9292 A-84A-84 186186 116116
실시예 15Example 15 3333 2-922-92 192192 120120
실시예 16Example 16 3636 2-922-92 180180 118118
실시예 17Example 17 4343 2-922-92 161161 122122
실시예 18Example 18 6161 2-922-92 175175 115115
실시예 19Example 19 8989 2-922-92 182182 121121
실시예 20Example 20 9292 2-922-92 180180 116116
비교예 4Comparative Example 4 V1 V1 A-84A-84 100100 100100
비교예 5Comparative Example 5 V2V2 A-84A-84 106106 107107
비교예 6Comparative Example 6 V2V2 2-922-92 8484 108108
표 2 및 3을 참고하면, 본 발명에 따른 화합물을 단독호스트 및 제2 호스트와 조합한 호스트로서 사용하였을 때 비교 화합물을 사용한 것 대비 효율, 및 수명이 크게 개선된 것을 확인할 수 있다. Referring to Tables 2 and 3, when the compound according to the present invention is used as a host in combination with a single host and a second host, it can be confirmed that the efficiency and lifespan are significantly improved compared to that using the comparative compound.
실시예들에 대하여 상세하게 설명하였지만 본 발명의 권리범위는 이에 한정되는 것은 아니고 다음의 청구 범위에서 정의하고 있는 본 발명의 기본 개념을 이용한 당업자의 여러 변형 및 개량 형태 또한 본 발명의 권리범위에 속하는 것이다.Although the embodiments have been described in detail, the scope of the present invention is not limited thereto, and various modifications and improvements by those skilled in the art using the basic concept of the present invention defined in the following claims also fall within the scope of the present invention. will be.

Claims (14)

  1. 하기 화학식 1로 표현되는 유기 광전자 소자용 화합물:A compound for an organic optoelectronic device represented by the following Chemical Formula 1:
    [화학식 1][Formula 1]
    Figure PCTKR2022005689-appb-img-000213
    Figure PCTKR2022005689-appb-img-000213
    상기 화학식 1에서,In Formula 1,
    Z1 내지 Z3은 각각 독립적으로 N 또는 CRa이고,Z 1 to Z 3 are each independently N or CR a ,
    Z1 내지 Z3 중 적어도 둘은 N이고,At least two of Z 1 to Z 3 are N,
    L1 내지 L3은 각각 독립적으로 단일 결합, 또는 치환 또는 비치환된 C6 내지 C30 아릴렌기이고,L 1 to L 3 are each independently a single bond, or a substituted or unsubstituted C6 to C30 arylene group,
    Ar1 및 Ar2는 각각 독립적으로 치환 또는 비치환된 C6 내지 C30 아릴기 또는 치환 또는 비치환된 C2 내지 C30 헤테로고리기이고,Ar 1 and Ar 2 are each independently a substituted or unsubstituted C6 to C30 aryl group or a substituted or unsubstituted C2 to C30 heterocyclic group,
    Ra 및 R1 내지 R4는 각각 독립적으로 수소, 중수소, 치환 또는 비치환된 C1 내지 C20 알킬기, 또는 치환 또는 비치환된 C6 내지 C20 아릴기이고,R a and R 1 to R 4 are each independently hydrogen, deuterium, a substituted or unsubstituted C1 to C20 alkyl group, or a substituted or unsubstituted C6 to C20 aryl group,
    n1은 1 내지 3의 정수 중 하나이고,n1 is one of integers from 1 to 3,
    n2 및 n3은 각각 독립적으로 1 또는 2의 정수이며,n2 and n3 are each independently an integer of 1 or 2,
    n4는 1 내지 4의 정수 중 하나이다.n4 is one of integers from 1 to 4.
  2. 제1항에 있어서,According to claim 1,
    상기 화학식 1은 하기 화학식 1-1 내지 화학식 1-4 중 어느 하나로 표현되는 것인, 유기 광전자 소자용 화합물:Formula 1 is a compound for an organic optoelectronic device, which is represented by any one of the following Formulas 1-1 to 1-4:
    [화학식 1-1][Formula 1-1]
    Figure PCTKR2022005689-appb-img-000214
    Figure PCTKR2022005689-appb-img-000214
    [화학식 1-2][Formula 1-2]
    Figure PCTKR2022005689-appb-img-000215
    Figure PCTKR2022005689-appb-img-000215
    [화학식 1-3][Formula 1-3]
    Figure PCTKR2022005689-appb-img-000216
    Figure PCTKR2022005689-appb-img-000216
    [화학식 1-4][Formula 1-4]
    Figure PCTKR2022005689-appb-img-000217
    Figure PCTKR2022005689-appb-img-000217
    상기 화학식 1-1 내지 화학식 1-4에서,In Formulas 1-1 to 1-4,
    Z1 내지 Z3, L1 내지 L3, Ar1, Ar2, R1 내지 R4 및 n1 내지 n4는 제1항에서와 같다.Z 1 to Z 3 , L 1 to L 3 , Ar 1 , Ar 2 , R 1 to R 4 and n1 to n4 are the same as in claim 1 .
  3. 제1항에 있어서,According to claim 1,
    상기 L1 내지 L3은 각각 독립적으로 단일 결합, 치환 또는 비치환된 페닐렌기 또는 치환 또는 비치환된 나프틸렌기인, 유기 광전자 소자용 화합물.The L 1 to L 3 are each independently a single bond, a substituted or unsubstituted phenylene group, or a substituted or unsubstituted naphthylene group, a compound for an organic optoelectronic device.
  4. 제1항에 있어서,According to claim 1,
    상기 Ar1 및 Ar2는 각각 독립적으로 치환 또는 비치환된 페닐기, 치환 또는 비치환된 바이페닐기, 치환 또는 비치환된 나프틸기, 치환 또는 비치환된 페난트레닐기, 치환 또는 비치환된 플루오레닐기, 치환 또는 비치환된 카바졸일기, 치환 또는 비치환된 디벤조퓨란일기, 치환 또는 비치환된 디벤조티오펜일기, 치환 또는 비치환된 디벤조실롤일기 또는 치환 또는 비치환된 벤조나프토퓨란일기인, 유기 광전자 소자용 화합물.Wherein Ar 1 and Ar 2 are each independently a substituted or unsubstituted phenyl group, a substituted or unsubstituted biphenyl group, a substituted or unsubstituted naphthyl group, a substituted or unsubstituted phenanthrenyl group, a substituted or unsubstituted fluorenyl group , A substituted or unsubstituted carbazolyl group, a substituted or unsubstituted dibenzofuranyl group, a substituted or unsubstituted dibenzothiophenyl group, a substituted or unsubstituted dibenzosilolyl group, or a substituted or unsubstituted benzonaphthofuran Illyin, a compound for an organic optoelectronic device.
  5. 제1항에 있어서,According to claim 1,
    상기 *-L2-Ar1 및 *-L3-Ar2는 각각 독립적으로 하기 그룹 Ⅰ에 나열된 치환기 중에서 선택되는 하나인 유기 광전자 소자용 화합물:The *-L 2 -Ar 1 and *-L 3 -Ar 2 are each independently one selected from the substituents listed in Group I: A compound for an organic optoelectronic device:
    [그룹 Ⅰ][Group I]
    Figure PCTKR2022005689-appb-img-000218
    Figure PCTKR2022005689-appb-img-000218
    상기 그룹 Ⅰ에서, In group I,
    D는 중수소를 의미하고,D means deuterium,
    n11은 1 내지 5의 정수 중 하나이고,n11 is one of integers from 1 to 5,
    n12는 1 내지 4의 정수 중 하나이고,n12 is one of integers from 1 to 4,
    n13은 1 내지 3의 정수 중 하나이며,n13 is one of integers from 1 to 3,
    *은 연결 지점이다.* is the connection point.
  6. 제1항에 있어서The method of claim 1
    하기 그룹 1에 나열된 화합물 중에서 선택되는 하나인 유기 광전자 소자용 화합물:A compound for an organic optoelectronic device, which is one selected from the compounds listed in Group 1:
    [그룹 1][Group 1]
    [1] [2] [3] [4] [1] [2] [3] [4]
    Figure PCTKR2022005689-appb-img-000219
    Figure PCTKR2022005689-appb-img-000219
    [5] [6] [7] [8][5] [6] [7] [8]
    Figure PCTKR2022005689-appb-img-000220
    Figure PCTKR2022005689-appb-img-000220
    [9] [10] [11] [12][9] [10] [11] [12]
    Figure PCTKR2022005689-appb-img-000221
    Figure PCTKR2022005689-appb-img-000221
    [13] [14] [15] [16][13] [14] [15] [16]
    Figure PCTKR2022005689-appb-img-000222
    Figure PCTKR2022005689-appb-img-000222
    [17] [18] [19] [20][17] [18] [19] [20]
    Figure PCTKR2022005689-appb-img-000223
    Figure PCTKR2022005689-appb-img-000223
    [21] [22] [23] [24][21] [22] [23] [24]
    Figure PCTKR2022005689-appb-img-000224
    Figure PCTKR2022005689-appb-img-000224
    [25] [26] [27] [28][25] [26] [27] [28]
    Figure PCTKR2022005689-appb-img-000225
    Figure PCTKR2022005689-appb-img-000225
    [29] [30] [31] [32][29] [30] [31] [32]
    Figure PCTKR2022005689-appb-img-000226
    Figure PCTKR2022005689-appb-img-000226
    [33] [34] [35] [36][33] [34] [35] [36]
    Figure PCTKR2022005689-appb-img-000227
    Figure PCTKR2022005689-appb-img-000227
    [37] [38] [39] [40][37] [38] [39] [40]
    Figure PCTKR2022005689-appb-img-000228
    Figure PCTKR2022005689-appb-img-000228
    [41] [42] [43] [44][41] [42] [43] [44]
    Figure PCTKR2022005689-appb-img-000229
    Figure PCTKR2022005689-appb-img-000229
    [45] [46] [47] [48][45] [46] [47] [48]
    Figure PCTKR2022005689-appb-img-000230
    Figure PCTKR2022005689-appb-img-000230
    [49] [50] [51] [52][49] [50] [51] [52]
    Figure PCTKR2022005689-appb-img-000231
    Figure PCTKR2022005689-appb-img-000231
    [52] [54] [55] [56][52] [54] [55] [56]
    Figure PCTKR2022005689-appb-img-000232
    Figure PCTKR2022005689-appb-img-000232
    [57] [58] [59] [60][57] [58] [59] [60]
    Figure PCTKR2022005689-appb-img-000233
    Figure PCTKR2022005689-appb-img-000233
    [61] [62] [63] [64][61] [62] [63] [64]
    Figure PCTKR2022005689-appb-img-000234
    Figure PCTKR2022005689-appb-img-000234
    [65] [66] [67] [68][65] [66] [67] [68]
    Figure PCTKR2022005689-appb-img-000235
    Figure PCTKR2022005689-appb-img-000235
    [69] [70] [71] [72][69] [70] [71] [72]
    Figure PCTKR2022005689-appb-img-000236
    Figure PCTKR2022005689-appb-img-000236
    [73] [74] [75] [76][73] [74] [75] [76]
    Figure PCTKR2022005689-appb-img-000237
    Figure PCTKR2022005689-appb-img-000237
    [77] [78] [79] [80][77] [78] [79] [80]
    Figure PCTKR2022005689-appb-img-000238
    Figure PCTKR2022005689-appb-img-000238
    [81] [82] [83] [84][81] [82] [83] [84]
    Figure PCTKR2022005689-appb-img-000239
    Figure PCTKR2022005689-appb-img-000239
    [85] [86] [87] [88][85] [86] [87] [88]
    Figure PCTKR2022005689-appb-img-000240
    Figure PCTKR2022005689-appb-img-000240
    [89] [90] [91] [92][89] [90] [91] [92]
    Figure PCTKR2022005689-appb-img-000241
    Figure PCTKR2022005689-appb-img-000241
    [93] [94] [95] [96][93] [94] [95] [96]
    Figure PCTKR2022005689-appb-img-000242
    Figure PCTKR2022005689-appb-img-000242
    [97] [98] [99] [100][97] [98] [99] [100]
    Figure PCTKR2022005689-appb-img-000243
    Figure PCTKR2022005689-appb-img-000243
    [101] [102] [103] [104][101] [102] [103] [104]
    Figure PCTKR2022005689-appb-img-000244
    Figure PCTKR2022005689-appb-img-000244
    [105] [106] [107] [108][105] [106] [107] [108]
    Figure PCTKR2022005689-appb-img-000245
    Figure PCTKR2022005689-appb-img-000245
    [109] [110] [111] [112][109] [110] [111] [112]
    Figure PCTKR2022005689-appb-img-000246
    Figure PCTKR2022005689-appb-img-000246
    [113] [114] [115] [116][113] [114] [115] [116]
    Figure PCTKR2022005689-appb-img-000247
    Figure PCTKR2022005689-appb-img-000247
    [117] [118] [119] [120][117] [118] [119] [120]
    Figure PCTKR2022005689-appb-img-000248
    Figure PCTKR2022005689-appb-img-000248
    [121] [122] [123] [124][121] [122] [123] [124]
    Figure PCTKR2022005689-appb-img-000249
    Figure PCTKR2022005689-appb-img-000249
    [125] [126] [127] [128][125] [126] [127] [128]
    Figure PCTKR2022005689-appb-img-000250
    .
    Figure PCTKR2022005689-appb-img-000250
    .
  7. 제1 화합물, 및 제2 화합물을 포함하고,a first compound, and a second compound;
    상기 제1 화합물은 제1항에 따른 유기 광전자 소자용 화합물이고,The first compound is a compound for an organic optoelectronic device according to claim 1,
    상기 제2 화합물은 하기 화학식 2로 표현되는 유기 광전자 소자용 화합물인, 유기 광전자 소자용 조성물:The second compound is a compound for an organic optoelectronic device represented by the following formula (2), a composition for an organic optoelectronic device:
    [화학식 2][Formula 2]
    Figure PCTKR2022005689-appb-img-000251
    Figure PCTKR2022005689-appb-img-000251
    상기 화학식 2에서,In Formula 2,
    X1은 O, S, NRb, CRcRd 또는 SiReRf이고,X 1 is O, S, NR b , CR c R d or SiR e R f ,
    Rb, Rc, Rd, Re, Rf, R7 및 R8은 각각 독립적으로 수소, 중수소, 치환 또는 비치환된 아민기, 치환 또는 비치환된 C1 내지 C30 알킬기, 치환 또는 비치환된 C6 내지 C30 아릴기 또는 치환 또는 비치환된 C2 내지 C30 헤테로고리기이고,R b , R c , R d , Re , R f , R 7 and R 8 are each independently hydrogen, deuterium, a substituted or unsubstituted amine group, a substituted or unsubstituted C1 to C30 alkyl group, a substituted or unsubstituted a C6 to C30 aryl group or a substituted or unsubstituted C2 to C30 heterocyclic group,
    n5는 1 내지 4의 정수 중 하나이고,n5 is one of integers from 1 to 4,
    환 A는 하기 그룹 Ⅱ에 나열된 고리 중에서 선택되는 어느 하나이고,Ring A is any one selected from the rings listed in Group II,
    [그룹 Ⅱ][Group II]
    Figure PCTKR2022005689-appb-img-000252
    Figure PCTKR2022005689-appb-img-000252
    상기 그룹 Ⅱ에서,In group II,
    *은 연결 지점이고,* is the connection point,
    X2는 O, S, NRg, CRhRi 또는 SiRjRk이고,X 2 is O, S, NR g , CR h R i or SiR j R k ,
    Rg, Rh, Ri, Rj, Rk, 및 R6 내지 R10은 각각 독립적으로 수소, 중수소, 치환 또는 비치환된 아민기, 치환 또는 비치환된 C1 내지 C30 알킬기, 치환 또는 비치환된 C6 내지 C30 아릴기 또는 치환 또는 비치환된 C2 내지 C30 헤테로고리기이고,R g , R h , R i , R j , R k , and R 6 to R 10 are each independently hydrogen, deuterium, a substituted or unsubstituted amine group, a substituted or unsubstituted C1 to C30 alkyl group, a substituted or unsubstituted a cyclic C6 to C30 aryl group or a substituted or unsubstituted C2 to C30 heterocyclic group,
    n6, n8 및 n10은 각각 독립적으로 1 내지 4의 정수 중 하나이고,n6, n8 and n10 are each independently one of an integer of 1 to 4,
    n7 및 n9는 각각 독립적으로 1 또는 2의 정수이고,n7 and n9 are each independently an integer of 1 or 2,
    R5 내지 R10 중 적어도 하나는 하기 화학식 a로 표현되는 기이고,At least one of R 5 to R 10 is a group represented by the following formula (a),
    [화학식 a][Formula a]
    Figure PCTKR2022005689-appb-img-000253
    Figure PCTKR2022005689-appb-img-000253
    상기 화학식 a에서,In the above formula (a),
    L4 내지 L6은 각각 독립적으로 단일 결합, 또는 치환 또는 비치환된 C6 내지 C30 아릴렌기이고,L 4 To L 6 are each independently a single bond, or a substituted or unsubstituted C6 to C30 arylene group,
    Ar3 및 Ar4는 각각 독립적으로 치환 또는 비치환된 아민기, 치환 또는 비치환된 C6 내지 C30 아릴기, 또는 치환 또는 비치환된 C2 내지 C30 헤테로고리기이고,Ar 3 and Ar 4 are each independently a substituted or unsubstituted amine group, a substituted or unsubstituted C6 to C30 aryl group, or a substituted or unsubstituted C2 to C30 heterocyclic group,
    *는 연결 지점이다.* is the connection point.
  8. 제7항에 있어서,8. The method of claim 7,
    상기 화학식 2는 하기 화학식 2-Ⅰ 내지 화학식 2-Ⅹ 중 어느 하나로 표현되는 유기 광전자 소자용 조성물:Formula 2 is a composition for an organic optoelectronic device represented by any one of Formula 2-I to Formula 2-X:
    [화학식 2-Ⅰ] [화학식 2-Ⅱ][Formula 2-Ⅰ] [Formula 2-Ⅱ]
    Figure PCTKR2022005689-appb-img-000254
    Figure PCTKR2022005689-appb-img-000254
    [화학식 2-Ⅲ] [화학식 2-Ⅳ][Formula 2-Ⅲ] [Formula 2-IV]
    Figure PCTKR2022005689-appb-img-000255
    Figure PCTKR2022005689-appb-img-000255
    [화학식 2-Ⅴ] [화학식 2-Ⅵ][Formula 2-V] [Formula 2-VI]
    Figure PCTKR2022005689-appb-img-000256
    Figure PCTKR2022005689-appb-img-000256
    [화학식 2-Ⅶ] [화학식 2-ⅤⅢ][Formula 2-VII] [Formula 2-VIII]
    Figure PCTKR2022005689-appb-img-000257
    Figure PCTKR2022005689-appb-img-000257
    [화학식 2-Ⅸ] [화학식 2-Ⅹ][Formula 2-IX] [Formula 2-X]
    Figure PCTKR2022005689-appb-img-000258
    Figure PCTKR2022005689-appb-img-000258
    상기 화학식 2-Ⅰ 내지 화학식 2-Ⅹ에서, In Formula 2-I to Formula 2-X,
    X1, X2, R5 내지 R10 및 n5 내지 n10은 제7항에서와 같다.X 1 , X 2 , R 5 to R 10 and n5 to n10 are the same as in claim 7.
  9. 제7항에 있어서,8. The method of claim 7,
    상기 제2 화합물은 하기 화학식 2-ⅠA 내지 화학식 2-ⅩA, 화학식 2-ⅡB 내지 화학식 2-ⅣB 및 화학식 2-ⅡC 내지 화학식 2-ⅨC 중 어느 하나로 표현되는 유기 광전자 소자용 조성물:The second compound is a composition for an organic optoelectronic device represented by any one of Formulas 2-IA to 2-XA, Formula 2-IIB to Formula 2-IVB, and Formula 2-IIC to Formula 2-IXC:
    [화학식 2-ⅠA] [화학식 2-ⅡA][Formula 2-IA] [Formula 2-IIA]
    Figure PCTKR2022005689-appb-img-000259
    Figure PCTKR2022005689-appb-img-000259
    [화학식 2-ⅢA] [화학식 2-ⅣA][Formula 2-ⅢA] [Formula 2-IVA]
    Figure PCTKR2022005689-appb-img-000260
    Figure PCTKR2022005689-appb-img-000260
    [화학식 2-ⅤA] [화학식 2-ⅥA][Formula 2-VIA] [Formula 2-VIA]
    Figure PCTKR2022005689-appb-img-000261
    Figure PCTKR2022005689-appb-img-000261
    [화학식 2-ⅦA] [화학식 2-ⅤⅢA][Formula 2-VIIA] [Formula 2-VIIIA]
    Figure PCTKR2022005689-appb-img-000262
    Figure PCTKR2022005689-appb-img-000262
    [화학식 2-ⅨA] [화학식 2-ⅩA][Formula 2-XA] [Formula 2-XA]
    Figure PCTKR2022005689-appb-img-000263
    Figure PCTKR2022005689-appb-img-000263
    상기 화학식 2-ⅠA 내지 화학식 2-ⅩA에서, In Formula 2-IA to Formula 2-XA,
    X1, X2, L4 내지 L6, Ar3, Ar4, 및 n6 내지 n10은 제7항에 정의한 바와 같고,X 1 , X 2 , L 4 to L 6 , Ar 3 , Ar 4 , and n6 to n10 are as defined in claim 7,
    n5는 1 내지 3의 정수 중 하나이다.n5 is one of integers from 1 to 3.
    [화학식 2-ⅡB][Formula 2-IIB]
    Figure PCTKR2022005689-appb-img-000264
    Figure PCTKR2022005689-appb-img-000264
    [화학식 2-ⅢB] [화학식 2-ⅣB][Formula 2-ⅢB] [Formula 2-IVB]
    Figure PCTKR2022005689-appb-img-000265
    Figure PCTKR2022005689-appb-img-000265
    상기 화학식 2-ⅡB 내지 화학식 2-ⅣB에서, In Formulas 2-IIB to Formula 2-IVB,
    X1, L4 내지 L6, Ar3, Ar4, n5 및 n7은 제7항에 정의한 바와 같고,X 1 , L 4 to L 6 , Ar 3 , Ar 4 , n5 and n7 are as defined in claim 7,
    n8은 1 내지 3의 정수 중 하나이다.n8 is one of integers from 1 to 3.
    [화학식 2-ⅡC] [화학식 2-ⅢC][Formula 2-IIC] [Formula 2-IIIC]
    Figure PCTKR2022005689-appb-img-000266
    Figure PCTKR2022005689-appb-img-000266
    [화학식 2-ⅣC][Formula 2-IVC]
    Figure PCTKR2022005689-appb-img-000267
    Figure PCTKR2022005689-appb-img-000267
    상기 화학식 2-ⅡC 내지 화학식 2-ⅣC 에서, In the formula 2-IIC to formula 2-IVC,
    X1, L4 내지 L6, Ar3, Ar4, n5 및 n8은 제7항에 정의한 바와 같고,X 1 , L 4 to L 6 , Ar 3 , Ar 4 , n5 and n8 are as defined in claim 7,
    n7은 1이다.n7 is 1.
    [화학식 2-ⅤC] [화학식 2-ⅥC] [Formula 2-VC] [Formula 2-VIC]
    Figure PCTKR2022005689-appb-img-000268
    Figure PCTKR2022005689-appb-img-000268
    [화학식 2-ⅦC] [화학식 2-ⅤⅢC][Formula 2-VIIC] [Formula 2-VIIIC]
    Figure PCTKR2022005689-appb-img-000269
    Figure PCTKR2022005689-appb-img-000269
    [화학식 2-ⅨC][Formula 2-ⅨC]
    Figure PCTKR2022005689-appb-img-000270
    Figure PCTKR2022005689-appb-img-000270
    상기 화학식 2-ⅤC 내지 화학식 2-ⅨC에서,In Formula 2-VC to Formula 2-IXC,
    X1, X2, L4 내지 L6, Ar3, Ar4, n5 및 n10은 제7항에 정의한 바와 같고,X 1 , X 2 , L 4 to L 6 , Ar 3 , Ar 4 , n5 and n10 are as defined in claim 7,
    n9는 1이다.n9 is 1.
  10. 제7항에 있어서,8. The method of claim 7,
    상기 R5 내지 R10은 각각 독립적으로 수소, 중수소, 치환 또는 비치환된 C1 내지 C30 알킬기, 또는 치환 또는 비치환된 C6 내지 C30 아릴기인, 유기 광전자 소자용 조성물.Wherein R 5 To R 10 are each independently hydrogen, deuterium, a substituted or unsubstituted C1 to C30 alkyl group, or a substituted or unsubstituted C6 to C30 aryl group, the composition for an organic optoelectronic device.
  11. 제7항에 있어서,8. The method of claim 7,
    상기 제2 화합물은 하기 화학식 2-ⅣB-2 또는 화학식 2-ⅤⅢA-2로 표현되는 것인, 유기 광전자 소자용 조성물:The second compound is a composition for an organic optoelectronic device, which is represented by Formula 2-IVB-2 or Formula 2-VIIIA-2:
    [화학식 2-ⅣB-2] [화학식 2-ⅤⅢA-2][Formula 2-IVB-2] [Formula 2-VIIIA-2]
    Figure PCTKR2022005689-appb-img-000271
    Figure PCTKR2022005689-appb-img-000271
    상기 화학식 2-ⅣB-2 및 화학식 2-ⅤⅢA-2에서,In Formula 2-IVB-2 and Formula 2-VIIIA-2,
    L4 내지 L6은 각각 독립적으로 단일 결합 또는 치환 또는 비치환된 페닐렌기이고,L 4 To L 6 are each independently a single bond or a substituted or unsubstituted phenylene group,
    상기 Ar3 및 Ar4는 각각 독립적으로 치환 또는 비치환된 페닐기, 치환 또는 비치환된 바이페닐기, 또는 치환 또는 비치환된 나프틸기이고,wherein Ar 3 and Ar 4 are each independently a substituted or unsubstituted phenyl group, a substituted or unsubstituted biphenyl group, or a substituted or unsubstituted naphthyl group,
    R5, 및 R7 내지 R10은 각각 독립적으로 수소, 중수소, 치환 또는 비치환된 C1 내지 C30 알킬기 또는 치환 또는 비치환된 C6 내지 C30 아릴기이고,R 5 , and R 7 to R 10 are each independently hydrogen, deuterium, a substituted or unsubstituted C1 to C30 alkyl group, or a substituted or unsubstituted C6 to C30 aryl group,
    n7 및 n9는 각각 독립적으로 1 또는 2의 정수이고,n7 and n9 are each independently an integer of 1 or 2,
    n8 및 n10은 각각 독립적으로 1 내지 3의 정수 중 하나이고,n8 and n10 are each independently one of an integer of 1 to 3,
    화학식 2-ⅣB-2의 X1은 NRb, O 또는 S이고,In Formula 2-IVB-2, X 1 is NR b , O or S,
    화학식 2-ⅣB-2의 n5는 1 내지 4의 정수 중 하나이고,n5 of Formula 2-IVB-2 is one of integers from 1 to 4,
    화학식 2-ⅤⅢA-2의 X1은 CRcRd 또는 SiReRf이고,In Formula 2-VIIIA-2, X 1 is CR c R d or SiR e R f ,
    화학식 2-ⅤⅢA-2의 X2는 O 또는 S이고,X 2 of Formula 2-VIIIA-2 is O or S,
    화학식 2-ⅤⅢA-2의 n5는 1 내지 3의 정수 중 하나이고,n5 in Formula 2-VIIIA-2 is one of integers from 1 to 3,
    Rb, Rc, Rd, Re 및 Rf는 각각 독립적으로 치환 또는 비치환된 C1 내지 C30 알킬기, 또는 치환 또는 비치환된 C6 내지 C30 아릴기이다.R b , R c , R d , R e and R f are each independently a substituted or unsubstituted C1 to C30 alkyl group, or a substituted or unsubstituted C6 to C30 aryl group.
  12. 서로 마주하는 양극과 음극,positive and negative poles facing each other,
    상기 양극과 상기 음극 사이에 위치하는 적어도 1층의 유기층을 포함하고,At least one organic layer positioned between the anode and the cathode,
    상기 유기층은 발광층을 포함하며,The organic layer includes a light emitting layer,
    상기 발광층은 제1항 내지 제6항 중 어느 한 항에 따른 유기 광전자 소자용 화합물; 또는 제7항 내지 제11항 중 어느 한 항에 따른 유기 광전자 소자용 조성물을 포함하는 유기 광전자 소자.The light emitting layer is a compound for an organic optoelectronic device according to any one of claims 1 to 6; Or an organic optoelectronic device comprising the composition for an organic optoelectronic device according to any one of claims 7 to 11.
  13. 제12항에 있어서,13. The method of claim 12,
    상기 유기 광전자 소자용 화합물, 또는 유기 광전자 소자용 조성물은 상기 발광층의 호스트로서 포함되는 유기 광전자 소자.The compound for an organic optoelectronic device or the composition for an organic optoelectronic device is an organic optoelectronic device included as a host of the light emitting layer.
  14. 제12항에 따른 유기 광전자 소자를 포함하는 표시 장치.A display device comprising the organic optoelectronic device according to claim 12 .
PCT/KR2022/005689 2021-04-23 2022-04-21 Compound for organic optoelectronic element, composition for organic optoelectronic element including same, organic optoelectronic element, and display device WO2022225340A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202280030104.XA CN117203190A (en) 2021-04-23 2022-04-21 Compound for organic optoelectronic element, composition for organic optoelectronic element comprising same, organic optoelectronic element, and display device

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
KR10-2021-0053170 2021-04-23
KR20210053170 2021-04-23
KR10-2022-0048304 2022-04-19
KR1020220048304A KR20220146332A (en) 2021-04-23 2022-04-19 Compound for organic optoelectronic device, composition for organic optoelectronic device, organic optoelectronic device and display device

Publications (1)

Publication Number Publication Date
WO2022225340A1 true WO2022225340A1 (en) 2022-10-27

Family

ID=83723018

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/KR2022/005689 WO2022225340A1 (en) 2021-04-23 2022-04-21 Compound for organic optoelectronic element, composition for organic optoelectronic element including same, organic optoelectronic element, and display device

Country Status (1)

Country Link
WO (1) WO2022225340A1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2023219337A1 (en) * 2022-05-11 2023-11-16 주식회사 엘지화학 Novel compound and organic light-emitting device comprising same

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20110119726A (en) * 2009-01-23 2011-11-02 메르크 파텐트 게엠베하 Materials for organic electroluminescence devices
KR20160046076A (en) * 2014-10-17 2016-04-28 삼성디스플레이 주식회사 Organic light-emitting device
KR20170033482A (en) * 2015-09-16 2017-03-27 삼성디스플레이 주식회사 Compound and Organic light emitting device comprising same
US20170244044A1 (en) * 2016-02-18 2017-08-24 Idemitsu Kosan Co., Ltd. Organic electroluminescent element and electronic device
KR20190010774A (en) * 2017-07-20 2019-01-31 삼성디스플레이 주식회사 Organic light emitting device

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20110119726A (en) * 2009-01-23 2011-11-02 메르크 파텐트 게엠베하 Materials for organic electroluminescence devices
KR20160046076A (en) * 2014-10-17 2016-04-28 삼성디스플레이 주식회사 Organic light-emitting device
KR20170033482A (en) * 2015-09-16 2017-03-27 삼성디스플레이 주식회사 Compound and Organic light emitting device comprising same
US20170244044A1 (en) * 2016-02-18 2017-08-24 Idemitsu Kosan Co., Ltd. Organic electroluminescent element and electronic device
KR20190010774A (en) * 2017-07-20 2019-01-31 삼성디스플레이 주식회사 Organic light emitting device

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2023219337A1 (en) * 2022-05-11 2023-11-16 주식회사 엘지화학 Novel compound and organic light-emitting device comprising same
EP4345099A4 (en) * 2022-05-11 2024-11-06 Lg Chemical Ltd Novel compound and organic light-emitting device comprising same

Similar Documents

Publication Publication Date Title
WO2019151682A1 (en) Compound for organic electric device, organic electric device using same, and electronic device thereof
WO2013105747A1 (en) Compound for organic electronic element, organic electronic element using same and electronic device thereof
WO2013081315A1 (en) Compound for organic electronic device, organic electronic device comprising same and electronic device comprising the organic electronic device
WO2018093107A1 (en) Organic compound and organic electroluminescent element comprising same
WO2021182893A1 (en) Organic light emitting device
WO2021215669A1 (en) Organic optoelectronic element compound, organic optoelectronic element composition, organic optoelectronic element, and display device
WO2021230651A1 (en) Organic electronic element comprising compound for organic electronic element, and electronic device thereof
WO2019172623A1 (en) Compound for organic electric device, organic electric device using same, and electronic device thereof
WO2014027822A1 (en) Novel compound and organic electroluminescent device comprising same
WO2020159333A1 (en) Compound and organic light emitting device comprising same
WO2023003403A1 (en) Organic light-emitting device
WO2023287228A1 (en) Organic light emitting device
WO2020159337A1 (en) Compound and organic light emitting device comprising same
WO2022231322A1 (en) Organic light-emitting device
WO2020071720A1 (en) Compound for organic electronic element, organic electronic element using same, and electronic device thereof
WO2019212290A1 (en) Compound for organic electric element, organic electric element using same, and electronic device thereof
WO2022225340A1 (en) Compound for organic optoelectronic element, composition for organic optoelectronic element including same, organic optoelectronic element, and display device
WO2022039365A1 (en) Organic light-emitting device comprising organic compound
WO2022019536A1 (en) Compound and organic light-emitting device comprising same
WO2021230714A1 (en) Organic light-emitting element
WO2021177769A2 (en) Composition for organic optoelectronic element, organic optoelectronic element, and display device
WO2020159335A1 (en) Compound and organic light emitting diode comprising same
WO2020159340A1 (en) Compound and organic light emitting device comprising same
WO2020159336A1 (en) Compound and organic light-emitting device including same
WO2022131869A1 (en) Novel compound and organic light-emitting device comprising same

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 22792039

Country of ref document: EP

Kind code of ref document: A1

WWE Wipo information: entry into national phase

Ref document number: 202280030104.X

Country of ref document: CN

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 22792039

Country of ref document: EP

Kind code of ref document: A1